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SUMMARY 
The interface between tendon/ligament and bone tissue is a complex transition of 
biochemical, cellular, and mechanical properties. Investigating computational and tissue 
engineering models that imitate aspects of this interface may supply critical design 
parameters for designing future tissue replacements to promote increased biochemical 
and mechanical integration between tendon/ligament and bone. Strategies for modeling 
this tissue have typically focused on the development of heterogeneous structures to 
create gradients or multiphasic materials that mimic aspects of the transition. However, 
further work is required to elucidate the role of specific mechanical and material stimuli 
in recapitulating features of the tendon/ligament-bone insertion. In particular, in 
constructs that exhibit variation in both mechanical and biochemical properties, the 
interplay of mechanical, material, and chemical signals can complicate understanding of 
the particular factors at work in interface formation. Thus, the overall goal of this 
dissertation was to provide insight into the role of mechanical strain and scaffold 
degradability on cell behavior within heterogeneous biomaterials. 
 Specifically, a method for determining cell vertical position within a degradable 
gel through a laminated interface was developed. A computational model was created to 
examine possible variation in local mechanical strain due to heterogeneity in mechanical 
properties and different interface geometries. Finally, the influence of biomaterial 
degradability on changes in encapsulated human mesenchymal stem cell (MSC) 
morphology under response to cyclic mechanical strain was explored. Together, these 
studies provide insight into mechanical and material design considerations when devising 





Ligaments and tendons restrict joint motion and provide load transfer between 
other components of the musculoskeletal system (1). Thousands of people are treated 
each year for injuries to tendon and ligament tissue (2). Upon acute injury due to physical 
activity or degenerative tendinopathy, replacement tissues are physically secured via 
mechanical interference (3). However, general agreement exists that reproduction of the 
biochemical and cellular heterogeneity of the natural interface between tendon/ligament 
and bone would improve tissue integration (4). Many tissue engineering approaches have 
been employed to investigate the development of this interface, using heterogeneous 
constructs to model the transition (4). In such constructs, the inherent complexity in the 
design may limit understanding of the particular contributions of individual design 
elements, such as cell type or scaffold geometry (5). Thus, some recent studies have 
focused on using just one type of cell, such as fibroblasts or marrow stromal 
cells/mesenchymal stem cells (MSCs), to create heterogeneous tissues (6-8). In particular, 
MSCs are employed due to their relative ease of harvest and their ability to differentiate 
toward a tendon/ligament fibroblast phenotype through the use of mechanical strain (9). 
However, applying mechanical strain to a construct with differences in geometry and 
mechanical properties may introduce subsequent variability in local strain environments. 
Furthermore, the use of biomaterial scaffolds that offer additional biofunctionality, 
including cell adhesion and enzyme-sensitive degradation, can facilitate additional cell 
behaviors such as cell migration (10). However, the interplay between biomaterial 
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degradation and mechanical strain on cell behavior are not well understood. Therefore, 
controlled experiments that elucidate the effects of various material and mechanical 
considerations in construct design can provide fundamental insight into the rational 
design of future approaches for engineering the interface between tendon/ligament and 
bone. 
 
1.2 Research Objectives 
In order to build a model system of the ligament bone-interface, multi-layered 
constructs composed of enzyme-sensitive hydrogels were fabricated. However, in order 
to understand the system’s capabilities and limitations, it was first necessary to 
characterize the effect of enzyme degradability on encapsulated cell migration and 
response to strain.  Therefore, the objective of the research presented in this dissertation 
was to improve understanding of the roles of tensile strain and scaffold degradability on 
MSC behavior after encapsulation in these hydrogels. Specifically, enzymatically-
degradable biomaterials were used to facilitate determination of cell position within a 
multi-layer construct. A finite element model was developed to investigate the effects of 
stiffness mismatch and material geometry on local strain environments within a 
biomaterial. In addition, a model biomaterial with adjustable sensitivity to enzymatic 
degradation was utilized to explore the role of degradability in enabling changes in 
human MSC (hMSC) shape and its subsequent effects on hMSC response to cyclic 
tensile strain. The goal of these studies was to provide additional understanding of the 
role of mechanics and material degradability on the behavior of cells encapsulated in a 
homogeneous material for future applications in model systems featuring heterogeneous 
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materials. The central hypothesis was that culture of hMSCs in an enzymatically-
sensitive biomaterial scaffold would allow significant changes in cell morphology, thus 
enabling cell migration in three dimensions as well as enhancing response to tensile 
loading. This hypothesis was explored through two specific hypotheses and research aims. 
 
Hypothesis I: Culture of cells in a biomaterial environment rendered susceptible to 
enzymatic degradation will enable large-scale directed cell migration across a laminated 
interface. 
Specific Aim I: Evaluate the effect of including a protease-sensitive peptide sequence 
into the polymer backbone of PEG-based hydrogels on changes in bovine MSC and HT-
1080 fibrosarcoma cell migration through a laminated hydrogel at 7 days. 
 Cell migration has been previously implicated in the invasion and remodeling of 
damaged tissues and has been proposed as a useful tool for regenerating tissue interfaces. 
To explore migration in synthetic biomaterial models for tissue engineering, migration 
has been enabled by incorporating peptide sequences into the material backbone to 
facilitate cell adhesion and cell-directed degradation. Laminated synthetic hydrogels 
provide an opportunity to model the heterogeneity of interface tissues, but the nature and 
extent of cell migration across a laminate interface is unknown. Thus, a biomaterial and 
image analysis system was established to evaluate the effect of hydrogel degradability on 
possible cell migration in a multilayer hydrogel. Bovine MSCs and HT-1080 
fibrosarcoma cells were encapsulated in hydrogels either sensitive or insensitive to 
protease degradation, and then laminated to a second gel section. Cell positions within 
each multilayer hydrogel were evaluated at 7 days. As a first pass at evaluating 
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chemotactically induced migration, HT-1080s were also encapsulated in either non-
degradable or slow-degrading gels and laminated to a hydrogel layer originally 
polymerized in FBS. Cell positions were similarly evaluated at 7 days. 
 
Hypothesis II: PEG-based biomaterials with increased susceptibility to enzyme 
degradation will enable increased cell spreading in encapsulated MSCs, enhancing the 
effect of a uniform distribution of cyclic tensile strain on MSC upregulation of gene 
expression and ECM deposition. 
 
Hypothesis IIA: Applied cyclic tensile strain in a PEG-based hydrogel will result in 
uniform local strain fields across the hydrogel. In constructs with mechanical 
heterogeneity, local strain distribution can be modified through adjustments in interface 
geometry. 
Specific Aim IIA: Develop a finite element model to characterize the effects of interface 
geometry and disparities in material stiffness on local strain distributions throughout a 
PEG-based hydrogel. 
 Tensile strain has previously been used, in our laboratory and others, to encourage 
differentiation of MSCs towards a tendon/ligament fibroblast phenotype when 
encapsulated in hydrogel materials. However, macroscopically applied strain may result 
in a distribution of local strains within a hydrogel depending on the point of applied load, 
material geometry, and variations in stiffness in individual portions of the hydrogel. A 
finite element model was developed to simulate the effects of 10% strain on local 
principal strain distributions within a representative hydrogel cultured in a tensile culture 
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bioreactor. Additionally, the effect of interface geometry and mismatches in modulus on 
local strain distributions were evaluated. Testing of OPF/PEG-DA hydrogels at different 
strain rates was performed as a first pass at validating assumptions made in creating the 
model. 
 
Hypothesis IIB: PEG-based hydrogels with greater sensitivity to enzymatic degradation 
will encourage spreading as well as greater tendon/ligament fibroblast-related gene 
expression and matrix deposition in response to tensile culture strain by embedded human 
MSCs. 
Specific Aim IIB: Characterize changes in encapsulated MSC morphology due to 
incorporation of differentially protease-sensitive peptides into the backbone of PEG 
hydrogels, as well as subsequent MSC response to cyclic tensile strain over 14 days. 
 Tensile strain has been used to differentiate MSCs towards a tendon/ligament 
fibroblast phenotype and may be useful in guiding the formation of the tendon/ligament 
portion within a tendon/ligament-bone interface. Interestingly, in 2D, cell shape has been 
implicated in directing MSC differentiation based on changes in actin contractility. Two 
peptide sequences with differences in sensitivity to protease degradation were 
incorporated in synthetic PEG hydrogels to investigate whether increased matrix 
degradability would encourage changes in MSC shape. It was hypothesized that 
differences in degradability would also be significant when encapsulated MSCs were 
exposed to cyclic tensile strain. Changes in MSC morphology in PEG-based hydrogels 
were compared between the incorporation of slow-cleaving and fast-cleaving protease-
sensitive peptides into the PEG polymer backbone. Next, hMSCs were encapsulated in 
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slow- or fast-degrading PEG hydrogels and subjected to either static or cyclic strain (10%, 
1 Hz, 3h on, 3h off) through 14 days. Cell circularity and angle were calculated to 
quantify changes in cell shape and alignment, respectively. Gene expression levels and 
ECM production between all four groups (slow- and fast-cleaving gels, dynamically 
strained and statically cultured) were measured. These were used to determine whether 
stretched MSCs were affected by increased sensitivity to biomaterial degradation. 
 
1.3 Significance and Scientific Contributions 
 The studies in this dissertation provide critical insight into multiple aspects of 
modeling regeneration of the ligament-bone interface. The use of a synthetic biomaterial 
environment for these studies allowed adhesion sites and protease-sensitive degradation 
sites to be presented in a precise manner, permitting the explicit control of certain 
behaviors such as cell spreading. Developing techniques for characterizing 3D cell 
position in a laminated hydrogel enables monitoring of mass cell migration in the 
remodeling of degradable, multi-layer tissue engineering constructs. Finite element 
modeling provided specific information regarding the theoretical extent and distribution 
of differences in local strain within hydrogel materials used in experimental studies, as 
well as crucial insight into the distribution of strain in future designs of heterogeneous 
scaffolds with variations in geometry and stiffness. The coupling of gel degradation and 
changes in MSC morphology with cyclic tensile strain provided additional understanding 
regarding aspects of the biomaterial interface that are necessary for encouraging 
tendon/ligament differentiation. These results provide useful information on future 
parameters for the design of tissue engineering strategies for regenerating the interface 
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between tendon/ligament and bone. 
 The exploration of degradable synthetic biomaterials has applications that extend 
to other aspects of tendon/ligament tissue engineering and tissue engineering in general. 
From a technical perspective, in addition to enabling changes in cell morphology within 
synthetic scaffolds, employing enzymatically-degradable PEG-based hydrogels as cell 
carriers permits complete degradation and recovery of cells after encapsulation, enabling 
subsequent analysis or other use. Experiments studying cell migration can utilize 
differentially enzyme-sensitive biomaterials in complex configurations to examine how 
biomaterials and tissues are infiltrated and remodeled by cells over time. In a different 
paradigm for tissue repair, biomaterials can be used as cell carriers for imparting a variety 
of stimuli to cells, to ‘prime’ cells towards a desired phenotype prior to recovery and in 
vivo therapeutic use. As such, results from this thesis increase understanding of the 
effects of biomaterial degradation on cell behavior. These findings may have significant 
impact not just on design parameters for interface tissue engineering, but on new 







BACKGROUND AND LITERATURE REVIEW1 
 
2.1 Tendon/Ligament and Its Insertion Into Bone 
2.1.1 Tendon/Ligament Function, Structure and Composition 
Tendons and ligaments are responsible for linking the musculoskeletal system; 
tendons transfer mechanical loads between muscles and bones, while ligaments bind bone 
to bone to restrict their motion (1). In the knee, ligaments play a particularly important 
role; being an inherently unstable joint, the knee relies on ligaments such as the anterior 
cruciate ligament (ACL) and the medial collateral ligament (MCL) to restrict 
tibiofemoral motion and maintain joint stability (1, 11). Tendons and ligaments function 
primarily in tension and exhibit similar cellular and biological composition (1, 12). 
Tendon and ligament are approximately 60% water and 40% cells and matrix-
related macromolecules (11, 13). The dominant cell type in tendon and ligament is the 
fibroblast; they are spindle-shaped and aligned longitudinally with the tissue (11). 
Biochemically, the main components of tendon and ligament tissue include collagens 
type I (90-95% of total collagen) and III (5-10%), with elastin (2%), glycoproteins and 
various proteoglycans (1-3%) composing the remaining dry weight (1, 11, 14). The 
aligned organization of collagen fibers gives tendon and ligament its characteristic 
hierarchical structure. Electron microscopy has shown that collagen fibers in tendon and 
ligament display a wavy crimp structure without load (1, 11). Collagen molecules 
assemble to form microfibrils (4 nm diameter), which further aggregate to form subfibrils 
(20 nm) and fibrils (50-500 nm). Collagen fibrils are organized along with fibroblasts to 
                                                
1 Portions of this chapter were adapted from Yang PJ, Temenoff JS. Engineering orthopedic tissue 
interfaces. Tissue Eng Part B Rev. 2009 Jun;15(2):127–141. 
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form fascicles. Finally, multiple fascicles form a whole tendon or ligament. (1, 11, 14). 
Mechanically, the crimp structure of collagen fibers in tendon and ligament permits small 
deformations without actual tissue tension and can be seen in the stress-strain curve of 
tendon/ligament tissue, which displays a toe region at low deformations (13). When 
under deformation, the alignment of individual collagen fibers gives tendons/ligament its 
extremely high tensile strength (1). 
The most dominant proteoglycan is decorin, thought to facilitate tendon fibril 
deformation by ensuring consistent fibril formation (14), but other proteoglycans can be 
found in minute amounts, including biglycan, fibromodulin, lumican, aggrecan, and 
versican (1, 15). Glycoproteins in tendon and ligament include tenascin-C; tenascin-C has 
been speculated to be an anti-adhesive or “inhibitory for spreading” molecule that allows 
cells to modify adhesion contacts to avoid overspreading during tissue mechanical strain 
(16). Tenascin-C is found to a greater degree in tendon and ligament than in other 




Figure 2.1. Diagram of direct insertion of tendon/ligament tissue into bone, 
depicting the four main areas of the transition (18). 
 
 
2.1.2 Insertion of Tendon/Ligament Into Bone 
At the interface, insertions of tendon or ligament into bone can be characterized as 
either direct or indirect (19). These types of insertions are also known as fibrous or 
fibrocartilaginous entheses (20). One example of a fibrous (indirect) insertion is the tibial 
insertion of the MCL (21). In fibrous insertions, a tendon or ligament attaches at acute 
angles to the bone through Sharpey’s fibers, collagen fibers that extend directly through 
to the bone. On the other hand, fibrocartilaginous entheses, or direct insertions, are also 
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found; one example is the femoral insertion of the MCL (21). Generally, this type of 
tendon/ligament-bone insertion is characterized by a transition zone of four general types 
of tissue. The first zone is fibrous connective tissue, generally similar to normal 
tendon/ligament. This tissue contains aligned collagen fibrils with fibroblasts embedded 
throughout the collagen matrix. The next zone is uncalcified fibrocartilage, in which 
collagen fibril bundles are larger and less parallel than in the first region. Type II collagen 
and aggrecan are found in this matrix. This zone is relatively avascular, with ovoid-
shaped, aligned cells. A flat tidemark has been found separating this zone and the next 
zone of calcified fibrocartilage (20). Calcified fibrocartilage contains hypertrophic, 
highly circular chondrocytes, with collagen X found only in this region (3). Between the 
calcified fibrocartilage and the fourth zone, bone, there is an interlocking region of tissue 
interdigitation, providing secure attachment between tissues (3, 20). Briefly, bone tissue 
contains osteoblasts, osteoclasts and osteocytes, with hydroxyapatite-mineralized 
collagen I fibers (1). Collagen type II is not present in bone (3). 
The mechanics of the interface involve two materials of vastly different 
mechanical properties; tendons and ligaments are very strong in tension, while bone is 
optimized for compressive loading (1, 14). Without a gradual transition in mechanical 
properties, as in indirect/fibrous insertions, stress concentrations may form at regions 
where two materials of significantly different mechanical properties are joined (3). 
However, in fibrocartilaginous (direct) insertions, uncalcified and calcified fibrocartilage 
tissues at the interface are superior in transferring compressive load, and the insertion site 
shows an increase in Young’s modulus across the transition (3, 22). Thus, 
fibrocartilaginous insertions provide the transitional zones of tissue to bridge the gap 
 12 
between the mechanical properties of ligament and bone (23).  
 
2.1.3 Tendinopathy, Pathology and Healing 
It is estimated that at least 200,000 people in the United States receive treatment 
for injuries to tendon or ligament tissue each year (2). Injuries to tendon/ligament tissue 
either arise from acute trauma or chronic disorders, with some interplay between intrinsic 
(tissue alignment and defects in biomechanics) and extrinsic (physical exercise) factors 
(24). While acute injuries can result in a large rupture or tearing of the tendon or ligament, 
chronic injury results in small microtrauma that, over time, can result in an acute rupture 
or tear (25, 26). These injuries are usually the product of excessive loading, leading to 
inflammation over time, or variable microstresses within the tissue, which can induce 
individual fiber damage (27). Even without tearing, however, chronically excessive 
loading can still result in inflammation (25). Because tendon and ligament are poorly 
vascularized and largely acellular tissues (11, 17), the result of an injury is typically an 
active but poor healing response, with granulation tissue, collagen fiber degeneration, 
increased cell concentration, and generally widespread inflammation (14, 25, 27). 
Repeated injury over time leads to chronic pain and further modulates cell activity due to 
cytokine release (28). 
Tendon and ligament repair in acute injuries can typically be described as three 
stages: the initial inflammatory response, increased cellularity and extracellular matrix 
deposition, followed by tissue remodeling (11, 25). In inflammation, serous fluid enters 
both damaged and surrounding tissues, and a hematoma is formed around the injury (26, 
29). Inflammatory cells are recruited to the area and begin breaking down and 
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phagocytosing the clot and other debris (25, 26). Following the inflammatory response, 
fibroblasts are recruited to the area and begin producing a provisional matrix to bridge the 
injury (21). This matrix consists of a higher ratio of collagen III to collagen I, and 
typically contains higher levels of glycosaminoglycans, DNA, water and fibronectin (11, 
21, 26). This provisional matrix is then remodeled by fibroblasts within the tissue, 
sometimes over years. This process is marked by both the conversion of collagen III to 
collagen I and a decrease in vascularity (19, 26, 27). 
 
2.1.4 Developments in Clinical Intervention for Acute Injuries to Tendon/Ligament 
The insertion of tendon/ligament tissue into bone is of particular concern in 
injuries; most tears occur not within the midsection of the tissue, but at its ends (11, 25). 
With regards to the anterior cruciate ligament (ACL) in the knee, its presence within an 
area of limited blood supply can affect the healing response (11). Most repairs of 
damaged ACL tissue involve the use of a ligament graft, in which the central third of the 
patellar ligament or the gracilis and semitendinosus (hamstring) tendons are used, with 
fairly similar outcomes regardless of the tissue used (18, 30-33). To perform the surgery, 
a bone tunnel is created and the tendon is affixed inside the tunnel with a metal fastener 
or degradable poly-L-lactic acid (PLLA) screw, the type of which can greatly affect graft 
success rates (34, 35). Depending on the patient, bone-ligament-bone transplants have 
also been performed (36).  
Results within the bone tunnel have largely been positive, with Sharpey’s fibers 
typically noted at the ligament-bone interface (37, 38). Clinical research strongly 
indicates, however, that restoration of a zonal insertion site, with regions of uncalcified 
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and calcified fibrocartilage, is the optimal outcome (39, 40). Multiple studies have 
emphasized the importance of good mechanical fixation; in early tests, reconstructed 
ACL grafts were found to fail at the fixation site upon mechanical testing (41, 42). This 
may be due to the lack of an insertion tissue region similar to what is found in normal 
tendon/ligament (43). With hamstring tendon grafts are used for ACL repair, poor bone 
tunnel integration has been shown to contribute to clinical outcomes that are less than 
ideal (44). Furthermore, when interference screws are used, the particular system used 
can contribute to graft laceration and early failure (45, 46). The limitations associated 
with graft fixation with poor bone integration can thus lead to increased graft failure and 
suboptimal clinical outcomes (3, 47). 
Thus, recent studies have begun to explore methods for recapitulating the 
interface in an in vivo setting. One study used recombinant bone morphogenetic protein-2 
(BMP-2) to induce ectopic bone formation in tendons, then transferred this structure to 
the surface of a bone to induce the formation of tendon-bone structures (48). A series of 
experiments from one laboratory have focused on various aspects of improving tendon-
bone healing; recent strategies include, for example, through blocking of TNF-α (49), a 
combination of calcium phosphate scaffolds and TGF-β3 to guide fibrocartilage 
formation (50), short-duration cyclic loading (51), and the overexpression of matrix 
metalloproteinases (MMPs) in stem cells to improve fibrocartilage formation and 
biomechanical strength (52). Similar use of demineralized bone matrix between tendon 
and bone facilitated increased amounts of fibrocartilage and mineralized fibrocartilage in 
a sheep model (53). The use of a synthetic sheet of polyglycolic acid (PGA) has also been 
tested in regenerating the insertion; however, mechanical properties were limited 
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compared to normal tendon (54).  
 
2.2 Tissue Engineering Tendon, Ligament and Its Interfaces 
2.2.1 Review of Current Work 
Engineering of tendon and ligament tissue, as well as the tendon/ligament-bone 
interface, requires strategies that ensure mechanical stability. Because the interface is 
crucial to proper repair, design constraints must also be applied based on the overall 
approach to insertion point regeneration; indeed, current work in interface engineering 
has focused on assisting graft anchorage (3). Although autografts (replacement tissue 
taken from the patient) and allografts (replacement tissue taken from a human cadaver 
source) are frequently used, the possibility of limited availability and donor site 
morbidity due to an immunogenic response are significant disadvantages (29, 55). 
Although many grafts have been developed using synthetic, non-degradable materials, 
they are not recommended as primary ACL replacements; in fact, many implanted 
synthetics end in failure due to fragmentation, fatigue and wear debris (29, 56). 
The goal of tissue engineering tendon and ligament tissue is to use a combination 
of cells, scaffolds and bioactive factors to recreate a replacement tissue. Silk, collagen 
and the poly-L-lactide family of synthetic polymers are the most widely explored 
scaffolds, while mesenchymal stem cells and tendon/ligament fibroblasts are typically 
chosen as cell sources (17, 29). It has been proposed that MSCs may be an optimal cell 
source due to their increased proliferation rates and increased collagen deposition (57). 
After the choice of a proper scaffold and cell source, additional growth factors can be 
added to either MSC or fibroblast-populated scaffolds to induce further ECM deposition, 
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such as TGF-ß, insulin growth factor-1 (IGF-1), platelet derived growth factor (PDGF) 
and bFGF (58). 
Because tendon/ligament tissue is primarily composed of collagen type I, collagen 
gels have been widely explored as scaffolds for engineering ligament tissue (17, 59). 
Although many studies report success with cell infiltration, tissue ingrowth and enhanced 
mechanical strength, most attempts do not generate matrices with mechanical properties 
similar to native tendon/ligament tissue (17, 60-65). Some studies, however, have 
produced scaffolds with mechanical properties similar to ligament. One experiment 
reported elastic moduli similar to native ligament tissue after 20 days in culture, with the 
presence of cells increasing construct peak stress (66).  
Thus, due to the overall issues with collagen gel mechanical strength, many 
researchers use fibers or hydrophobic scaffolds. One natural material that has been 
widely explored is silk; silk fibers can be woven into a rope-like structure and have been 
tailored to match the stiffness of normal tendon/ligament tissue without reduction of 
ultimate tensile strength (17, 67, 68). After seeding on these fibers, MSCs demonstrated 
proliferation and ECM secretion over 14 days in culture (68). Scaffolds using synthetic 
polymers, typically PLLA and PGA, have also been utilized in tendon/ligament tissue 
engineering (29, 69-74). Like silk, several studies have woven PLLA fibers into 3D 
braids (29, 70, 72, 74). The 3D braiding technique, along with the use of PLLA allows 
for close control of mechanical properties, pore sizes, degradation properties, and overall 
geometry; a single braid can contain both a porous intraarticular zone as well as less 
porous bony attachment zones to assist in the formation of an interface (72).  
Based on these scaffolds, one group has established multiphase matrices to 
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engineer the tendon/ligament-bone insertion point using scaffolds based on poly(lactic-
co-glycolic acid) (PLGA) and bioactive glass (5, 75-77). In these studies, three distinct 
scaffolding phases were formed – one for ligament, one for bone, and a fibrocartilage 
interface. A study with bovine fibroblasts and osteoblasts seeded on either side of the 
middle phase demonstrated cells migrating into the middle layer (78). A subsequent 
subcutaneous implantation study in athymic rats using a triculture of bovine fibroblasts, 
chondrocytes and osteoblasts revealed the development of a fibrocartilaginous layer, with 
collagen X observed between the fibroblast and chondrocyte layer; mineralization was 
confined to the osteoblast layer (5).  
Other experiments have also used innovative transfection strategies to create 
scaffolds with heterogeneous properties, with areas representing tendon/ligament and 
separate areas representing bone tissues. In one example, poly(L-lysine) was used in to 
spatially immobilize a Runx2 retrovirus onto a collagen scaffold. With Runx2 inducing 
osteogenesis in primary rat dermal fibroblasts, the scaffold developed a similar gradient 
of transcription factor expression and matrix deposition consistent with osteoblastic 
differentiation (6). Another approach used lentiviral and adenoviral transfection to 
express Smad8ca and bone morphogenetic protein-2 (BMP-2) in murine and human stem 
cells. Although the scaffold used was not pre-designed to create heterogeneous tissues, 
interface regions were spontaneously generated following in vivo implantation in mice 
(79). 
Finally, a number of other approaches have been employed towards forming 
tissue constructs that recapitulate multiple interfaces between ligament and bone, forming 
a single bone-ligament-bone construct. One approach used PEG hydrogels with 
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incorporated hydroxyapatite particles as anchors in a bone-ligament-bone construct; 
hydroxyapatite was shown to improve the attachment of a fibrin-based scaffold (80). A 
follow-up study used a calcium phosphate-based brushite cement as anchors for a fibrin 
scaffold seeded with embryonic chick tendon fibroblasts. Brushite showed marked 
improvement in anchoring the fibrin gel, and some evidence of a tidemark at the interface 
was shown (81). Finally, a recent scaffoldless approach has been used in a number of 
studies to engineer a bone-ligament-bone-like construct. In this strategy, bone marrow 
stromal cell (BMSC) monolayers spontaneously rolled up on laminin-coated surfaces. 
After culturing with osteogenic differentiation medium, “bone constructs” were pinned 
and cultured on a second monolayer of BMSCs cultured with ligament differentiation 
medium, that is, growth medium plus TGF-β (7). After spontaneous formation of bone-
ligament-bone-like constructs, these were used as replacement medial collateral 
ligaments (MCLs) in a rat model and allowed full recovery of knee function at 4 weeks. 
A recent followup study used similar constructs as ACL replacements in a sheep model, 
and found a functional enthesis, and increased mechanical properties reminiscent of 
native tissue after six months in vivo (8). 
These studies illustrate the potential of using various tissue engineering principles 
to create homogeneous and heterogeneous constructs that recapitulate various aspects of 
native tendon and ligament tissue, as well as their complex and zonally organized 
interfaces with bone tissue. 
 
2.2.2 Hydrogels in Orthopaedic Tissue Engineering 
Hydrogels have been used as model and applied scaffolds for orthopaedic tissue 
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engineering in general (82-88); as such, hydrogels have been increasingly used for tendon 
and ligament tissue engineering applications (59, 65, 89). By crosslinking polymer chains, 
scaffolds can then be formed and swelled in aqueous solution to form highly hydrated 
hydrogel network structures (90, 91). Cells can be homogenously encapsulated within 
hydrogels, allowing hydrogels to act as a cell carrier (92). Hydrogels have been formed 
from both natural and synthetic materials. Natural materials offer increased 
biocompatibility and bioactivity for encapsulated cells; however, the inherent complexity 
of a natural scaffold, along with such concerns as batch-to-batch variability and 
limitations on chemical modification are significant drawbacks (93). Synthetic materials 
can be precisely and uniformly engineered to exhibit specific chemical and mechanical 
properties; however, any bioactive functionality must be expressly included (94). 
However, this affords a particular advantage: by engineering bioactive moieties in a 
tailored fashion, one can study specific cell behaviors in a discrete and controlled 
approach. 
One such synthetic polymer that has been widely studied in tissue engineering is 
poly[ethylene glycol], or PEG; examples of PEG and its derivatives in orthopaedic tissue 
engineering include osteochondral interface tissue engineering (87), cartilage tissue 
engineering (95-97), and bone tissue engineering (98-100). PEG is widely studied due to 
its non-fouling properties (101), which enables PEG to be a “blank slate” upon which 
additional bioactive functionality can be specifically included in the hydrogel formulation. 
Furthermore, PEG can be modified with hydrolytically degradable fumarate groups to 
produce such polymers as oligo[poly(ethylene glycol)] fumarate (OPF) (102). OPF is 
cytocompatible (102, 103) and has been used extensively for bone, cartilage and tendon 
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tissue engineering (89, 104-108). To crosslink and form PEG-based hydrogels, PEG is 
usually chemically modified to include acrylate groups. The resulting PEG-diacrylate 
(PEG-DA) polymerizes with itself as well as OPF via free radical polymerization; 
polymerization occurs through a chain-growth mechanism that involves chain transfer of 
the radical to a free double bond on either the acrylate or fumarate groups (109). Radical 
initiators include the thermally responsive tandem ammonium persulfate (APS) and 
tetramethylethylenediamine (TEMED), as well as the photosensitive Irgacure 2959 (105, 
110-112). 
 
2.3 Considerations for Hydrogel-Based Tissue Engineering Models of Ligament 
 In the work presented in this dissertation, the use of synthetic hydrogels in a 
tensile culture bioreactor facilitated the detailed study of certain cell behaviors found in 
natural tissues. In this system, bioactive functionalities were presented in the 
microenvironment of a cell in a highly controlled manner to elucidate the role of each 
functionality – enzyme-directed degradation and mechanical strain – in certain cell 
behaviors which may be biologically relevant for regenerating the interface, including 
cell migration, changes in cell morphology, and gene expression/ECM deposition in 
response to the application of a specific tensile strain regimen. Aspects of the material 
and mechanical considerations in this model system are reviewed in the following 
sections. 
 
2.3.1 Biomaterial Modification 
2.3.1.1 Enabling Adhesion 
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In this work, PEG hydrogels were modified with additional bioactive moieties to 
elicit and facilitate several desired cell behaviors. One widely used bioactive peptide 
sequence that was included was the adhesion peptide RGD. RGD has been extensively 
characterized as an enabler of cell adhesion to formerly non-adhesive surfaces (113), and 
its dose-dependent effects have been investigated in a variety of orthopaedic tissue 
engineering studies (114-118). RGD has been implicated in ensuring encapsulated stem 
cell survival by preventing anoikis, or cell apoptosis due to lack of adhesion to its ECM 
(113, 119, 120). RGD enables cell adhesion through the protein family of integrins; 
integrins are transmembrane, heterodimeric receptors that bind a variety of extracellular 
matrix proteins (113). As one may surmise, a wide variety of extracellular matrix 
molecules display RGD sites, and RGD binds a wide variety of integrins, including the 
popularly studied αvβ3 and α5β1 integrins, in a dose-dependent manner (113). However, 
with regards to the α5β1 integrin, cytoskeletal force switches the integrin state to control 
binding of the PHSRN synergy site on fibronectin, providing increased mechanical 
strength to the bond (121, 122). Importantly, integrin expression in cells is dependent on 
many extracellular factors, including whether cells are cultured on 2D surfaces or in 3D 
matrices and whether the α5β1 synergy site is available for binding (123, 124). Following 
integrin activation and initial cell binding via integrin binding to extracellular ligands, 
focal complexes – mostly consisting of αvβ3 integrins – can cluster to form focal 
adhesions (125). Two groups of proteins, talins and kindlins, bind to β integrins and in 
turn connect them with the actin cytoskeleton (126). Thus, RGD can be included in PEG 
hydrogel systems to facilitate cytoskeletal involvement with its biomaterial environment 
via adhesive peptides. Linking of cells to its extracellular matrix also facilitates 
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mechanotransduction, or the sensing of mechanical aspects of the ECM (more below). 
 
2.3.1.2 Enabling Cell-Mediated Degradation 
Another bioactive functionality that has been studied in recent years has served to 
increase the degradability of hydrogels by including enzyme-sensitive peptide sequences 
in the backbone of a synthetic polymer. This functionality differs from previous efforts in 
enabling ester hydrolysis in previously non-degradable synthetic polymers, e.g. PEG and 
OPF (99, 102). Typically, natural ECM tissue is typically degraded via cell-secreted 
proteases, including matrix metalloproteinases (MMPs), which enable cell behaviors such 
as spreading within a 3D environment, migration and tissue invasion (10). Including 
enzyme-sensitive sequences enables cells to easily replace an implanted biomaterial with 
new tissue; indeed, a lack of degradability has been implicated in preventing full healing 
of tissue defects, due to the inability of cells to properly infiltrate the biomaterial (127-
129). MMPs are a family of zinc-dependent metalloproteinases that cleave a variety of 
extracellular matrix molecules; all MMPs share common motifs in their active sites and 
inactivating propeptides (130). There are several subclasses of MMPs, of which a few are 
mentioned here: the collagenases, including MMP-1, MMP-8 and MMP-13, which cleave 
collagen types I, II and III; gelatinases, including MMP-2 and MMP-9, which cleave 
collagen types I-V and XI as well as laminin and aggrecan core protein; and membrane-
bound MMPs (MT-MMPs) which can activate MMP-2 and degrade collagen types I, II 
and III (131, 132). 
Significant effort has been given to finding peptide sequences that allow for facile 
recapitulation of cell-mediated degradation and downstream behaviors in a synthetic 
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environment. One of the earliest efforts used a collagenase-sensitive peptide sequence, 
LGPA, taken from the α1(I) chain of collagen I, and incorporated it into a PEG hydrogel 
to enable degradation (133, 134). Importantly, PEG hydrogels formed with this sequence 
could be completely degraded via addition of exogenous bacterial collagenase (135). 
Another more frequently used peptide, GPQGIWGQ, was developed from a more 
thorough search of candidate collagenase-sensitive peptide sequences (136), and has been 
widely used to study cell-mediated migration, tissue remodeling, and applications for 
bone or cardiovascular tissue engineering (98, 137, 138). More recently, a candidate 
peptide sequence, VPMSMRGG, was developed from a randomized dodecapeptide 
library with high cleavage sensitivity to MMP-1, MMP-2 and MMP-9 (139, 140). Each 
successive investigation has yielded peptides that are far more sensitive than original 
sequences, and offer increased degradation and desired cell responses in a smaller time 
frame (140). Other peptides have been developed for sensitivity to other enzymes such as 
plasmin (141). The use of cleavable peptides that are differentially sensitive to the same 
family of proteases can create contrasts in cell behavior based on the degradability of a 
particular sequence. 
 
2.3.1.3 Encouraging Migration Within Biomaterials 
Concomitant to the idea that biomaterial degradability encourages tissue 
remodeling is the concept of cell migration and invasion into the tissue as part of the 
remodeling process (142). Two aspects of tissue engineering design factor into migration: 
first, chemical or physical signals that may induce cells to migrate; and second, how 
biomaterials may be designed to encourage or discourage migration.  
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Many factors can induce cells to migrate; in one study, protease-digested 
fragments from a bone marrow stromal cell-seeded collagen matrix chemotactically 
induced cell migration in a transwell assay, suggesting that musculoskeletal matrix 
remodeling may in itself induce stem cell migration (143). Other factors implicated to 
cause stem cells to migrate include oxidative stress; soluble factors, including serum, 
platelet-derived growth factor (PDGF) AB and BB, and insulin-like growth factor 1; 
other soluble cytokines such as macrophage migration inhibitory factor and TGF-β1; and 
cocultures with other cell types, ostensibly through the release of chemotactic factors 
(144-153). With regards to other non-soluble signals, durotaxis, or migration in response 
to mechanical gradients (154-156) and haptotaxis, or migration in response to 
immobilized signals (157) have also been demonstrated. 
Once the appropriate signal to migrate has been provided, multiple factors can 
affect the extent and form of cell migration, including matrix stiffness and biomaterial 
MMP sensitivity (158, 159). Several studies have demonstrated αvβ3 integrin-linked cell 
surface localization of MMP-2, assisting in cellular invasion (160, 161). The presence of 
adhesion peptides within the biomaterial matrix, such as RGD, also appears to be 
necessary for cells to spread and migrate (162, 163). In 2D and 3D, migration has been 
shown to be biphasically dependent on the concentration of adhesion ligands; low 
concentrations prevent generation of force necessary to migrate, high concentrations 
prevent cells from breaking adhesions to move forward, and intermediate concentrations 
provide a balance of both (134, 164). However, in 3D, steric hindrance and stiffness of 
the matrix were computationally modeled to interfere with migration (164). This 
computational model has been verified in several studies. Maximum migration was found 
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in gels of the lowest stiffness (165) and is also dependent on high levels of proteolytic 
degradation to migrate through small mesh sizes such as mesh sizes of PEG gels (166-
168). Even with proteolytic degradation, depending on gel sensitivity to degradation, the 
matrix can still be a barrier for cell proliferation in 3D, depending on the nature of the 
matrix structure and its degree of crosslinking (169). 
 
2.3.2 Mechanical Stimuli 
2.3.2.1 Matrix Geometry and Stiffness 
When considering cell differentiation, a cell’s mechanical environment, including 
stiffness and geometry, have been shown to affect cell fate. In particular, extensive 
investigation has been performed concerning the effects of cell shape on various cell 
behaviors. An initial hallmark study investigated the effect of area and integrin 
attachment on cell growth and apoptosis; low areas promoted apoptosis and inhibited 
growth, while αvβ3 integrin binding appeared to promote cell survival (170). Using 
mesenchymal stem cells, which can differentiate into adipocyte and osteoblast lineages, a 
separate study demonstrated cell area regulated MSC adipogenic (small area) and 
osteogenic (large area) differentiation in identical mixed media. Upon further 
examination, it was shown that the ability to spread, described as cytoskeletal tension 
regulated by the GTPase RhoA, was the main driver of osteogenic vs. adipogenic 
differentiation (171). A recent, detailed investigation of cell shape features and MSC 
differentiation demonstrated that shapes or bioactive factors that enabled higher 
cytoskeletal tension, even given the same area, would result in increased osteogenic 
differentiation via a RhoA-driven mechanism (172). Along with geometry, matrix 
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stiffness can also influence stem cell differentiation. In a seminal paper by Engler et. al, a 
nonmuscle myosin II-driven mechanism was proposed to explain changes in MSC 
lineage direction based on matrix stiffness alone; with higher stiffness, MSC focal 
adhesions increased (173). This has been applied in orthopaedic tissue engineering 
applications; one recent study used a combinatorial approach to test a range of PEG 
hydrogel stiffnesses in inducing osteoblast differentiation, as well as demonstrate the 
feasibility of creating hydrogels with a seamless transition of mechanical properties  
(174). Interestingly, the influence of initial cell shape on subsequent cell response to 
mechanical strain has not been previously measured. Studies establishing differences in 
cell shape prior to mechanical strain in 2D and 3D would provide additional information 
regarding the influence of cytoskeletal organization on response to inducers of 
differentiation such as strain. 
 
2.3.2.2 Mechanical Strain 
Along with passive mechanical factors, active strain is frequently employed to 
control stem cell behavior for tissue engineering bone (175), cartilage (176, 177), and 
especially tendon/ligament (9, 65, 89, 178). Through the use of cyclic mechanical strain, 
markers of tendon and ligament tissue – collagen I, collagen III and tenascin-C, for 
example – have been upregulated in cells encapsulated in either natural or synthetic 
materials (9, 65, 89). While a variety of strain protocols have been employed, a 
commonly used protocol is 10% strain at 1 Hz (65, 179-182); specifically, a loading 
protocol of 10% strain at 1 Hz, with 3 hours of active loading and 3 hours of 0% strain, 
was shown to upregulate expression of collagen I in MSCs encapsulated within a fibrin 
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construct (183). In our laboratory, tensile culture has been employed to upregulate genes 
and ECM deposition associated with tendon/ligament fibroblasts, including collagen I, 
collagen III and tenascin-C (89). 
Mechanical strain is thought to induce changes in encapsulated cells via 
mechanotransduction events through integrin binding and changes in cytoskeletal 
organization. Using NIH 3T3 cells, one set of experiments showed that mechanical strain 
was found to activate αvβ3 integrin and increase binding to ECM proteins (184). In one 
study investigating integrin expression and binding in cells derived from ligament tissue, 
7% uniaxial strain was found to upregulate collagen I gene expression (185). Upon 
further investigation, strain was found to increase αv expression, and collagen I gene 
expression was dependent on αvβ3 integrin binding. Integrin binding has been linked to 
various intracellular pathways including FAK and RhoA/ROCK signaling, which in turn 
can mediate stretch-induced differentiation of hMSCs (186-188). Thus, integrin binding 
in PEG-based hydrogels, facilitated through the inclusion of RGD, is a pathway for 
applied mechanical strain to induce changes in gene expression in encapsulated cells.  
 
2.3.3 Co-culture and Laminated Hydrogels 
Due to the zonal nature of the tendon/ligament-bone interface, and because of the 
widely varying cellular, biochemical and mechanical characteristics within the tissue, a 
variety of approaches have been employed to engineer the interface (4). As previously 
mentioned, multiphase scaffolds have been employed; however, an important aspect of 
interface tissue design has been the use of multiple cell types. In a 2D coculture study of 
fibroblasts and osteoblasts, markers reflective of fibrocartilaginous tissue, such as 
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collagen type II and aggrecan, were detected following 21 days of culture (189). In a 
study using a compound 3D scaffold with three different regions, co-cultures of 
fibroblasts and osteoblasts resulted in a collagen I matrix being deposited throughout the 
ligament and interface portions of the scaffold, with detectable mineralization in the 
osteoblast compartment (78). Moreover, a triculture of fibroblasts, chondrocytes and 
osteoblasts in a similar multiphasic system resulted in a collagen II and proteoglycan rich 
region between the fibroblast and chondrocyte layers (5).  
Co-culture may also be enabled in hydrogel materials by laminating sections 
together during polymerization; this has been demonstrated in OPF and PEG-DA 
hydrogels using a thermally-based free radical initiator, with no reduction in the 
mechanical properties of the interface (104). Subsequent studies have employed 
photoresponsive radical initiators and microfluidic systems to generate patterning of 
multiple cell types (190). Laminated hydrogels have been frequently explored in 
orthopaedic tissue engineering, mostly as strategies for generating osteochondral 
scaffolds. In one in vivo study, MSCs differentiated with either osteogenic or 
chondrogenic medium were seeded into either end of a laminated hydrogel, created 
through sequential photopolymerization. Following 12 weeks of implantation, histology 
identified stratified layers of cartilaginous and osseous tissues, with infiltration between 
tissues (87). Another study used multilayer constructs to link chondrocytes extracted 
from superficial and deep zones of cartilage in proximity to recreate the zonal 
organization of articular cartilage (191). Recently, multilayer scaffolds have also been 
used to encapsulate MSCs for osteochondral regeneration (192); in two recent studies, 
biochemical composition of photopolymerized scaffolds was shown to direct a single 
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MSC population to differentiate into the superficial, transitional, and deep zones of 
articular cartilage, both as separately designed scaffolds and as one multi-layer hydrogel 
(193, 194). 
Such laminates afford the capability to investigate paracrine signaling between 
multiple cell types, detecting changes in markers of differentiation in one cell type due to 
soluble signals from another cell type in proximity. Understanding these fundamental 
relationships between cell types in 3D co-culture can improve efforts to generate 





METHOD FOR DETERMINING CELL VERTICAL POSITION IN 
LAMINATED PEG-BASED HYDROGELS 
3.1 Introduction 
In tendon and ligament tissue engineering, one of the critical goals in modeling 
the tissue environment and fabricating replacement biomaterial constructs for therapeutic 
use is engineering the interface between tendon/ligament and bone (3, 4). The interface is 
composed of heterogeneous regions of tissue, transitioning from a highly fibrous and 
aligned collagen matrix, through regions of cartilaginous and calcified cartilaginous 
tissue, to highly calcified bone (18). Interfaces between tendon/ligament and bone have 
been studied using a variety of tissue engineering strategies that can often involve 
constructs with controlled heterogeneity. This includes the formation of multiphase 
matrices (5), single hydrogels with gradients of differentiated osteoblasts (6), and 
scaffoldless approaches using monolayers that are directed to spontaneously form bone-
ligament-bone-like structures (7, 8). 
In heterogeneous structures, cell migration has been implicated in construct 
regeneration. In one study, 3D triphasic matrices were used to coculture fibroblasts and 
osteoblasts on separate sides, with a cell-free layer in the middle. Following 5 weeks of 
culture, cells had migrated into the middle region, with increased matrix production and 
vascularization in the previously cell-free layer (78). Directed migration on and within 
materials has been attributed to haptotaxis (157) as well as chemotaxis; that is, soluble 
gradients of chemotactic factors that induce cells to migrate. Such soluble factors may be 
generated by different cell types when in coculture. For example, MSCs have been also 
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shown to migrate in a distance-dependent manner when co-cultured with endothelial cells 
in a microfluidic-patterned scaffold (148). Chemotactic factors may thus encourage cells 
to migrate as part of tissue repair. 
Biomaterial model systems enable simultaneous examination of migration within 
a material as well as the formation of multi-layer materials. This laboratory has explored 
the use of poly(ethylene glycol) (PEG), a synthetic polymer that can be thermally- or 
photo-crosslinked to form a hydrogel that provides a “blank slate” for providing bioactive 
functionalities to cells (195). Cell migration has been employed in PEG hydrogels to 
study neural stem cell-ECM interactions (196, 197), angiogenesis (138, 198, 199), and 
bone defect repair (98, 127). In natural polymers such as collagen, cell migration is 
facilitated via larger pore sizes and the fibrillar structure of the material (167). However, 
proteolytic activity in PEG gels is necessary to allow migration in 3D due to a small pore 
size that restricts movement (165) by the integration of protease-sensitive peptides (133, 
134). By also including adhesion sites, which are necessary for cell spreading and 
migration, synthetic hydrogels can enable study of cell migration (10, 140, 163, 200); 
controlled spatial patterning of adhesive ligands to direct cell movement within 
enzymatically sensitive gels has been previously investigated (201, 202). 
In addition to enabling migration within homogeneous scaffolds, PEG-based gels 
have also been used to form laminated structures, where the initial layer is only partially 
crosslinked before another layer is added and crosslinked into the first (104). Laminated 
hydrogels have been used for a variety of orthopaedic tissue engineering applications, 
mostly with applications towards cartilage and osteochondral interface tissue 
regeneration (87, 191, 192, 194). Depending on the crosslinking time of the first layer, 
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addition of the second layer causes intermixing of both layers; thus, the thickness of the 
interface between two hydrogel layers can be manipulated (191). While many aspects of 
the laminate interface have not been studied, it is posited that, due to interpenetration of 
the second layer with an already polymerized hydrogel, that the interface likely exhibits a 
smaller mesh size than either of the two adjoining layers. A smaller mesh size would 
limit diffusion (203, 204) and cell movement through an interface would require 
additional proteolytic degradation to create pore sizes large enough for cell movement 
(168). The customizability of PEG gels allow these parameters to be studied in close 
detail. 
To investigate aspects of the interface, PEG gels offer a controlled system with 
which enzyme sensitivity and other gel parameters can be closely studied as it relates to 
migration through multiphasic structures to model interface development. However, no 
techniques currently exist for monitoring the position of cells over time in with regard to 
their 3D movement through a multi-layer material; systems to track 3D cell migration 
either employ radial migration from a fibrin clot, in which migration is random and 
undirected; or individual 3D cell tracking, which provides precise information about a 
single cell’s movement but cannot be performed on a large scale (205). Thus, the goal of 
this particular work was to develop a system for monitoring cell Z-position that could be 
employed towards tracking the large-scale migration of cells within a 3D laminated 
hydrogel structure for use in exploring interface tissue engineering. To do this, bovine 
MSCs and a highly migratory human fibrosarcoma cell line (HT-1080) were 
encapsulated within a single layer of a dual-layer PEG hydrogel and cell Z-position was 
determined at 1 and 7 days.  
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3.2 Methods 
3.2.1 Polymer synthesis 
OPF was synthesized as previously reported (102). Briefly, poly(ethylene glycol) 
(Mn = 10,000 Da; Sigma–Aldrich) was azeotropically distilled and subsequently 
dissolved in distilled methylene chloride (MeCl; Fisher) to produce a ~40% (v/v) solution. 
Distilled fumaryl chloride (FuCl, Sigma–Aldrich) and triethylamine (TEA; Sigma– 
Aldrich) in a molar ratio of 1 PEG:0.9 FuCl (2 TEA:1 FuCl) were slowly added dropwise 
to the PEG solution, and the reaction was held under nitrogen on ice. The OPF 
formulation was continuously stirred for 48–72 h at 25°C under nitrogen to ensure 
reaction completion. Next, excess methylene chloride was evaporated and the Cl–TEA 
salt was removed by filtration (Whatman). The OPF was recrystallized twice in ethyl 
acetate (Fisher) and washed three times in ethyl ether (Fisher). The resulting powder was 
vacuum dried at <5 mmHg and stored in a sealed container at -20 °C until further use. 
PEG-DA was also synthesized as previously reported (157). Briefly, 24 g PEG 
3.4K (Sigma-Aldrich) was dissolved in 60 mL distilled MeCl, then reacted at a 2:1 molar 
ratio with acryloyl chloride (AcCl, added dropwise, Sigma-Aldrich) and at a 1:1 molar 
ratio with TEA to create a 40% (w/v) solution under nitrogen overnight. Workup was 
performed by reaction with 2M K2CO3 (Fisher) at a 2:1 K2CO3:AcCl molar ratio and 
separation into aqueous and organic phases. This was followed by drying the solution 
with anhydrous MgSO4 (Fisher) and precipitating the polymer in ethyl ether (Fisher). 
Product was filtered, vacuum dried and frozen at -20ºC until use. 
PEG-DA (Mn 3770 ± 10, PI 1.1 ± 0.0), PEG 3.4K (Mn 3400 ± 30, PI 1.1 ± 0.0), 
OPF 10K (Mn 19,800 ± 100, PI 4.6 ± 0.1) and PEG 10K (MW 12,900 ± 200; PI 1.1 
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± 0.0) were characterized via gel permeation chromatography as previously reported 
(109). 
To create enzymatically-degradable PEG, the unmodified peptide Gly-Gly-Gly-
Leu-Gly-Pro-Ala-Gly-Gly-Lys (GGGLGPAGGK; Aapptec, Louisville, KY) was reacted 
with Acrl-PEG-succinimidyl valerate (Acrl-PEG-SVA, MW 3400; Laysan Bio, Arab, 
AL) at a 1:2.2 peptide:Acrl-PEG-SVA molar ratio in 50 mM NaHCO3 buffer (Fisher) at 
pH 8.5 for 3h. The resulting solution, Acrl-PEG-GGGLGPAGGK-PEG-Acrl 
(enzymatically-degradable PEG), was then dialyzed for two days and lyophilized to form 
the final product. Similarly, the peptide GRGDS (EMD Chemicals, Gibbstown, NJ) was 
reacted at a 1:2 molar ratio with Acrl-PEG-SVA, then dialyzed and lyophilized to 
synthesize Acrl-PEG-GRGDS (RGD). 
 
3.2.2 Cell sources 
Bovine marrow stromal cells (MSCs) were harvested via a previously described 
protocol (118). The femur and tibia of an immature calf were isolated (Research 87, 
Boylston, MA), and marrow was placed into low glucose DMEM containing 10% FBS, 
10 mL/L A/A, and 0.01% basic fibroblast growth factor (bFGF; PeproTech, Rocky Hill, 
NJ). The resulting tissue was then physically disrupted by repeatedly pipetting using 50 
and 10 mL pipettes, followed by 16, 18 and 20 gauge needles. After centrifugation, the 
fatty layer was removed and the mixture was plated for 30 min to allow rapidly adhering 
cells to adhere to tissue culture plastic. The remaining cells in solution were then 
expanded in T-150 tissue culture flasks until confluency, then placed in Dulbecco’s 
Modified Eagle Medium (DMEM; Mediatech) with 20% fetal bovine serum (FBS; 
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Hyclone, Thermo Fisher, Waltham, MA) and 10% DMSO and stored in liquid nitrogen 
until further use. HT-1080 cells (American Type Culture Collection; Manassas, VA) 
were cultured according to manufacturer’s guidelines in Eagle’s Modified Essential 
Medium (EMEM; Mediatech) augmented with 10% FBS, 10 mL/L A/A, 1 mM sodium 
pyruvate (Mediatech) and 1% non-essential amino acids (Mediatech). Before 
encapsulation, cells of either cell type were replated for 3 days in T-150 tissue culture 
flasks in their respective media to eliminate transitory effects from the thawing process. 
 
3.2.3 Hydrogel formulations 
In all experiments, total polymer was 10% of the initial total gel weight. Polymer 
formulations consisted of either enzymatically-degradable PEG or a mixture of 50% OPF 
10K and 50% PEG-DA by weight. Thus, a 0% enzymatically-degradable PEG hydrogel 
would consist of 50% OPF 10K, and 50% PEG-DA by weight. Acrl-PEG-GRGDS at 1 
µmol RGD/g swollen gel was added to facilitate cell adhesion. To distinguish one layer 
from another, 500 µM rhodamine methacrylate was added to enable visualization of the 
layer. After dissolving the polymer formulation in phosphate buffered saline (PBS; 
Invitrogen) and sterile filtering, 18 mM ammonium persulfate (APS; Sigma-Aldrich) and 
18 mM tetramethylenediamine (TEMED; Sigma-Aldrich) were used to thermally 
crosslink each gel for 10 min. Information regarding the investigation of hydrogel 
properties and degradation due to incorporation of enzymatically-degradable peptides 
into PEG hydrogels can be found in Appendix A; the enzymatically degradable peptide 
used in this study was the “slow-degrading” peptide characterized there. 
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3.2.4 Encapsulation and lamination 
To examine cell migration between two layers, hydrogel laminates were formed 
in 13-mm diameter, 1.5-mm deep two-stage Teflon molds (see Figure 3.1 for diagram). 
First, a polymer solution containing 500 µM rhodamine methacrylate (Sigma) was 
deposited into a Teflon well and, using a reverse mold, gels were created approximately 
400-500 µm thick. Following polymerization, a second layer was added on top of the first 
layer and allowed to polymerize. This created a heterogeneous hydrogel laminate that 
was approximately 1 mm thick overall. In layers with cells, either MSCs or HT-1080s 
were seeded at 20 x 106 cells/mL. The experimental groups were composed as follows: 
• Group A: top, bovine MSCs in 0% or 100% enzymatically-degradable PEG; 
bottom, 100% enzymatically-degradable PEG dissolved in PBS. 
• Group B: top, HT-1080 cells in 0% or 100% enzymatically-degradable PEG; 
bottom, 100% enzymatically-degradable PEG dissolved in PBS. 
• Group C: top, HT-1080 cells in 0% or 100% enzymatically-degradable PEG; 
bottom, 100% enzymatically-degradable PEG dissolved in serum. 
• Group D: top, cell-free 0% enzymatically-degradable PEG;  
bottom, HT-1080 cells in 0% enzymatically-degradable PEG, dissolved in PBS. 
Groups A and B were studied to explore the effects of enzymatically-degradable PEG 
and characterize changes in cell position between the two different cell types. Group C 
was included as a first pass at studying the effect of chemotactic factor diffusion on 
changes in cell position. Finally, Group D was included to determine the accuracy in 




Figure 3.1. Diagram of gel polymerization and experimental group setup. 
 
Following polymerization of both layers, constructs were flipped so the first layer 
was above the second one, and cultured in 12-well plates containing the appropriate 
medium for that cell type. At 1 day, gels were moved to 24-well plates and stainless steel 
annuli were placed on top of each gel to prevent gels from flipping over in each well. 
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Appropriate medium for each cell type was changed every 2-3 days thereafter. 
 
3.2.5. Cell position analysis 
 
 
Figure 3.2. Diagram depicting image analysis. 
 
At 1d and 7d after encapsulation, gels (n=3) were stained with 1 µM calcein AM 
(Invitrogen) for 1 h and imaged using confocal microscopy to evaluate cell migration 
through each construct. Three Z-stacks for each construct, with an interval of 10 µm, 
were taken through the entire detectable thickness of the hydrogel (Figure 3.2, 1) and 
subsequently processed using custom macros written in ImageJ. First, Z-stacks (900 x 
900 µm in the XY-plane) were resliced every 5 µm to create Y-stacks of images in the 
XZ-plane (Figure 3.2, 2-3). As gels were often not parallel to the imaging surface during 
imaging, the skew in the first and last image of each resliced stack was manually 
measured. A macro in ImageJ subsequently rotated each image in the resliced stack, 
reversing skew and translating the image to align the entire stack along the Z-direction 
(Figure 3.2, 4-5). Finally, images were compressed into a single XZ image using the 
maximum pixel intensity along the Y-axis for each pixel (Figure 3.2, 5), and green pixels 
(representing live cells) were binned every 50 µm according to their distance within and 
away from the cell layer. By measuring each individual image stack, the thickness of the 
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red hydrogel layer could be determined, and was used to calculate the percentage of 
green pixels that were computed to have a Z-distance beyond the red layer. 
 
3.2.7 Statistics 
Data are represented as mean ± standard deviation. Data were normalized with a 
Box-Cox transformation and were statistically compared using a three-factor ANOVA 
with Tukey’s HSD post-hoc test. The factors were encapsulation type (MSCs with PBS 
blank layer, HT-1080s with PBS blank layer, and HT-1080s with FBS blank layer), gel 
type, and day. 
 
3.3 Results 
3.3.1 Monitoring of cell position 
Cell encapsulation in a hydrogel with incorporated rhodamine methacrylate 
resulted in the visualization of green cells seeded within a red layer of hydrogel (Figure 
3.3). The average thickness of the cell layer across all gels was 470 ± 80 µm; there was 
no significant variation between gels of different formulations (data not shown). The 
tilted appearance of some imaged gels originates from a slight tilt in the gels themselves 
as they were imaged. Due to the lack of accurate resolution in the Z-direction, errant 
capture of light above and below the position of the actual cell distorted and stretched the 
vertical appearance of encapsulated cells.  Moreover, in some cases, considerable settling 
of cells led to cells being seeded far away from the lamination point. At both 1 and 7 days, 
few cells were visually observed beyond the end of the red hydrogel layer. This pattern 
was consistent across MSCs and HT-1080 cells, across seeding in 100% or 0% 
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enzymatically-degradable PEG gels, and across bottom layers polymerized in either FBS 
or PBS (Groups A, B and C). In laminated gels where cells were seeded in the bottom 
layer (Group D), both top and bottom layers were clearly demarcated by rhodamine and 




Figure 3.3. Confocal images (XZ-plane) of bovine MSCs and HT-1080 cells 
encapsulated in either 0% or 100% MMP-cleavable PEG hydrogels at 1 and 7 days. 
For Groups A, B, and C, only the first rhodamine labeled layer is shown; the rest of 
the gel was not visible. For Group D, both layers are visible. Experimental group 





3.3.2 Image analysis 
The normalized distributions of green within each hydrogel group at day 7 were 
plotted (Figure 3.4). Cells that were seeded in the bottom layer (Group D) were easily 
detected by image analysis; 99.6% of green was not in the red layer (data not shown). In 
Groups A and B, where the bottom layer was instead a cell-free layer that had been 
polymerized in PBS, the distribution of green pixels did not appear to vary, regardless of 
cell type or top layer gel type. However, when the bottom layer was polymerized in FBS 
instead (Group C), the distribution of green visually appeared to extend somewhat further 
than other formulations. At day 1, all Group C constructs displayed greater percentages 
of green beyond the cell layer than their Group A and Group B counterparts (Figure 3.5). 
Group B 0% constructs also displayed greater percentages than Group A 0% constructs. 
At day 7, the average percentage of green in Group C 0% gels was significantly greater 










Figure 3.4. Average distribution of green pixels through the hydrogel, starting from 
the top of the cell layer, at day 7 (n=3). HT-1080s seeded in bottom layer (Group D, 





Figure 3.5. Percentage of green pixels with a z-distance past the measured red 
hydrogel layer. * significantly different from MSCs in the same gel type. ¶ 
significantly different from HT-1080s of same gel type. † represents different from 




 In order to model and regenerate tissue interfaces, multiphasic hydrogels may be 
employed to separate cell types and mimic aspects of the transition. It is also believed 
that migration within constructs, possibly generated by chemotactic factors from 
cocultured cells, may be involved in regeneration of the interface. PEG-based systems 
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have employed MMP-sensitive peptides and adhesion peptides to facilitate cell spreading 
and migration within crosslinked scaffolds. To track possible migration in multi-layer 
materials, however, new techniques are required for monitoring cell movement in 3D. 
The goal of this particular study was to develop a method towards tracking large-scale 
cell movement in a multi-layer hydrogel, using bovine MSC and HT-1080 fibrosarcoma 
cells as candidate cell types for encapsulation. 
The two-stage process used for encapsulating cells led to the formation of a two-
layer gel (Figure 3.3). Cells were seeded in a rhodamine-labeled layer composed of either 
0% or 100% enzymatically-degradable PEG, and were then laminated to a cell-free layer 
of 100% enzymatically-degradable PEG. Lamination generated a consistent delineation 
between layers; using seeded cells to represent a second layer, confocal imaging revealed 
a distinct lamination point between gel sections (Figure 3.4 bottom left). Cell movement 
beyond the red layer was thought to be indicative of migration across the laminated 
interface. However, cells settled as gels polymerized, leading to the inconsistent 
placement of most cells far away from the interface; observationally, this appeared to be 
more of an issue with 100% enzyme-degradable gels, as the prepolymer solution 
viscosity appeared to be lower relative to 0% enzyme-degradable gels. Consequently, 
when combined with the significant thickness of the gel layer (around 470 µm), it was 
not even possible to identify cells that had moved within the cell layer but that had not 
moved across the interface. Settling also placed most cells hundreds of microns away 
from the point of lamination, requiring most cells to migrate substantial distances before 
capturing with this analysis. Future work, however, could exploit cell settling to move 
cells closer to the interface; additionally, reducing the thickness of a cell-seeded layer in 
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future work would reduce the distance required to migrate towards the point of 
lamination.  
Confocal imaging provided information regarding the 3D position of cells within 
a gel; in addition to XY-positions, repeated XY imaging through the thickness of a 
construct provided crucial Z-position information. However, there were limitations 
associated with imaging that somewhat restricted the utility of this information. Tilting of 
gels could not be controlled during imaging, and subsequently distorted the precise 
coordinates of cells within the gel. To compensate, resliced image stacks were manually 
measured and rotated/translated to account for image skew. Following correction of 
manual tilt, representative 2D images were projected from each resliced stack, using 
green pixel data to represent the presence of cells. Compared to the data available in a 
normal image stack, one dimension (Y) was lost to retain XZ data of cells. The influence 
of multiple cells in the XZ plane aligned along the same Y-coordinate was lost in the 
summation; this is reflected in the scattered nature of images in Figure 3.3. Additionally, 
given the fundamental limitations of standard confocal microscopy, cells were distorted 
in the Z-direction due to light above and below the cell that was captured during imaging. 
Finally, the thickness of the gels (~1000 µm) at times prevented practical imaging 
through the complete thickness of the gel, weakening the reliability of Z-distance data at 
the edges of the hydrogel. 
However, despite these limitations, cells seeded in the bottom layer could still be 
easily identified (Figure 3.3 bottom left, Figure 3.4 bottom), demonstrating the general 
accuracy of this type of image analysis. When compared to other work, this analysis 
technique compares favorably in terms of data collected. (205). In radial migration and 
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other coculture studies, although cells are technically seeded in a 3D gel, 2D migration is 
what was actually measured (98, 140, 142, 148, 167, 201). In studies that track individual 
cell migration, 3D movement is captured and measured via confocal microscopy, but 
tracking has not been scaled to large-scale monitoring of directed cell movement (137, 
200, 206). Finally, in transwell studies, information regarding cell migration is binary, 
with little knowledge regarding distance, and migration can be affected by other factors, 
such as pore sizes in the transwell insert and adherence to the filter membranes (134, 205, 
207). Using the analysis technique developed here, data along one dimension was lost in 
favor of measuring cell position along the Z-axis, something that has not been previously 
done on a large scale. In future work, however, enhanced imaging techniques, such as 
two-photon confocal microscopy, could determine cell Z-positions more accurately. It 
would then be quite feasible to discard potentially ambiguous pixel data in favor of using 
thresholding and particle analysis, linking between multiple images, to enable the 
determination of individual cell X, Y, and Z coordinates within a material. Coupled with 
live cell imaging, cell tracking of large numbers of cells could combine the current large-
scale analysis of XY-data with the finesse of individual cell tracking in 3D. 
Overall, few cells were observed beyond the red layer in microscopy images. 
However, a percentage of HT-1080s encapsulated in gels and laminated to blank gel 
layers polymerized in serum appeared to reside beyond the blank layer as determined by 
image analysis (Figures 3.4, 3.5). Serum contains multiple chemotactic factors, and 
human MSCs migrate in response to serum (153). HT-1080 cells have been shown to 
migrate over great distances in response to certain chemotactic factors. In one experiment, 
HT-1080 cells migrated 700 µm over 48 hours in 3D collagen gels in response to 
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lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) (208). However, studies 
to validate HT-1080 chemotaxis in serum were not performed in this study, and random 
cell motility was not verified prior to use. Moreover, serum was not explicitly retained in 
the gel during polymerization, and would have likely diffused from the matrix during and 
after swelling. Thus, any effects would only be observed over short periods of time. 
Although the distribution of green in these laminated gels appeared to extend beyond the 
original cell layer, this conclusion is, again, severely limited by the previously discussed 
microscopy limitations. Future efforts could use hydrogel layers modified to release 
specific chemical factors over a specified time period to observe long-term migration 
(204). Such a system would also have to restrict physical diffusion of chemotactic factors 
outside of the hydrogel scaffold, to ensure the formation of a chemical gradient. 
One limitation throughout this study was the use of an enzymatically-degradable 
peptide sequence that was hypothesized to be cleavable by MMPs with specificity for 
collagen type I (133). Specific cleavage kinetics of this sequence using different MMPs 
and other enzymes have not been determined. However, since the development of this 
sequence, other peptide sequences have been developed with extremely high sensitivity 
for MMP-1 and MMP-2 (139, 140). The types of MMPs secreted by bovine MSCs and 
HT-1080s were not characterized in this study; however, HT-1080s have been shown to 
express abundant MMP-1 and MMP-2 (209). The use of peptides highly sensitive to 
proteases secreted by encapsulated cells are required to enable sufficient degradation of 
the matrix to allow migration over time (165). At the time that this study was performed, 
however, sequences with greatly increased susceptibility to protease degradation were not 
available. Future work could utilize faster-degrading sequences, for example, the fast-
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degrading sequence GGVPMSMRGGGK that was investigated in Appendix A and 
Chapter 5. 
Large-scale migration of cells was investigated in this study as part of possible 
cell infiltration through the interface of a synthetic, protease-sensitive construct. 
Significant cell infiltration and remodeling of MMP-sensitive PEG hydrogels has been 
previously demonstrated in a rat cranial model; however, the time scale of such 
remodeling was five weeks, significantly longer than this 7-day study (98). Nevertheless, 
migration through laminated PEG gels has not been previously demonstrated. Limited 
work has been done to characterize the nature of the interface as it pertains to 
crosslinking time (191); however, the mesh size and permeability of such an interface has 
not been investigated. To laminate a second layer, the prepolymer solution must 
interpenetrate and entangle with the first layer of gel as it polymerizes. Consequently, it is 
expected that average mesh size in the interface would be reduced, limiting diffusion and 
thus the movement of chemotactic factors (203, 210). A decreased mesh size would also 
further restrict migration through the interface given the increased number of sites to 
proteolytically cleave. Thus, it may be that the interface itself will not function as the 
primary gateway for soluble factor diffusion; diffusion into surrounding medium may be 
just as or more relevant. Future models of migration could act to encourage directionally 
persistent cell migration through generation of directed chemotactic gradients and 
construct environments that facilitate movement in a single direction, such as an aligned 
biomaterial scaffold (211). In developing those models, use of the technique described 
here would provide significant insight into the 3D position of cells migrating within a 
multi-layer construct. Future refinement of this system would enable high-throughput cell 
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tracking through improved microscopy techniques and subsequent image analysis. 
 
3.5 Conclusions 
 The experiments in this study demonstrate the use of a protease-sensitive 
synthetic hydrogel that can be laminated to create a multi-layer scaffold with defined 
separation of cells. Such a system could be used to investigate possible chemotactic 
migration of cells through the lamination interface. The technique outlined in this work 
provides additional information regarding the 3D position of cells within a multi-layer 
hydrogel. However, significant improvements are needed to design a system that can 
effectively induce and monitor large-scale migration in specifically targeted cell types 
using a chemical gradient. Such a system would provide new insight into the nature and 







FINITE ELEMENT MODELING PREDICTS STRAIN DISTRIBUTION IN PEG 
HYDROGELS UNDER CYCLIC TENSILE STRAIN 
4.1 Introduction 
A number of tissue engineering models exist for engineering tendon and ligament 
tissue (29). Many strategies have used tensile strain to upregulate genes associated with 
tendon and ligament fibroblasts (9, 65, 89). However, certain behaviors, including 
collagen III expression, have been previously reported to be strain dose-dependent (212, 
213). A highly variable strain distribution within a tissue engineering construct would 
therefore make it difficult to correlate applied overall strain with bulk encapsulated cell 
response, as cells in certain regions of a material may experience lower or higher local 
strains than the macroscopically applied strain. To shed insight into the distribution of 
strain, finite element modeling has been employed to computationally model a scaffold 
with specified mechanical properties. Detailed information can then be predicted 
regarding the distribution of strains and forces throughout the material when macroscopic 
strain is applied. Computational modeling enables the facile investigation of hypothetical 
loading scenarios and provides physical data that may be difficult to determine otherwise. 
For example, finite element modeling has simulated the effects of the pericellular matrix 
on the micromechanical environment of chondrocytes undergoing loading (214, 215); 
whole knee joint kinematics including bones, tendons and ligaments (216); and shear 
stresses due to fluid flow in native tendon tissues (217). 
The work in this dissertation (Chapter 5) employs the use of a tensile culture 
bioreactor which has been used to study the application of cyclic tensile strain on cells 
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encapsulated in hydrogel-based scaffolds (89, 178, 218). In the initial design of this 
system, a finite element model was developed to characterize the distribution of strain 
under different loading amplitudes. However, due to the way in which constructs were 
strained, where a metal peg directly interacted with holes punched into the constructs, the 
model revealed significant variation in strains throughout the construct; under 10% 
applied strain, local principal strains varied from approximately 0.5-5.5% (218). To 
improve the uniformity of applied strain, a newer construct design allowed integration of 
prepolymer solution into porous polyethylene endblocks, enabling strain to be applied to 
the stiff endblock instead of directly to the gel (178). This construct design was recently 
employed in our laboratory to investigate the effects of 10% cyclic strain on the 
upregulation of MSC gene expression and ECM deposition associated with 
tendon/ligament fibroblasts (89). In both of these studies utilizing the newer construct 
design, however, the distribution of strain throughout the hydrogels used was not 
characterized. Thus, it was important for this work, and for future studies using this 
tensile culture bioreactor, to evaluate the distribution of principal strains within a 
representative construct undergoing cyclic tensile strain. Such data would provide 
validation of the construct design and justify analysis of encapsulated cells as a single 
population. 
The poly(ethylene glycol) (PEG)-based hydrogels used for the aforementioned 
study (89) have been used to successfully encapsulate cells for a wide variety of tissue 
engineering applications (97, 98, 219). By modifying poly(ethylene glycol) with acrylate 
groups, PEG is made crosslinkable via photo- and thermally-sensitive free radical 
initiators (105, 112). The nature of PEG free radical polymerization allows the lamination 
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of multiple gels by partially crosslinking one gel before depositing the next liquid 
prepolymer (87, 104, 190). By controlling crosslinking and lamination, multiple gel types 
can be patterned next to each other, each with specifically tailored cellular or mechanical 
characteristics (104, 190). Laminated structures have been employed to model and study 
complex tissues, including cartilage (191, 194). Other types of heterogeneous structures 
have been employed as models for interfacial tissues, including the insertion of 
tendon/ligament into bone (5, 6, 78). These structures typically contain variations in 
geometry, biochemical/cellular composition, and/or mechanical properties. 
If strain is applied to heterogeneous materials, finite element modeling provides 
the ability to anticipate variations in local strain based on differences in material 
geometry and mechanical properties. For example, in a recent study, tensile strain was 
been used in tandem with scaffold geometry to facilitate spatially heterogeneous cell 
differentiation based on a predicted distribution of compressive and tensile forces (65). 
Mismatches in mechanical properties and differences in laminate geometry could modify 
the distribution of strain within a heterogeneous material. Moreover, the distribution of 
strain may change temporally due to material remodeling by encapsulated cells (6).  
 Thus, there were two objectives in this work. First, a finite element model was 
developed to characterize the uniformity of local strains in hydrogels cultured in a tensile 
culture bioreactor. Next, models incorporated different interface geometries and 
differences in stiffness between laminated sections, to determine the extent of changes in 
strain distribution due to the laminate interface and mismatches in stiffness in different 
sections of the hydrogel. Lastly, a first pass was made at testing assumptions that were 
made in the development of the finite element models by measuring the tensile modulus 
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of PEG-based hydrogels.  
 
4.2 Methods 
4.2.1 Finite element modeling 
 
 
Figure 4.1. Image of fabricated gels in tensile culture bioreactor. 
 
A finite element (FE) model of the PEG hydrogel construct was developed with 
Abaqus 6.11-1 (Simulia, Providence, RI) to analyze the strain distributions during tensile 
loading. The model was developed from an existing tensile culture bioreactor (Figure 4.1). 
The hydrogel (9.5 x 12.5 x 1.6 mm) was modeled using 11400 linear elastic elements 
with reduced integration (C3D8R) and the endblocks (9.5 x 7.5 x 1.6 mm) were modeled 
using 5010 linear elastic elements (C3D8R). The gel was assigned an isotropic modulus 
of 22 kPa and an assumed Poisson's ratio of 0.3 to compare with a previous finite element 
model used with this system (195, 218). The polyethylene endblocks were assigned a 
much higher modulus relative to the gel (10 MPa). The gel was fixed to each endblock at 
both ends. To simulate peg displacement similar to the tensile culture bioreactor, one 
endblock was fixed in space while the other endblock was sinusoidally moved at 10% 
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strain (1.25 mm) at 1 Hz. Displacements were applied using 50 equal time steps from 0% 
to 10% strain. Within the hydrogel, principle strains at each time point were calculated 
for post-processing analysis. 
Following creation of the initial model, other geometries and stiffnesses were 
tested alongside the simple uniform described above. Laminates were simulated by 
creating two separate parts, each made of the same material, and connecting nodes of 
opposing faces to simulate lamination. Different laminate divisions were considered, 
including a flat line, a simple curve, an S-curve containing convex and concave sections, 
and an interlocking structure. To simulate lamination, constraints were applied to join 
opposing faces of each laminated section; however, lamination points were not specified 
with an elastic modulus that was different from the individual sections. Using a simple 
flat line laminate, the stiffness of one section was varied relative to the other, by a factor 
of 2, 5, 10, or 20, to observe the differences between mismatches in modulus. Maximum 
principal strain is reported as mean ± standard deviation of all gel elements. 
 
4.2.2 Synthesis of OPF and PEG-DA 
OPF was synthesized as previously reported (102). Briefly, poly(ethylene glycol) 
(Mn = 10,000 Da; Sigma–Aldrich) was azeotropically distilled and subsequently 
dissolved in distilled methylene chloride (Fisher) to produce a ~40% (v/v) solution. 
Distilled fumaryl chloride (FuCl, Sigma–Aldrich) and triethylamine (TEA; Sigma– 
Aldrich) in a molar ratio of 1 PEG:0.9 FuCl (2 TEA:1 FuCl) were slowly added dropwise 
to the PEG solution, and the reaction was held under nitrogen on ice. The OPF 
formulation was continuously stirred for 48–72 h at 25 °C under nitrogen to ensure 
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reaction completion. Next, excess methylene chloride was evaporated and the Cl–TEA 
salt was removed by filtration (Whatman). The OPF was recrystallized twice in ethyl 
acetate (Fisher) and washed three times in ethyl ether (Fisher). The resulting powder was 
vacuum dried at <5 mmHg and stored in a sealed container at -20 °C until further use. 
PEG-DA was synthesized as previously reported (157). Briefly, 24 g PEG 3.4K 
(Sigma-Aldrich, St. Louis, MO) was dissolved in 60 mL distilled methylene chloride 
(MeCl; Fisher Scientific, Pittsburgh, PA), then reacted at a 2:1 molar ratio with acryloyl 
chloride (AcCl, added dropwise, Sigma-Aldrich) and at a 1:1 molar ratio with 
triethylamine (Sigma-Aldrich) to create a 40% (w/v) solution under nitrogen overnight. 
Workup was performed by reaction with 2M K2CO3 (Fisher) at a 2:1 AcCl molar ratio 
and separation into aqueous and organic phases. This was followed by drying the solution 
with anhydrous MgSO4 (Fisher) and precipitating the polymer in ethyl ether (Fisher). 
Product was filtered, vacuum dried and frozen at -20ºC until use. OPF 10K was also 
synthesized as previously described (102). PEG 10K (Sigma-Aldrich) was distilled and 
dissolved in distilled MeCl to produce a 40% (v/v) solution. Distilled fumaryl chloride 
(FuCl; Sigma-Aldrich) and triethylamine (TEA; Sigma-Aldrich) at 1:0.9 PEG:FuCl and 
2:1 TEA:FuCl molar ratios were added dropwise to the PEG solution and the reaction 
was conducted under nitrogen at 0ºC. The reaction was stirred for an additional 48-72h at 
25ºC to ensure reaction completion, at which time excess MeCl was evaporated and 
TEA-Cl salt was removed. The resultant product was recrystallized twice in ethyl acetate 
(Fisher) and washed three times in ethyl ether, then filtered, vacuum dried and stored at -
20ºC until use. PEG-DA (Mn 3770 ± 10, PI 1.1 ± 0.0), PEG 3.4K (Mn 3400 ± 30, PI 1.1 
± 0.0), OPF 10K (Mn 19,800 ± 100, PI 4.6 ± 0.1) and PEG 10K (MW 12,900 ± 200; PI 
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1.1 ± 0.0) were characterized via gel permeation chromatography as previously reported 
(109). 
 
4.2.3 Mechanical testing of OPF:PEG-DA hydrogels 
Constructs for tensile culture were fabricated using a 50:50 wt% mixture of OPF 
10K and PEG-DA. Phosphate buffered saline (PBS) was added to fabricate a 90% wt 
water gel. Next, thermally activated free radical initiators ammonium persulfate (APS) 
and tetramethylethylenediamine (TEMED) were added to a final concentration of 0.018 
M, and solutions were deposited into a Teflon mold, invading porous polyethylene 
endblocks as previously described (89). Constructs were polymerized at 37ºC for 10 min, 
then moved into excess PBS and allowed to swell overnight at room temperature. 
Following swelling, constructs were mechanically evaluated by fitting metal rods 
through each endblock and mounting the construct on an ELF 3200 mechanical testing 
system (EnduraTEC/Bose) (Figure 4.2). Force was recorded using a 1 N load cell and 
data was recorded through computer-based data acquisition software (WinTest, 
EnduraTEC). Sample height, width and length were recorded using digital calipers and 
stress and strain were calculated from the force and displacement curves of each sample. 
To measure stress-strain curves at different strain rates, constructs (n≥4) were tested at 5 
different rates at room temperature: 2.5%, 5%, 10%, 20% and 40% strain/sec. Gels were 
manually hydrated with PBS during loading. Average Young’s modulus were compared 




Figure 4.2. A tensile culture gel being tested in a mechanical testing system. 
 
4.3 Results 
4.3.1 Finite element modeling 
 
 
Figure 4.3. Strain field in hydrogel after 10% deformation. 
False-color plots of maximum principal strains were created to depict the relative 
distribution for strain through the middle of the gel (Figure 4.3). At maximum 
displacement during cyclic loading, peak strains were located at the corners of the gel. 
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Lowest strains were observed where the gel interfaces with each endblock. Within the 
central region of the hydrogel (XY-plane), the maximum principal strains were uniform 
with little variation of strain. There was little variation in strain through the thickness of 
the construct (Z-direction). For 10% total displacement, the maximum principal strains 
ranged from 6.8%-13.9% (Figure 4.4). However, 88.8% of elements had a principal strain 




Figure 4.4. Distribution of principal strain in hydrogel. Left, three-dimensional 
distribution of strain in hydrogel with legend. Right, histogram of maximum 










Figure 4.6. Differences in strain distribution between laminates with different 
relative stiffnesses. Above, distribution of strain in laminates with differences in 
stiffness between each side. Bottom left, histograms depicting the distribution of 
strain in the right gel section. Bottom right, average principle strain. 
 
Changes in interface geometry did not affect the strains or strain distribution 
(Figure 4.5). However, by modifying the stiffness of a single section, changes were seen 
in the resulting strain profiles (Figure 4.6). By increasing the mismatch in stiffness 
between sections, magnitude-dependent changes in strain were detected throughout the 
gel. As long as the modulus ratio between the two sections was identical, changing 




Figure 4.7. Differences in strain distribution between different laminates. Right 
laminate is half the modulus of the left laminate. Bottom left, histograms depicting 




 When combined with changes in stiffness, differences in interface geometry 
resulted in stress concentrations at the points of greatest difference in modulus (Figure 
4.7). Strains in stiffer laminated sections (left sides) were noticeably lower, while 
sections with lower modulus (right sides) exhibited higher strains. The distribution of 
strain appeared to be correlated with the horizontal dimensions of the particular section; 
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in other words, areas of shorter horizontal width exhibited higher strains. With the 
interlocking laminate model, areas of higher modulus tended to shield areas of lower 
modulus (arrows). This was reflected in histogram data depicting the distribution of 
principal strains in the right gel sections of the various laminates (Figure 4.7, bottom left). 
Distribution of strain varied with interface geometry; any deviation from a flat line 
laminate widened the strain distribution. The interlocking laminate showed the most 
variation in strain due to shielding from the stiffer section, reducing the local principal 
strains in those areas. However, the average maximum principal strains were observed to 
be relatively similar (Figure 4.7, bottom right). 
 
 
Figure 4.8. Young’s modulus of OPF:PEG-DA tensile culture hydrogels strained at 
different rates. Left, average Young’s modulus among the five strain rates tested 
(strain/sec). There were no statistical differences between any rates (n = 4-6 ± SD, p 
< 0.05). Right, representative stress-strain curves immediately prior to construct 
failure are shown for each strain rate tested.  
 
 
4.3.2 Mechanical testing results 
All constructs strained at different rates were measured to have a Young’s 
modulus of ~5 kPa (Figure 4.8). Upon inspection after failure, gels were not noted to 
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have frequently broken at the interface between the endblocks and hydrogel material. 
There was no statistically significant difference between the Young’s modulus calculated 





In tissue engineering constructs that are composed of sections with varying 
geometries and mechanical properties, mechanical forces will induce varying strain fields 
across each section depending on differences in modulus and the particular geometries 
between each section. Even in a construct of uniform mechanical properties, however, 
particulars regarding geometry and the specific application of loading may prevent strain 
from being uniformly applied throughout the scaffold. Cells are responsive to their local 
mechanical environment in a magnitude-dependent manner, and mechanical forces have 
been shown as a putative factor in cell differentiation in a wide variety of orthopaedic 
tissue engineering contexts (65, 89, 220-222). Therefore, for studies involving tensile 
culture, such as those in Chapter 5, finite element modeling enabled the distribution of 
strain to be studied within various geometric configurations and variations in stiffness.  
This work demonstrates that within a uniformly constructed scaffold with a high 
degree of symmetry and attention to minimizing contact forces within a tensile culture 
bioreactor, the majority of local principal strains remained between 9% and 10.5%, with 
approximately 5% standard deviation (Figure 4.4). This construct design (Figure 4.1, first 
explored in (178)) was devised to improve on a previous scaffold, where metal pegs 
contacted the gel directly via holes punched into the gel; direct contact led to a large 
disparity in local strains  (218). Within this model, the attachment of the hydrogel region 
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to the much stiffer endblocks did lead to heterogeneity in local strains, as the corners 
tended to shield the middle edges from strain (Figure 4.4). However, heterogeneity in this 
model was greatly reduced when compared to the previous iteration of construct design 
(218). Drawing from the results of the model, heterogeneity appears difficult to eliminate 
in a system where components with relatively high stiffness directly interact with much 
softer hydrogels. 
In this report, the lamination of interfaces did not alter the strain distribution 
(Figure 4.5). In reality, structures are laminated when, after the first structure has been 
polymerized, the second prepolymer solution is placed adjacent to the first. Although 
mixing can be rendered negligible (190), the prepolymer solution appears to diffuse into 
the first hydrogel to form a mechanical link (191, 210). This interpenetrating region may 
have increased mechanical properties due to increased crosslinking at the interface, but 
the resulting change in mechanical properties has never been measured. Knowledge of 
the dimensions and modulus of such a region would increase the accuracy of the model 
and provide additional insight into large differences in strain near the interface due to its 
likely higher modulus. As a first pass, characterization techniques that investigate 
micron-scale mechanical properties, such as nanoindentation or atomic force microscopy, 
could be employed to create a map of stiffness of the interface; such techniques have 
been previously used to characterize both hydrogels and tissues (86, 223-225). 
Alternatively, employing elastographic or similar particle-tracking techniques to map the 
interface during applied strain could be used in reverse, to build a model that 
approximates the distribution of strain in a laminated hydrogel (226). Profiling interfaces 
via surface mapping could provide relative differences in stiffness over the interface 
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region, providing a first approximation of changes in stiffness relative to its two adjoining 
layers. 
Changes in modulus between laminated gel sections were shown to have altered 
the local strain fields in both sections (Figure 4.7). If laminates contained different 
material compositions or were seeded with different types of cells, laminates could also 
change in stiffness over time. In one example, a collagen scaffold with a gradient of 
immobilized Runx2 retrovirus was used to osteogenically differentiate rat fibroblasts; 
differences in mechanical properties were noted after 6 weeks in culture (6). Other 
studies have generated gradients of increasing modulus in a single PEG scaffold (174, 
227). Applied cyclic tensile strain to these constructs would induce heterogeneous strain 
fields, but with encapsulated cells degrading the biomaterial and/or depositing ECM, 
local strain fields could change over time. Additionally, if heterogeneities are designed, 
mechanical forces could be used to spatially target differentiation depending on local 
strain fields. The results of these models indicate that strain fields should be modeled 
prior to application of strain to actual constructs, to provide detailed profiles of the local 
strain environment. Moreover, constructs may require monitoring and mechanical 
characterization over time (e.g., the aforementioned AFM or particle tracking-based 
imaging techniques) to clarify the evolution of changes in mechanical properties as cells 
remodel their microenvironment. This information would provide a time profile of local 
strain distribution to elucidate possible temporal effects of applied macroscopic strain. 
The use of different interfaces modified the distribution of strain experienced by 
the softer laminate (Figure 4.8). It was shown that the use of an interlocking laminate, 
with areas that were shielded by the stiffer section, created apparent areas of higher and 
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lower local strains. The use of other types of laminates also created similar differences in 
the distribution of strain. Although average strains did not appear to vary, different levels 
of strain, as noted in the interlocking design, could cause dose dependent reactions in 
encapsulated cells as reported previously (212, 213). Further design could reveal optimal 
interfaces to encourage limited or increased heterogeneity, to control the localization of 
applied strain to desired areas. For example, scaffolds could be designed to target strain-
linked fibroblastic differentiation in one portion, and minimized in another section, using 
control of interfaces and mechanical properties. 
To further increase the accuracy of the model, other data regarding the failure of 
these gels could be experimentally determined. For example, ultimate tensile strength 
was not measured for gels used in this system; thus, materials in this finite element model 
would continue to deform without failure, whereas OPF/PEG-DA constructs failed in 
mechanical testing. Anecdotally, OPF/PEG-DA hydrogels required applied strains well 
beyond 10% (the magnitude of strain applied in Chapter 5) to fail (Figure 4.8). However, 
premature failure would prevent certain magnitudes of strain from being applied in 
hydrogel constructs that are more brittle. Failure in response to stress risers and low 
ultimate tensile strength would therefore be important to characterize to improve the 
fidelity of the model. 
Another assumption in the model was the modeling of the hydrogel as an ideal 
elastic material. Hydrogels are known to behave similarly to rubbers (228), in which the 
viscous component is functionally negligible. Within the range of strain rates tested, 
OPF:PEG-DA hydrogels did not appear to exhibit strain-rate dependent behavior in the 
form of different Young’s modulus (Figure 4.8). Were the viscous component of these 
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hydrogels a significant factor, increased strain rate would, generally speaking, translate to 
an increased measured Young’s modulus. However, the method used in this study did not 
thoroughly characterize the viscoelastic properties of these hydrogels; other analyses (e.g., 
dynamic mechanical analysis and rheological measurements) would provide the storage 
and loss moduli (G’ and G”), as well as the phase angle δ (228). This analysis has been 
performed in PEG gels in two previous studies (167, 169). In both studies, PEG gels were 
found to have G” values that were two orders of magnitude less than measured values of 
G’. When compared to collagen gels, collagen G” values were less than an order of 
magnitude relative to G’, and δcollagen = 17.7º compared to δPEG = 2.3º (167). It was 
posited that the difference in crosslinking (physical crosslinking in collagen versus 
covalent crosslinking in PEG) translated to functionally viscoelastic versus ideal elastic 
behavior. Given this previous work, and the first pass characterization of gels in this 
study, the assumption of ideal elasticity is reasonable for the finite element models 
presented here. However, refining the accuracy of the model may require a more detailed 
characterization of G’ and G” for the hydrogels used in this system. 
Finally, another possibly important consideration in this model that was ignored 
was the consideration of poroelasticity in the finite element model. As the hydrogel 
materials tested are fundamentally poroelastic due to their initial water weight (90%) and 
subsequent uptake of water during swelling, the effects of tensile strain could affect fluid 
flow through the construct (218). The effects of fluid flow and its resultant shear stress 
have been modeled in native tendon tissues to have significant effects on MMP-13 
expression in rat tail tendons (217). In particular, cell response was shown to be sensitive 
to strain rate as well as amplitude. Thus, modeling possible hydrostatic pressures and 
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fluid velocities resulting from a variety of tensile strain regimens would provide 
additional insight into additional mechanically-driven effects that would affect cells 
encapsulated within a porous, synthetic construct. 
Finite element models have been employed to study information regarding the 
distribution of strains in other hydrogel systems as well as in actual tissues. A finite 
element model of a proteolytically-degradable PEG hydrogel undergoing applied strain 
showed a similar distribution of strains within the construct; however, different boundary 
conditions for the model prevent direct comparison (229). Other finite element models of 
materials undergoing cyclic loading have provided additional insight into other aspects of 
biomaterial constructs; for example, a finite element was employed to investigate the 
effect of cyclic loading on fluid flow and solute transport within a poroelastic structure 
(230). With regards to tendon tissues, the aforementioned model of fluid flow in tendon 
tissue provided information regarding the effects of fluid-induced shear stress on cell 
response to loading within a transversely isotropic environment (217). Another study 
investigated the application of biaxial strain on local strain distribution in the meniscus, 
which is spatially heterogeneous and contains significant anisotropy due to its 
biochemical composition (18, 231). Although PEG-based gels are not intrinsically 
anisotropic (167), anisotropy in mechanical properties would introduce another form of 
heterogeneity within biomaterial constructs. Adding additional parameters based on these 
studies, then, would further refine the model and greatly expand its utility. 
 
4.5 Conclusions 
 This study represents a first attempt at characterizing the effects of applied strain 
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on local strain distribution within homogeneous and heterogeneous constructs, using an 
existing tensile culture bioreactor as a base for a finite element model of the forces 
applied to a biomaterial scaffold. Results indicate that manipulation of differences in 
modulus and interface geometry can indeed modulate variations in local strain 
distribution. In using complex tissue engineering constructs with multiple designed 
heterogeneities present within a single biomaterial scaffold, applying strain can therefore 
be used to spatially target changes in strain-dependent differentiation depending on 
geometry and modulus variation within a material. Further characterization of the 
poroelastic and viscoelastic properties of these hydrogels, as well as the dimensions and 
modulus of the lamination interface, would provide improved information and increase 
the relevance of the model for describing possible changes in local strain fields 






MANIPULATION OF DEGRADABILITY IN PEG-BASED HYDROGELS 
ELICITS CHANGES IN MESENCHYMAL STEM CELL MORPHOLOGY AND 
LIMITED EFFECTS ON TENDON/LIGAMENT FIBROBLAST-RELATED 
MARKERS UNDER CYCLIC TENSILE STRAIN 
5.1 Introduction 
It has been estimated that at least 200,000 people in the United States receive 
treatment for injuries to tendon or ligament tissue each year (2). In response, a multitude 
of tissue engineering approaches have been employed to engineer replacement fibrous 
tissues, many of which include scaffold materials such as PLLA, silk and collagen type I 
(18). Typically, either tendon/ligament fibroblasts or multipotent mesenchymal stem cells 
(MSCs) have been explored as cell sources for these constructs (232, 233). However, 
MSCs offer an advantage in that they can be easily isolated and expanded to sufficient 
numbers for therapeutic use (17). For those utilizing MSCs as a cell source, a number of 
approaches employing culture under tensile strain to induce differentiation toward a 
fibroblastic lineage have been investigated (9, 59, 89, 181). However, more information 
is needed to clarify the role that the biomaterial scaffold may play in affecting MSCs’ 
response to external loading during the pre-culture (differentiation) period in order to 
optimize pre-culture conditions for maximal cell differentiation. 
In response, our laboratory has designed a well-controlled model system to better 
understand how changing the degradability of the extracellular environment will affect 
changes in cell morphology and subsequent differentiation under tensile loading. 
Previous studies have shown that, in addition to tensile strain, the local extracellular 
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environment, including stiffness and geometry (173), can affect cell fate. The regulation 
of cell shape and area has been implicated in driving MSC differentiation into either 
osteoblast or adipocyte lineages (171, 172). For chondrogenic differentiation, a rounded 
shape has been shown to be highly linked with gene upregulation indicative of 
chondrogenesis (234, 235). In engineering tendon/ligament tissues, changes in cell shape 
have been shown to affect collagen I and collagen III expression in anterior cruciate 
ligament cells seeded on blends of PCL/chitosan (236). However, by using a primarily 
synthetic biomaterial with targeted degradation sites, such as that employed in this study, 
the local extracellular environment can be precisely tailored to enable cell spreading in a 
highly controlled manner, facilitating examination of the interplay between cell shape and 
response to tensile strain.  
In order to create this model system, poly(ethylene glycol) (PEG)-based synthetic 
hydrogels were chosen due to their cytocompatibility and the relative ease of tailoring 
these systems with specific functionalities (10). Our laboratory has previously utilized 
PEG-based hydrogels to direct differentiation of MSCs towards a tendon/ligament 
fibroblast phenotype (89). To engineer cell-mediated degradation in these synthetic 
scaffolds, matrix metalloproteinase (MMP)-sensitive sequences were integrated into the 
hydrogel (133, 140). MMPs are a family of endopeptidases that degrade extracellular 
matrix (ECM) components. These may be secreted by MSCs to cleave surrounding ECM 
and enable cell-initiated spreading, migration and matrix deposition (10, 237).  
Several MMP-cleavable sequences have been previously incorporated in PEG-
based hydrogels, originally including LGPA, derived from the collagen I α1(I) peptide 
chain, and more recently, VPMSMRGG, derived from a combinatorial approach using a 
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completely randomized dodecapeptide library and demonstrating enhanced susceptibility 
to MMP-1 and MMP-2 (133, 135, 139, 140). Using peptides with comparatively slow or 
fast cleavage kinetics allows the possibility of selectively manipulating cell morphology 
by altering the degradation rate of the surrounding matrix. Therefore, the objective of 
these studies was to characterize cell morphology in fast- and slow-degrading MMP-
cleavable hydrogels, as well as examine the effects of the degradability of the 
surrounding hydrogel on MSC response to cyclic tensile strain in a custom-designed 
tensile culture bioreactor. 
 
5.2 Methods 
5.2.1 PEG-peptide polymer synthesis 
MMP-sensitive PEG products were synthesized according to published protocols 
(238). Slow-degrading (GGGLGPAGGK) and fast-degrading (GGVPMSMRGGGK) 
peptide sequences (Aapptec) were dissolved in 50 mM sodium bicarbonate buffer at pH 
8.5. Acrl-PEG-succinimidyl valerate (Acrl-PEG-SVA; Mn ~3400; Laysan Bio) was 
added at a ratio of 1:2.2 peptide:Acrl-PEG-SVA. After reacting for 3 hours with gentle 
stirring, the mixed solution was transferred into 3500-5000 Da molecular weight cutoff 
dialysis tubing (Spectrum Labs) and dialyzed for 2 days to remove unreacted reagents. 
Similarly, GRGDS (PeproTech) was conjugated to Acrl-PEG-SVA as above, and 
dialyzed against 1000 Da molecular weight cutoff tubing (Spectrum Labs). All three 
products, Acrl-PEG-GGGLGPAGGK-PEG-Acrl, Acrl-PEG-GGVPMSMRGGGK-PEG-
Acrl and Acrl-PEG-GRGDS, were lyophilized (Labconco) and stored at -20ºC. 
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5.2.2 Cell culture 
Human MSCs were obtained from the Texas A&M Health Science Center 
College of Medicine Institute for Regenerative Medicine at Scott & White at passage 1. 
Following cell expansion for studies, cells (passage 2) were seeded in triple flasks (Nunc) 
at 50 cells/cm2 following recommended protocols. The growth medium used was α-MEM 
with 16.3% fetal bovine serum (FBS, Atlanta Biologicals), 1% antibiotic/antimycotic 
(Mediatech), and 4 mM L-glutamine (Mediatech). (Note: The fetal bovine serum lot used 
was pre-screened for MSC growth while maintaining collagen I, collagen III and 
tenascin-C gene expression.)  Following expansion, cells were frozen at passage 2 in 
liquid nitrogen until further use. For these studies, cells from three separate donors were 
thawed, expanded separately, and combined prior to encapsulation at passage 3. 
 
5.2.3 Cell encapsulation and tensile culture 
Both slow-degrading and fast-degrading PEG were used to encapsulate cells as 
follows. 1 µmol Acrl-PEG-GRGDS/(g swollen hydrogel) was added to each polymer 
type to enable cell adhesion. Polymer was dissolved in phosphate buffered saline (PBS) 
to create a 90 wt% water solution, then sterile filtered using a 0.2 µm glass prefilter 
(Nalgene). 0.07 wt% Irgacure 2959 (D2959; Ciba) in PBS/dimethyl sulfoxide was added 
to enable photopolymerization using UV light. Next, hMSCs were added at a final 
concentration of 10 x 106 cells/mL, and the hydrogel solution was deposited into Teflon 
molds, integrate with porous polyethylene endblocks as previously described to form gels 
12.5 x 9.5 mm x 1.6 mm (89). Following 10 minutes of exposure to UV light (10.5 
mW/cm2; 365 nm; UVP), tensile constructs were placed into 6-well plates containing α-
 73 
MEM with 10% FBS, 1% antibiotic/antimycotic (Mediatech), 4 mM L-glutamine 
(Mediatech), and 50 µg/mL ascorbic acid (Sigma). Constructs were allowed to swell 
overnight to reach equilibrium swelling prior to culture. 
Swollen fast-degrading and slow-degrading constructs with encapsulated MSCs 
were loaded into the tensile culture bioreactor and a loading regimen was applied for the 
duration of the experiment as reported previously (89). Specifically, constructs were 
maintained using 10% sinusoidal cyclic strain (5% offset, 5% amplitude) at 1 Hz for 3 h, 
followed by 3 h at 0% strain. Control hydrogels, both fast-degrading and slow-degrading 
constructs, were placed into a similar culture system and held at 0% strain. Culture 
medium was replaced every 2-3 days. 
 
5.2.4 Cell viability, confocal imaging, image processing and particle analysis 
At 1, 7 and 14 days, constructs (n=3) were removed from the bioreactor and 
incubated in LIVE/DEAD fluorescent staining solution (1 µM calcein AM and 1 µM 
ethidium homodimer-1 in PBS; Invitrogen) for 1h, then imaged in PBS on a confocal 
microscope (Zeiss LSM 510). Images were taken every 10 µm through the entire 
thickness of the gel from three separate regions in each sample.  
Image files were processed using ImageJ 1.45h (http://imagej.nih.gov/). For 
circularity analysis, each image stack was smoothed using ImageJ’s nearest neighbor 
function, and the green channel was isolated and thresholded using a cutoff of 60 (out of 
255; threshold arbitrarily set). For each image, a particle analysis was performed to 
identify particles greater than 60 square pixels, and area (in µm2), circularity, and a best 
fit ellipse was calculated for each particle in each image slice. Circularity is defined as 
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4πA/P2, where A and P are the area and perimeter of the particle. A perfect circle would 
have a circularity of 1; circularity decreases towards 0 in more elongated (spread) cells. 
To prevent cells on the surface of the gel from being considered, and to prevent single 
particles from being counted multiple times, 5 images 50 µm apart, 200 µm from either 
edge were isolated from each stack. This was performed in an automated fashion by 
automatically calculating a best fit line in MATLAB (MathWorks) using a least squares 
regression and the average circularity of each slice within a stack. The five images were 
selected based on the best fit line having a near-flat slope and a high goodness of fit. 
Particles were combined from multiple stacks (≥3 stacks per gel). To calculate particle 
alignment, the angle of the major axis of each best-fit ellipse was calculated relative to 
the x-axis of the image; 90º describes a particle oriented perpendicular to the x-axis. 
Histograms describing the distributions of particle circularity and angle were normalized 
to the total number of particles in each sample (relative frequency) before plotting, so that 
the area under each curve is 1. 
 
5.2.5 Cell number 
At 1, 7 and 14 days after culture, constructs were removed from the tensile culture 
bioreactor and the wet weight of the hydrogel was measured. Gels were mechanically 
disrupted using a pellet grinder (VWR International) and 500 µL distilled deionized 
water was added. To release DNA from encapsulated cells, samples were subjected to 
three repetitions of freeze-thaw cycles followed by sonication (Ultrasonik 28X, NEY). 
DNA content, representative of cell number, was determined by assaying the supernatant 
with PicoGreen reagents and included DNA standards (Invitrogen). Results were 
 75 
normalized against the hydrogel wet weight. 
 
5.2.6 Gene expression 
At 1, 7, and 14 days after culture, constructs were removed from the tensile 
culture bioreactor, allowed to rest in culture medium for 2h, and processed using a pellet 
grinder as previously described. RNA was isolated from the disrupted hydrogels using 
QIAshredder columns (Qiagen), and RNA was purified using an RNeasy mini kit 
(Qiagen). To create cDNA, cDNA was synthesized using SuperScript III reverse 
transcriptase (Invitrogen) and nucleotide mix (Promega). Real-time polymerase chain 
reaction (PCR) was performed using custom designed primers, SYBR Green (Applied 
Biosystems), and a StepOnePlus™ Real-Time PCR System (Applied Biosystems). To 
analyze PCR amplification data, the raw fluorescence data was processed using 
LinRegPCR (v12.11; http://www.hartfaalcentrum.nl (239)). Genes examined included 
collagen I, collagen III, and tenascin-C as markers for tendon/ligament fibroblast gene 
expression (9). Starting concentrations of each target gene were normalized to a 
geometric mean of three housekeeping genes – glyceraldehyde phosphate dehydrogenase, 
β-actin, and 18S ribosomal RNA (240). Scleraxis, a transcription factor expressed in 
tendon progenitor cells, was also examined via PCR (65, 241). Finally, MyoD, a marker 
for myofibroblast differentiation, was also evaluated (65, 241, 242). Sequences for the 





Table 5.1. Forward and reverse primers used in RT-PCR. 
Gene Forward primer Reverse primer 
Collagen I gaaaacatcccagccaagaa gccagtctcctcatccatgt 
Collagen III tacggcaatcctgaacttcc gtgtgtttcgtgcaaccatc 
Tenascin-C ccacaatggcagatccttct gttaacgccctgactgtggt 
Scleraxis gcgcgagcgagaccgcaccaaca cccgccagcagcacgttgccc 
MyoD gtcgagcctagactgcctgt gtatatcgggttggggttcg 
GAPDH gagtcaacggatttggtcgt ttgattttggagggatctcg 
18S rRNA cgatgggcggcggaaaatagcctttgc cagtggtcttggtgtgctggcctcgg 
β actin gcagtcggttggagcgagcatcccc tcccctgtgtggacttgggagaggac 
 
5.2.7 Histology and immunohistochemistry 
At 1 and 14 days, samples were removed from the tensile culture bioreactor and 
placed into a solution of 5% sucrose in PBS under vacuum. Over 2 h, the concentration 
was increased to 15% sucrose. Next, over 4 h, gels were subjected to increasing 
concentrations of 20% sucrose:OCT (VWR) to achieve a 1:2 20% sucrose in PBS:OCT 
solution. After vacuum infiltration overnight, samples were gently frozen in liquid 
nitrogen and stored at -80ºC. Infiltrated hydrogels were cryosectioned at 20 µm. Sections 
were fixed in acetone, blocked with 0.3% hydrogen peroxide in methanol, then blocked 
with 1% BSA solution with 2% goat serum and 0.1% Triton X-100. For primary antibody 
binding, sections were incubated overnight in mouse anti-human collagen I, collagen III, 
or tenascin-C (Abcam). Sections were then incubated for 30 min with goat polyclonal 
biotin-conjugated anti-mouse immunoglobulin G (Abcam), followed by signal 
amplification using an avidin-conjugated horseradish peroxidase as part of a Vectastain 
Elite ABC kit (Vector Laboratories). Finally, sections were exposed to diaminobenzidine 
chromogen (Abcam) for 4 min to generate color change. Negative controls were stained 




Results are reported as mean ± standard deviation. For statistical analysis, particle 
analysis and PCR amplification data for each gene were first transformed using a Box-
Cox transformation (243). A three-factor ANOVA with Tukey’s post hoc multiple 
comparison test was used to determine statistical significance with p≤0.05 to indicate 
significance between individual samples. For circularity, cell number, and gene 
expression analysis, the factors were day, strain condition, and gel type. To analyze angle 
distribution in individual gels, chi-squared goodness of fit tests (compared to a uniform 





5.3.1 Confocal microscopy and image analysis 
 
Figure 5.1. LIVE/DEAD images of encapsulated hMSCs (n=3) at 1, 7, and 14 days, 
cultured dynamically. (Images taken from gels cultured statically appeared similar 
to images from dynamically cultured gels.) Scale bar: 100 µm. 
 
As indicated by green staining visible in confocal microscopy, MSCs remained 
viable in both slow- and fast-degrading hydrogels, cultured statically or dynamically, 
through 14 days of culture (Figure 5.1). At day 1, MSCs were not visibly spreading in 
any gel type or strain condition, and this continued through day 7. However, at day 14, a 
certain amount of spreading was visually evident in all gels. No difference was seen 





Figure 5.2. a) Percentage of cells below circularity of 0.7 in each gel type and culture 
condition at 1, 7, and 14 days. b) Histograms of cell circularity distribution in 
representative statically cultured samples; curves are normalized so the area 
underneath each curve is 1. * represents significance versus the same sample type on 
day 1; ¶ versus the same sample type on day 7; § versus the other gel type at the 
same time point (n = 3, p ≤ 0.05). 
 
To differentiate between “spread” and “unspread” cells for particle analysis, a 
circularity <0.7 was chosen to represent “spread” cells, based on average circularity 
values among all groups at day 1 (data not shown). Corroborating with confocal 
microscopy images, few significant differences in the percentage of spread cells were 
found between day 1 and day 7 (Figure 5.2a). Static fast-degrading gels on day 1 and 
dynamic fast-degrading gels on day 7 had more spread cells than slow-degrading groups. 
However, more cells were spread in fast-degrading gels at day 14, regardless of strain 
condition. Staining for F-actin using AF546-phalloidin demonstrated qualitative changes 
in the nature of actin organization in fast-degrading, statically cultured gels compared to 
slow-degrading, statically cultured gels at day 14 (Appendix Figure B.1). Almost all day 
14 samples also had a higher percentage of spread cells than their day 1 and day 7 
counterparts. To closely examine the differences between circularity distributions, 
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histograms of circularity values were also calculated (Figure 5.2b). At day 1, the majority 
of cells trended towards a highly circular shape (circularity of 1). At day 14, more cells in 
slow-degrading gels had lower circularities; however, the trend of cells in fast-degrading 
gels towards low circularity was much more dramatic. No differences were visually noted 
in circularity distribution between static and dynamic gels. 
 
 
Figure 5.3. Histogram of particle alignment with x-axis from representative image 
stacks taken at day 14, normalized to total number of particles in each sample so the 
area under each curve is 1; 90° represents oriented perpendicular to the x-axis. 
 
Finally, particle alignment data was collected to determine whether cells had 
oriented in the direction of strain. There was no difference in average angle between any 
sample group at any time point (data not shown). Angle distributions were plotted (Figure 
5.3). Visually, there were no notable differences in distribution between gel type, strain 
condition, or time. To qualitatively determine if angle distributions in individual gels 
were non-uniform, chi-squared goodness of fit tests were used to compare each gel’s 
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angle distribution against a uniform distribution (n=3 for each gel group). Gels that 
demonstrated significant differences were scattered across dynamically and statically 
strained gels, slow-degrading and fast-degrading gels, and time points, with no more than 
one gel per sample type exhibiting a significant difference in distribution. 
 
 
Figure 5.4. PicoGreen data from encapsulated hMSCs (n≥5), cultured statically or 
dynamically, at days 1, 7, and 14. Data are normalized to gel wet weight. * 
represents significance versus the same sample type at day 1 (p < 0.05). 
 
5.3.2 Cell number 
DNA content/gel wet weight (indicative of cell number per gel) did not change 
between any group at each time point (Figure 5.4). However, all groups at day 14 and day 
7 were significantly lower than day 1 groups, indicating a decrease in DNA content (and 




Figure 5.5. RT-PCR data of encapsulated hMSCs (n≥5), cultured statically or 
dynamically, at days 1, 7, and 14. Data are normalized to their respective day 1 
groups. * represents significance versus the same sample type at day 1; ¶ versus the 
same sample type at day 7; # versus the other strain condition at the same time 
point; § versus the other gel type at the same time point (p < 0.05). 
 
 
5.3.3 Gene expression 
Scleraxis was maintained or downregulated over 14 days; static samples were 
downregulated at 14 days relative to day 1 samples, while dynamic samples were not 
different from day 1 (Figure 5.5). MyoD amplified late (average cycle number 39.3) and 
data was noisy (not shown). Overall, collagen I mRNA expression was downregulated 
over time; samples at day 14 were significantly lower than either day 1 or day 7 samples. 
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Statically cultured samples at day 7 were also significantly lower than day 1 samples and 
their dynamically cultured counterparts. 
In contrast, collagen III was upregulated in most sample types at 7 days relative to 
day 1 samples, and all day 14 samples except the slow-degrading, static group were 
upregulated relative to their day 7 equivalents. In particular, there were significantly 
higher expression levels of collagen III in dynamically strained groups than statically 
cultured samples at day 14, regardless of gel type. Tenascin-C expression levels at day 7 
were significantly upregulated in all groups relative to day 1 samples; however, all day 
14 samples except the fast-degrading dynamic group were downregulated relative to day 
7. Nevertheless, all day 14 samples remained significantly upregulated relative to day 1 
samples, and there were also significant differences noted between hydrogel type for each 
culture condition (static and dynamic). However, fast-degrading, dynamic samples at 
days 7 and 14 showed significantly lower tenascin-C expression relative to their slow-
degrading counterparts.  
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Figure 5.6. Histology of collagen I, collagen III and tenascin-C of MSCs 






At day 14, all samples showed changes in cell morphology reflective of 
qualitatively increased spreading noted in Figures 5.1 and 5.2 (Figure 5.6). 
Immunohistochemistry revealed the presence of collagen I in all samples at day 1, with 
apparent increases in cell-associated deposition at day 14. The presence of collagen I did 
not appear to be different between static and dynamic samples. Cell-associated collagen 
III deposition was observed only at day 14, with more apparent staining in dynamically 
strained samples. Tenascin-C staining was seen at day 1 and continued through day 14; 
dynamically strained constructs seemed to show more prevalent staining overall. No cell-
associated staining was observed in control sections that were not stained with primary 




In these experiments, hydrogels were fabricated using two established MMP-
cleavable peptides with different MMP sensitivities and used to examine how 
degradability of the surrounding matrix affects MSC response to tensile strain (133, 140). 
Fabricated gels showed no statistical differences in fold swelling (Figure A.5), indicating 
that no differences exist in initial mesh size between the two hydrogel types (104). 
However, after exposure to collagenase, gels rapidly degraded. In contrast, non-
degradable gels, with no bioactive peptides, resisted collagenase degradation. Moreover, 
enzyme-sensitive gels remained unchanged in culture medium over one week, 
demonstrating that active collagenase enzyme, and not other factors in medium, was the 
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main effector of changes in hydrogel integrity. The implications of these results are 
twofold: 1) cells should be able to locally degrade the gel by releasing proteases, and 2) 
cells encapsulated within an MMP-sensitive hydrogel could be recovered, via addition of 
exogenous enzyme, for further analysis or implantation into tissue defects. Thus, this 
system allows cells to be exposed to highly controlled 3D environments, with precise 
biochemical and mechanical stimulation, to “prime” cells prior to retrieval for further 
therapeutic applications.  
Confocal microscopy and image analysis were used in tandem to verify cell 
viability within the construct as well as evaluate changes in MSC morphology during 
culture (Figure 5.1).  At 14 days, cell spreading was visually noted in both types of gels, 
with image analysis revealing that significantly more cells were spread in fast-degrading 
gels relative to slow-degrading gels, regardless of strain condition (Figure 5.2). By 
staining for actin filaments, qualitative differences in the cytoskeletal network between 
cells in slow- and fast-degrading gels were also observed (Supplementary Figure B.1). 
Although the exact proteases secreted by these MSCs were not characterized, enough 
active enzyme was produced to cleave local matrix and allow spreading to occur, as 
clearly evidenced in the LIVE/DEAD images (Figure 5.1). The combination of these 
degradation and cell morphology results demonstrate the high amount of control that 
exists in the use of synthetic hydrogels, which provide a blank slate for the precise 
inclusion and presentation of bioactive factors. In contrast, natural materials, such as 
collagen, provide a default level of bioactivity that cannot be as easily tailored and 
therefore may be less useful in isolating effects of specific matrix properties on cellular 
response to exogenous cues. 
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Particle alignment to the x-axis was calculated by the generation of best fit 
ellipses to represent each particle, followed by angle measurement of the major axis 
relative to the x-axis (Figure 5.3). To determine if angle distributions in individual gels 
were non-uniform, particle angle distribution for each gel was compared against uniform 
distributions using a chi-squared goodness-of-fit test. The inconsistent nature of gels that 
exhibited non-uniform distributions suggests that cells did not align when static or 
dynamic strain was applied. The presence of a covalently crosslinked, non-aligned 
scaffold – as opposed to fibrous collagen gels, where pore sizes are larger and facilitate 
cell movement (167) – may have deterred cell reorientation over this time period. This 
result can be correlated with a two-part study of human foreskin fibroblasts in 
proteolytically degradable PEG gels (229, 244). Here, cells were shown to reorient in the 
direction of strain following the application of 20% static strain for 24h (244). However, 
cyclic strain (5%, 0.5 Hz, 24h) did not induce changes in reorientation. Although gels 
between those studies and this one are not directly comparable due to differences in gel 
type and other particulars of crosslinking, future study of cell reorientation in these types 
of gels may require the characterization of different strain regimens in inducing changes 
in cell orientation. 
From PicoGreen data (Figure 5.4), although cell number decreases over time, 
these results correlate with earlier work in our laboratory showing similar effects with 
MSCs encapsulated in non-degradable hydrogels (89). Importantly, no differences were 
noted in DNA content between gel types or strain conditions in this study, and confocal 
microscopy images demonstrated cells were viable at all time points. Thus, cell number is 
likely not a driving factor behind differences seen among different gel types or strain 
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conditions. In this study, DNA content was assayed using DNA collected from manually 
disrupted gels. Because gels were not completely degraded beforehand, the gel likely 
retained a significant fraction of total DNA. A brief experiment was conducted to 
compare manual disruption versus enzymatic gel degradation using MSCs encapsulated 
in fast-degrading, statically cultured gels. Results indicated that degrading the gels indeed 
resulted in a significant and dramatic increase in the assayed amount of DNA 
(Supplementary Figure B.2). This points to future use of enzymatic gel degradation to 
more accurately determine gel DNA content. Nevertheless, an overall decreasing cell 
number suggests that proliferation continues to be limited by a small hydrogel mesh size 
(169). Further work remains in providing space for cell proliferation in these materials 
while maintaining sufficient mechanical properties to allow tensile loading over relevant 
time periods. 
After loading for up to 14 days, MSCs embedded in both gel types were evaluated 
for expression of genes related to the tendon/ligament fibroblast phenotype (Figure 5.5). 
Scleraxis, a transcription factor expressed by tendon progenitor cells in developing 
mesenchymal tissues, is often considered a tendon fibroblast marker (65, 181, 241). In 
this study, scleraxis was minimally expressed relative to housekeeping genes (data not 
shown), and was maintained or downregulated in all groups. In contrast, scleraxis was 
upregulated in a study using rat MSCs in a collagen gel using the same strain amplitude 
and rate, but with no rest period over 7 days (65). Another study utilizing primary human 
MSCs in collagen gels showed maintenance of scleraxis expression under 1% strain at 1 
Hz for 30 min/day over 7 days (181). Finally, in a recent study, cells from a C3H10T1/2 
mesenchymal stem cell line in collagen gels upregulated scleraxis expression under 10% 
 89 
strain at 0.1 Hz with 10s rest periods (245). Variations in scleraxis expression from what 
was observed in this study may be attributable to differences in type of scaffold 
(collagen), cells, or strain regimen employed by other groups.  
MyoD expression was erratic and did not vary across gel types or culture 
conditions. The use of MyoD as an indicator and effector of myofibroblast differentiation 
is well established (242, 246, 247); however, while MyoD has been studied in examining 
MSC response to surfaces of different stiffnesses (173), the regulation of MyoD in 
tendon/ligament fibroblast differentiation has not been studied. Given the use of 
mechanical tension in this study, the downregulation of collagen I, and the presence of 
collagen III, there was a possibility that myofibroblast differentiation was occurring in 
MSCs in this system (248). The data seem to indicate that cells in this system are not 
differentiating towards a myofibroblast phenotype. Some studies have suggested that 
myofibroblastic differentiation is desired, and that myofibroblasts are simply “activated” 
fibroblasts (249, 250). However, myofibroblasts have been associated with inflammatory 
responses, including tendon disorders, wound healing processes, and fibrosis (242, 251). 
Further attempts to engineer tendon/ligament should account for myofibroblastic 
differentiation, whether in a cooperative or antagonistic approach. 
Contrary to some previously published reports (65, 89), collagen I gene 
expression was downregulated over time in all gels; however, although differences were 
shown between static and dynamic gels at day 7, this difference was not evident at day 14. 
These results differ from previous results in our laboratory using the same strain regimen, 
although those experiments used a scaffold that was not enzyme-degradable and MSCs 
from a different cell bank (89). The reason for the downregulation is unclear, although 
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one report suggests that some changes in gene expression are dependent on scaffold and 
cell orientation (252). Although cells were able to spread in these scaffolds, no alignment 
was visually detected over time in dynamically or statically strained samples in any 
hydrogel type (Figures 5.1 and 5.3). Since no orientation was observed in these gels, the 
lack of directional bias may have inhibited potential changes to collagen I expression. 
However, other results using bone marrow-derived MSCs in a collagen scaffold have 
indicated collagen I remains relatively unchanged under strain (181).  From 
immunostained sections, collagen I deposition was detected at day 1 and more intense 
staining was observed at day 14, regardless of gel and strain parameters (Figure 5.6). The 
deposition observed may simply be a reflection of a high resident level of gene 
expression observed at day 1 relative to other tested genes (data not shown); therefore, 
additional gene upregulation might not be expected in this system. 
Collagen III and tenascin-C are frequently used as markers of tendon/ligament 
fibroblast differentiation (9, 17, 59, 89, 253-255). Dynamically strained samples, 
regardless of gel type, demonstrated an increase in collagen III expression, both over time 
and relative to static samples. Correspondingly, immunostaining revealed collagen III 
staining only in dynamically strained gels. This correlates well with data from our 
laboratory and other studies (59, 89). Tenascin-C levels in all gels at days 7 and 14 were 
upregulated relative to day 1, with generally higher expression at day 7 relative to day 14. 
Importantly, however, dynamic samples exhibited significantly higher expression levels 
of tenascin-C relative to static samples on day 14.  Tenascin-C has been previously 
shown to be regulated by mechanical strain (256) but has also been speculated to play an 
‘inhibitory for spreading’ role that allows cells to modify adhesion contacts to avoid 
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overstretching (16). Thus, restricting the ability to alter cell shape under strain may have 
triggered increased tenascin-C expression in slow-degrading dynamic gels relative to 
fast-degrading dynamic gels on days 7 and 14. Differences in gene expression levels, 
however, were not readily correlated with immunostaining. Tenascin-C was detected at 
day 1 and day 14, with visually increased staining in all samples at day 14. The lack of 
differences between groups at day 14 may have been related to the consistent expression 
levels between groups on day 7. Longer culture times might provide tensile strain-related 
upregulation of gene expression more time to emerge in the form of increased staining at 
time points beyond day 14. 
In this study, all samples, whether statically or dynamically cultured, were 
removed from the tensile culture bioreactor for a minimum of 2 hours before RNA was 
extracted from cells. Limited information is available concerning the kinetics of gene 
regulation after applying mechanical strain to cells in orthopaedic tissues (257-259). In a 
study where chondrocytes were subjected to hyperosmotic loading, aggrecan promoter 
activity was maintained one hour after isosmotic loading was resumed but had returned to 
normal levels by the next time point, five hours after loading (257). Other studies have 
detailed effects of mechanical strain that last several hours. Strain-related 
phosphorylation of ERK1/2 in rat Achilles tendon fibroblasts in a fibrin gel required only 
10 minutes of strain, returned to basal levels after one hour, and the refractory period 
lasted six hours (259, 260). This suggests that downstream effects of ERK activation do 
not require strain to be applied beyond a short duration (261). In another study, chick 
embryo fibroblasts required a minimum of two hours of cyclic strain (10%, 0.3 Hz) 
followed by 4 hours of rest to upregulate tenascin-C expression levels (258). These 
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studies in tandem imply that transient changes in strain-linked gene expression may last 
through several hours. Collagen III and tenascin-C expression levels in dynamic samples 
were upregulated at day 14 relative to day 1 samples; both day 1 and day 14 samples 
were subjected to a period of cyclic strain with rest, suggesting that higher expression 
levels in tenascin-C are an adaptation to strain applied over time. Future studies could be 
performed to characterize the temporal aspects of strain-induced gene expression to 
optimize strain regimens for directing long-term construct culture.  
Together, the results of this study indicate that in a synthetic hydrogel system with 
highly controlled presentation of adhesive and degradable bioactive ligands, MSCs were 
shown to differentiate towards a tendon/ligament fibroblast phenotype based on changes 
in relevant gene expression and ECM deposition. This experiment, along with previous 
experiments in our laboratory (89), suggests that tendon/ligament differentiation can be 
recapitulated based on the application of mechanical strain, without providing natural 
cues in the form of a collagen, fibrin or fibronectin-based biomaterial. This experiment 
also suggests that the level of hydrogel susceptibility to MMP degradation, with 
corresponding changes in morphology of embedded cells, does not affect MSC response 
to cyclic tensile strain. However, it should be noted that, in these experiments, significant 
cell spreading was seen only at 14 days, which was the longest time point examined. A 
longer culture period may be needed to allow changes in spreading to affect gene 
expression levels accordingly. Alternatively, cells could be precultured in gels to allow 
spreading prior to tensile loading, as cell shape has been demonstrated as a potent 
influence on differentiation state (172). However, the interplay between mechanical strain 
and cell geometry on cell differentiation is not fully understood, and requires further 
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clarification (262). It is also possible that the inclusion of RGD peptides in all gel types, 
which interact with integrins on MSCs, might facilitate cytoskeletal interactions with the 
synthetic scaffold and enable sensing of mechanical strain (113). Thus, cells in slow-
degrading gels may be able to respond to tensile strain even if their ability to spread is 
limited. 
Finally the pericellular matrix surrounding a cell may factor into local principal 
strains experienced by the cells. Deposition of collagen I, collagen III, and tenascin-C 
were localized to encapsulated cells (Figure 5.6), which may reflect protein within or 
adjacent to the cell. In bone and cartilage tissues, it is believed that small strains can be 
amplified into larger strains via effects of fluid drag forces on the pericellular matrix 
surrounding an encapsulated cell (263-266). Moreover, factoring pericellular matrix into 
a finite element model of cell-matrix interaction in cartilage resulted in stress 
concentrations at the cell border due to different mechanical properties of the cell, the 
pericellular matrix and the extracellular matrix (214). In this study, any pericellular 
matrix secreted by cells could have factored into MSC response to strain by 
communicating forces different from macroscopic predictions (Chapter 4). Manipulating 
the expression and distribution of this matrix, and characterizing the mechanical 
properties of deposited matrix, could therefore permit the examination of pericellular 
effects on cell differentiation (267). A recent finite element model of fluid flow within 
tendon tissue was designed to predict fluid flow-induced shear stresses (217), but actual 
shear stresses in vivo are currently unknown. Synthetic gels could be employed as part of 
validating finite element models that predict shear stresses on encapsulated cells due to 
pericellular matrix deposition, and may shed insight into the effect of macroscopic strain 
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on shear stresses experienced by cells.  
 
5.5 Conclusions 
The experiments described here demonstrate that morphology of MSCs can be 
influenced by the degradability of the surrounding matrix. Similar to previous reports, 
MSCs embedded in our MMP-sensitive gels react to tensile strain through upregulation 
of collagen III and tenascin C, which are ECM molecules associated with the 
tendon/ligament fibroblast phenotype. However, little difference in response to tensile 
strain from cells embedded in either slow or fast-degrading gels was observed. Such 
results suggests that in these degradable, synthetic hydrogel systems, spreading may not 
be a major factor controlling MSC response to cyclic strain, at least over this time period. 
However, these findings further support this system as a well-controlled platform that 
allows exploration of the effects of matrix biochemistry on resulting cell response to 
exogenous cues, such as mechanical loading. As such, these experiments contribute key 
parameters toward the design of future biomaterial carriers and strain regimens to prime 






CONCLUSIONS AND RECOMMENDATIONS 
6.1 Summary 
 Tendon/ligament-bone interface model systems have the potential to provide 
critical design parameters for enhancing integration in clinical strategies to repair damage 
to tendon and ligament tissues. Determining the particular cell type, application of 
various external stimuli, and biomaterial design are some of the challenges still to be 
resolved to reproduce the biochemical and mechanical heterogeneity of the native 
interface. MSCs are frequently used as a cell source for tendon/ligament tissue 
engineering due to their ease of isolation and expansion (57) and their ability to 
differentiate into multiple cell types, including tendon/ligament fibroblasts (17). The 
overall goal of this dissertation was to examine how the roles of mechanical strain and 
matrix degradability regulate MSC behaviors such as morphology, migration and matrix 
deposition/gene expression to guide parameters for future design of heterogeneous 
biomaterials. Specifically, a method was developed for monitoring the vertical position of 
cells encapsulated within a laminated hydrogel. The effects of applying macroscopic 
strain on the local strain distribution within uniform and heterogeneous hydrogels were 
explored in a computational model. Finally, the role of scaffold degradability on changes 
in cell shape and resultant MSC gene expression/matrix deposition in response to cyclic 
strain was studied. Together, these studies provided insight into the contribution of 
scaffold degradability and cyclic strain on MSC morphology, movement and 
differentiation towards a tendon/ligament fibroblast phenotype as part of regenerating the 
interface between tendon/ligament and bone. 
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Chapter 3 investigated the effects of including protease-sensitive sequences into 
non-degradable PEG hydrogels on possible MSC and HT-1080 migration through a 
laminated hydrogel interface. In a hydrogel layer with cells that was laminated to a 
second enzymatically-degradable hydrogel layer, the Z-position of cells within their 
hydrogel layer could be observed and measured through 7 days of culture. However, 
definitive migration was not observed in this system. In a hydrogel laminated to another 
hydrogel polymerized in serum, increased percentages of cells appeared to extend outside 
the originally seeded gel from image analysis, but this could not be visually confirmed. 
These results suggest that the protease-sensitive peptide used was ineffective in enabling 
cell-directed degradation and are overall inconclusive with regard to enabling migration 
across the laminated interface. Techniques developed for characterizing cell position in 
3D, however, could act as the basis for useful analytical tools in designing future 
laminated hydrogels to monitor chemotaxis-related cell migration. 
 The studies in Chapter 4 characterized the range and distribution of local strain 
within a simulated hydrogel cultured within a tensile culture bioreactor. The designed 
finite element model revealed that strain within a tensile culture construct, as cultured in 
Chapter 5, was uniform throughout the material. When laminates with different interface 
geometries were formed, the distribution of strain remained unchanged. However, as 
individual laminated sections increased in relative stiffness, stress concentrations formed 
due to mismatches in modulus between laminated sections. Increasing the complexity of 
the interface geometry appeared to widen the distribution of local strains. As a first pass 
at validating assumption of complete elasticity in the model, measured OPF/PEG-DA 
construct stiffness was independent of strain rate. These results indicate that the model 
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accurately represents the local strain environment in terms of pure elastic response to 
strain. However, hydrogels possess other fundamental properties such as poroelasticity.  
Further refinements to account for these additional material considerations are needed to 
accurately model all mechanical factors in the local microenvironment. 
 Chapter 5 assessed the influence of increased scaffold degradability on changes in 
encapsulated human MSC morphology as well as MSC response to cyclic tensile strain 
over 14 days. More cells encapsulated in fast-degrading PEG hydrogels were spread 
relative to their slow-degrading counterparts at 14 days. Cyclic tensile strain upregulated 
collagen III and tenascin-C expression at day 14, in both types of gels, relative to both 
their day 1 and static counterparts. However, certain genes commonly associated with 
tendon/ligament fibroblast differentiation, such as scleraxis and collagen I, were either 
downregulated or maintained with cyclic strain over time. Interestingly, cells were 
observed to deposit increased cell-associated collagen I and tenascin-C in all sample 
types at 14 days. Cell-associated deposition of collagen III at 14 days was observed only 
in dynamically strained gels, regardless of gel type. Together, these results indicate that 
while cyclic tensile strain induces MSCs towards a tendon/ligament fibroblast phenotype, 
increased degradability appears not to affect MSC response, at least over this time period.  
Overall, the findings in this dissertation provide further clarity into the roles of 
biomaterial degradation and cyclic strain on cell spreading, migration and differentiation 





The research presented in this dissertation advances understanding of the roles 
that strain and material degradation play in tendon/ligament fibroblast differentiation and 
of the related considerations required in engineering the tendon/ligament-bone interface. 
Material properties were shown to affect the range and distribution of local strain within a 
biomaterial construct, and degradability was shown to lead to changes in encapsulated 
cell morphology, but had limited effects on cell response to cyclic strain in the 
experimental timeframe. One important concept in this work was the interplay of various 
material, mechanical, and temporal factors in inducing changes in encapsulated cell 
phenotype. 
Including enzyme-sensitive peptides into the backbone of the hydrogel facilitated 
cell-directed degradation and enabled complete degradation of gels with addition of 
exogenous enzyme. Degradation studies showed that complete degradation of a slow-
degrading PEG-based hydrogel could be accomplished if 50% (by weight) or more of the 
polymer formulation was sensitive to enzymatic cleavage. The two peptides used in these 
studies had varying rates of protease sensitivity, as evidenced by the time required to 
degrade the gels in exogenous solution (1 hour vs. 10 min) and the significant difference 
in cell morphology between human MSCs encapsulated in both types of gels (Figure 5.1). 
The data regarding spreading of bovine MSCs in OPF/PEG-DA gels doped with 
increasing concentrations of slow-cleaving PEG is also instructive; changes in cell 
circularity in these gels was dependent on the presence of the RGD adhesive peptide, not 
on the amount of slow-cleaving PEG present (Figure A.4). Further culture of hMSCs in 
these gels led to slight changes in morphology over time; however, significantly more 
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cells in fast-degrading PEG were spread compared to their slow-cleaving counterparts 
(Figure 5.2). The implication here is that the degradation kinetics of the peptide used was 
a significant factor in changes in cell morphology. Circularity analysis appeared to 
distinguish between relatively unadherent, adhered, and spread cells, based on the 
circularity data among various studies (Figures A.4 and 5.2). The circularity values are 
not directly comparable because images were not collected in exactly the same manner, 
and the cell types used in Appendix A and Chapter 5 were not identical. However, using 
a circularity of 0.7 to distinguish between spread and unspread cells, 30% spread cells 
represented cells in scaffolds without RGD; ~50-60% represented cells in materials with 
RGD; and ≥ 80% spread cells represented appreciable gel degradation. When studies in 
Chapter 3 were performed, a more easily cleaved sequence had not been developed; thus, 
significantly longer culture times would likely be necessary to see any large-scale, 
detectable changes in migration using the slow-cleaving sequence. Naturally, use of a 
more highly protease-sensitive PEG might enable such studies in a shorter timeframe. 
However, behavior of cells in PEG-based hydrogels would still be different than cells 
encapsulated in collagen or fibrin gels, where pore sizes are orders of magnitude greater 
(roughly 1 µm compared to ~20 nm) (167) and thus facilitate cell migration. Future 
experiments should perhaps employ PEG-based materials designed with greater pore 
sizes to hopefully enable comparable migration rates with natural polymer hydrogels. 
When hMSCs were cultured in the tensile culture bioreactor, directed cell 
migration was not studied, as there was no a priori reason to expect directed, large-scale 
cell movement as conceived in Chapter 3. However, in a system where multiple cell types 
are cocultured in the same construct, soluble factor communication between cell types 
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may induce chemotaxis-driven migration, as other coculture experiments in 3D have 
demonstrated (148). Naturally, gradients of chemotactic factors may also induce large-
scale cell migration in 3D as well. The work in Chapter 3 highlights the ability to capture 
the Z-position of encapsulated cells, providing additional information in coculture 
experiments where cells may migrate perpendicular to the plane of imaging. However, in 
laminated materials with multiple layers, a second prepolymer solution must diffuse into 
the first and create a mechanical link via interpenetration of the first layer (191). 
Therefore, the interface itself would likely exhibit a lower mesh size, impeding soluble 
factor diffusion as well as migration across the interface (203, 210). Migration also 
appears to be distance-dependent, concomitant with soluble factor diffusion between cell 
types (148). The use of degradable biomaterials thus enables further characterization of 
cell migration in 3D. With respect to interfaces, cell migration may be employed to 
populate and remodel regions that were previously cell-free (3, 78). However, use of non-
degradable and degradable areas in tandem, using a multi-layer structure, provides 
opportunities to study spatial aspects of interface tissue remodeling; for example, one cell 
type could be immobilized in a non-degradable layer, secreting soluble factors to induce 
chemotactic migration of a separate cell type into an area of different mechanical 
properties. Such a model could perhaps mimic aspects of ligament-bone interface 
formation – multiple cell types, variations in mechanical properties, and possible cell 
invasion/remodeling – in a highly configurable in vitro model using degradable 
biomaterials. 
The role of mechanical forces in tendon/ligament fibroblast differentiation has 
been previously studied (65, 89). Here, chapters 4 and 5 investigated the role of cyclic 
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tensile strain in MSC differentiation. Although cyclic strain has been previously shown to 
upregulate genes and deposit ECM associated with tendon/ligament fibroblasts in PEG-
based systems (89), the nature of the local strain environment was not known. Thus, in 
Chapter 4, a finite element model was designed in a hydrogel in the tensile culture 
bioreactor used in Chapter 5. The model predicted stress concentrations at areas of 
modulus mismatch; overall, however, the majority of local strains throughout the 
construct were between 9 and 10.5% (Figure 4.4). This result supported gene expression 
and matrix deposition from all locations in the gel as being sufficiently, consistently 
related to the application of 10% strain to be evaluated as one population. If substantial 
deviation in local strain was predicted, great care would have had to be taken in isolating 
particular regions of each gel to properly correlate local strains with the gene expression 
and ECM deposition of cells in each region. As such, the finite element model provided 
clarity into the possible range of local strains and clarified whether or not the gel could be 
evaluated as a single entity. The model also determined that the use of stiff polyethylene 
endblocks represented an improvement over a previous design; finite element modeling 
predicted large variation in local strains within the central region of the old construct 
(218). Thus, the development of this system significantly improves the uniformity of 
local strain throughout the material. However, in future development of interface tissue 
model systems, cocultures of different cell types, e.g. MSCs and osteoblasts, could lead 
to spatial differences in mechanical properties due to mineralized matrix deposition by 
osteoblasts (6). Alternatively, gels with laminated sections or graded stiffnesses could be 
used (174). Local strains in these gels would therefore not correlate with the magnitude 
of applied strain. Thus, the model presented here provides insight into the distribution of 
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strain due to mismatches in modulus, gives guidance for manipulating strain fields in 
future studies, and highlights the need for spatially mapping stiffness to provide a more 
accurate picture of how strains are distributed over the entirety of a heterogeneous 
material. 
The accuracy of any model depends on the accuracy of its input variables and the 
fidelity and reliability of its behavior. While the presented model provided an accurate 
first approximation of local strains within the hydrogel, additional data would be required 
to increase its accuracy and make conclusions regarding more precise claims, including 
the strains and forces are actually being applied to cells. Previous finite element models 
related to this system factored poroelasticity into the model (218); indeed, hydrogels are 
fundamentally poroelastic materials, as their weight is primarily water, and as water is 
free to flow in and out of the polymer matrix. Finite element models which model fluid 
flow on cells in 3D materials have shown that fluids moving within a tissue structure can 
induce shear stresses on cells (263-265). As a more precise explanation, this is thought to 
be due to fluid pulling on the pericellular matrix surrounding the cell, creating a drag 
force that amplifies local strain (266). In bone, this is thought to explain the paradox in 
bone tissue where tissue-level strains of < 0.2% produce biochemical responses in cells 
that require strains that are an order of magnitude higher in in vitro studies (266). Thus, 
fluid flow may be incorporated into finite element to determine more precise information 
about the cell's mechanical microenvironment. Such models have already been developed 
for tendon tissue (217), but not for in vitro gels in this system. Further characterization of 
any pericellular matrix deposited in these gels by encapsulated MSCs may shed insight 
into the role of fluid flow on strains experienced by MSCs. 
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The concept of modulus mismatch is a significant factor in the utility of the finite 
element model. Although the model predicted stress concentrations due to differences in 
stiffness between the gel and the polyethylene endblocks, variations in strain due to 
interface geometry were not detected when both sections of a laminate hydrogel had the 
same modulus. Limited information is available regarding the mechanical stiffness of the 
interface. As discussed previously, however, due to diffusion of the second prepolymer 
solution into the first, the interface itself would likely exhibit a lower mesh size and 
would therefore have different mechanical properties, as higher mesh size is correlated to 
lower modulus (210, 268). Characterization of the interface modulus, as well as 
knowledge of the dependence of interface dimensions on crosslinking time, would lead to 
differences in stiffness between the two laminated sections, and would generate 
subsequent variation in local mechanical strains. This could be performed via 
nanoindentation or atomic force microscopy (86, 223, 225) to measure surface properties, 
to provide a first pass approximation of differences in stiffness. Differences in stiffness 
would also be found at the cell-matrix interface due to potential disparities in the modulus 
of pericellular matrix. Here, cell associated collagen I, collagen III, and tenascin-C were 
detected at 14 days in some or all samples (Figure 5.6), which could indicate the presence 
of pericellular matrix. In cartilage, deposited pericellular matrix has also been shown to 
have a different modulus than surrounding ECM (269). This information has informed 
finite element models that predict strains at the cell-pericellular matrix interface that are 
greater than strains in the surrounding ECM (214, 270). Including the dimensions and 
mechanical properties of deposited ECM modulus (267) would provide a foundation for a 
finite element model of a cell’s mechanical microenvironment in these gels. 
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 Results of Chapter 5 revealed that MSCs undergoing cyclic tensile strain 
(modeled in Chapter 4) upregulated genes associated with tendon/ligament fibroblasts, 
including collagen III and tenascin-C (Figure 5.5). The variety of tensile strain regimens, 
cell types, and biomaterial scaffolds used in tendon/ligament tissue engineering makes 
direct comparison with individual studies difficult. However, combined with a previous 
experiment conducted in this laboratory (89), this chapter indicates that tendon/ligament 
fibroblast differentiation can be achieved in the absence of a natural biomaterial such as 
collagen, fibrin or fibronectin by using a completely synthetic scaffold with highly 
controlled presentation of adhesive and degradable ligands and cyclic strain. This work 
represents an important step forward in describing the sufficiency of mechanical strain 
alone in promoting ligamentous differentiation of MSCs encapsulated in an arbitrary 3D 
environment, and dissolves the notion that a complete recapitulation of the native 
environment is necessary to ensure desired changes in cell phenotype. 
It is important to note, however, that other genes representative of 
tendon/ligament differentiation were either maintained or downregulated over time, 
including scleraxis and collagen I. There is general agreement regarding the upregulation 
of collagen III and tenascin-C gene expression in cells undergoing cyclic strain (59, 89, 
125, 271-273). Less agreement exists with regard to scleraxis (65, 181, 245) and 
differences may indeed be attributable to the type of scaffold (collagen versus PEG in this 
study), cell type, or strain regimen. Collagen I expression is typically increased under 
cyclic strain, but upregulation is not consistent (65, 89, 181); in this work, cyclic strain 
only maintained collagen I expression through 14 days. However, resident collagen I 
expression levels were high relative to other tested genes (not shown), and collagen I was 
 105 
observed in immunostaining in all gel types, along with tenascin-C and collagen III 
(cyclic only) staining, at day 14 (Figure 5.6). Positive staining showed protein mostly 
localized around the cell; however, soluble secreted ECM molecules may have diffused 
from the gel and would not have been detected in immunostaining. Together, the 
variation in reports between gel types, strain regimens and scaffolds make it difficult to 
establish an accepted set of differentiation markers and strain regimens that induce 
upregulation of those markers. Moreover, it is unclear whether long-term application of 
cyclic strain, in a similar fashion to osteogenic and adipogenic differentiation protocols, 
induce a differentiation state in MSCs that is maintained even after strain is no longer 
applied. Thus, future refinement would help produce standardized conditions that could 
be used to properly evaluate the extent of tendon/ligament differentiation. 
 Interestingly, the gel type did not significantly influence the gene expression and 
ECM deposition of MSCs undergoing cyclic tensile strain. In this system, significant 
degradation (as measured by changes in cell shape) was only detected at 14 days; longer 
culture may be needed to allow time for degradation-driven changes to take hold. Gels 
may also be precultured in advance, to allow significant degradation to occur prior to 
cyclic loading. However, it is possible that mechanotransduction via integrin binding is 
primarily responsible for strain-induced changes in MSC behavior, enabling cells in 
slow-degrading gels to respond similarly even though degradation was restricted. Thus, 
cells could be cultured in degradable scaffolds that enable migration and material 
remodeling, allowing other aspects of cell behavior to be studied without significant 
changes to gene expression and ECM deposition as a result of using a degradable or non-
degradable material. Further study of degradability and its connection to MSC response, 
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however, would provide additional clarity.  
 
6.3 Future Directions 
The findings in this dissertation provided significant insight into the roles of 
biomaterial degradation and applied cyclic strain on MSC spreading, migration and 
differentiation towards a tendon/ligament fibroblast phenotype. Future work can utilize 
the insights gained from this dissertation, where cell behavior was mostly studied in 
homogeneous materials, as a foundation for future studies that apply degradation and 
strain to heterogeneous biomaterials to gain biological insight for improving interface 
tissue engineering therapies. 
The ability of cells to migrate within their environment can be exploited in the 
design of biomaterial models used to provide insight into how cells infiltrate and remodel 
tissues. The studies in this dissertation provided limited conclusions regarding the extent 
and control of migration. However, the use of synthetic materials with engineered 
protease sensitivity equivalent to natural polymers, or a similarly controllable system for 
degradation, would allow for characterization of cell migration as a function of matrix 
degradability. Additionally, directed (and thus not random and non-specific) migration 
could be studied using a defined bioreactor system to generate defined concentration 
gradients of soluble factors within a biomaterial. Such a system would allow for a 
combinatorial approach to investigating the factors responsible for enabling or restricting 
cell migration, and could utilize techniques developed in this dissertation for tracking 
migration on a large scale. For example, one could study the extent of migration over 
time, the length and variation in chemotactic gradients of a given factor that are required 
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to elicit cell migration, permissiveness of the biomaterial matrix to soluble factor 
diffusion, or the volumetric density of degradation ligands for encouraging or restricting 
movement. Together, a controlled design would enable a combinatorial approach to 
explore univariate or multivariate factors in driving cell migration. Such a biomaterial 
system could also provide opportunities for investigating other factors in cell migration, 
including durotaxis- and haptotaxis-driven mechanisms. For example, gradients of 
stiffness in hydrogels generated by differential crosslinking times, or control of specific 
integrin binding through targeted peptide sequences, would be highly valuable in 
characterizing other aspects of migration in 3D. 
Although migration due to chemotactic factors was briefly explored in this 
dissertation, what was not explored was cell migration, gene expression, and ECM 
deposition in response to paracrine signaling due to coculture with another cell type. 
Knowledge regarding the extent of chemotaxis in 3D may prove useful before even 
attempting to place cells in coculture; for example, coupling matrix degradability with 
coculture may encourage cell migration due to chemotactic factors released by one cell 
type, placing both cell types closer in proximity and further enhancing the effect of 
possible paracrine signaling. A priori knowledge of the effect of soluble factors, then, 
would elucidate whether cell migration could occur to a substantial degree in a particular 
system due to coculture, and would provide insight into whether migration would be 
necessary in terms of encouraging ECM deposition and remodeling of a biomaterial 
construct designed for regenerating an interface. Coculture also adds an additional layer 
of complexity due to possible crosstalk between cell types – both via paracrine and direct 
cell-cell contact – and it will be necessary to carefully distinguish the effects of paracrine 
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crosstalk from the other individual stimuli in a tensile culture bioreactor - namely strain, 
scaffold degradability, other mechanical factors, time, and exogenously added soluble 
signals.  
While finite element modeling demonstrated that local strain fields vary with 
variations in stiffness and interface geometries, the exact mechanical perturbations that a 
cell ultimately senses remain unknown. Future work could modify the finite element 
model to account for the effects of poroelastic fluid flow on forces acting on the cell. The 
effect of strain on an individual cell could also be predicted more accurately by 
accounting for different cell geometries based on possible changes in cell shape. 
Characterizing the mechanical properties of the interface would also provide additional 
information to the model; differences in modulus between the interface and the gel itself 
would lead to stress concentrations, and, owing to its likely increased modulus, possibly 
reduce local strain at the interface, further broadening the distribution of strain. 
Furthermore, cells encapsulated in these gels were shown to deposit cell-associated 
matrix over time. As this process occurs, strain fields within the construct could be 
significantly altered. This would also occur in laminates seeded with different cell types, 
such as MSCs in one layer and osteoblasts in another; long-term culture could further 
modify local strain fields due to spatially targeted deposition of ECM with different 
mechanical properties, such as mineralized matrix. Measurement of local mechanical 
properties over time would provide additional parameters to refine the accuracy of the 
finite element model, and could elucidate the changing influence of mechanical strain as 
the construct is remodeled by encapsulated cells. 
Throughout development of future constructs, continuous employment of finite 
 109 
element modeling would provide a basis for interpreting the contribution of various 
mechanical factors – whether passive mechanical properties or active mechanical stimuli 
– on the experimental performance of the model/construct design. In addition to 
experiment analysis, modeling could also be used to inform future construct designs; with 
an accurate model, ever more complex geometries and heterogeneities could be explored 
to predict theoretical strains experienced by encapsulated cells in elaborate 3D tissue 
structures. Models which capture the temporal and spatial effects of tensile strain, then, 
could provide insight into the design of future clinical solutions for tendon/ligament 
tissue replacement; for example, localizing macroscopically applied strain to an MSC-
seeded soft section of a tissue engineering construct by designing an osteoblast-seeded 
stiffer section, or designing constructs to induce spatially targeted differentiation in 
different regions of a construct based on mechanical strain alone. The distribution of 
strain, as well as its resulting effects on construct development, would not be known in 
advance unless finite element modeling were performed. 
Some of the aforementioned proposed studies – the nature of chemotactic 
migration in 3D, the nature of cell migration and crosstalk in coculture, and 
spatiotemporal changes in local distributions of strain – are combined in the study of 
interface tissues, where the development of heterogeneity may require the interaction of 
mechanical forces, materials with bioactive functionality, cell migration within the 
interface region, and crosstalk between the constituent cell types adjoining the interface. 
For example, interfaces between orthopaedic tissues – whether cartilage-bone, meniscus-
bone, tendon/ligament-bone, or muscle-tendon – contain a great deal of heterogeneity in 
their biochemical and mechanical characteristics. As an example, a tissue engineering 
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model system could be designed to support a coculture of cell types representing 
adjoining sides of the interface, using chemotactically-induced migration to populate a 
region with cells. Over time, the changing mechanical properties of the interface region – 
perhaps modeled in advance – could lead to spatially targeted cell differentiation due to 
local differences in strain. Here, the studies in this dissertation provide a base for 
monitoring cell migration, modeling local strains within heterogeneous materials, and 
characterizing the effects of scaffold degradability on strain-linked differentiation. 
With regards to non-orthopaedic tissues, synthetic, degradable, heterogeneous 
biomaterials could be designed to model other tissue interfaces and characterize the role 
of cell migration in their development or repair, with the additional factor of mechanical 
loading in influencing cell differentiation. In other tissues, such as blood vessels and skin, 
the heterogeneity of these tissues could be simulated by multi-layer degradable 
biomaterials to characterize the nature of cell migration in events such as inflammation 
and wound repair. Gaining a clear picture of migration through various interface regions 
would provide insight into the nature of remodeling in these tissues. 
In considering other future work, current studies only investigated changes in 
degradability of the matrix as it related to changes in cell shape, gene expression, and 
ECM deposition in response to cyclic tensile strain. Changes in cell shape have been 
shown to affect MSC differentiation in mixed media, but these studies have been done in 
2D. Although control of adhesion and 3D shapes would not be as easily designed in this 
system as on a 2D surface, nevertheless, this system may allow for studying similar 
effects of cell shape on other types of MSC differentiation (either osteogenic or 
adipogenic) in 3D. By extending this experiment to laminated structures with different 
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materials and cells in each layer, changes in cell shape could be restricted to cells in 
certain layers. This would enable the additional investigation of effects of cell shape 
and/or cytoskeletal organization on cell response to coculture, that is, paracrine signaling 
between cell types. 
Questions abound regarding the role of MSCs and differentiation towards a 
tendon/ligament fibroblast phenotype as it pertains to engineering of the interface. While 
tendon/ligament fibroblast differentiation is typically marked by collagen I, collagen III 
and tenascin-C gene expression and ECM deposition, it is unclear whether this 
"tenogenic" differentiation state is an end state similar to adipogenic, chondrogenic, or 
osteogenic differentiation, in which a cell's phenotype is difficult to reverse. It is also 
unknown whether strain induces permanent effects on cell behavior. If "tenogenic" 
differentiation is fragile, induced differentiation may not be retained following in vivo 
implantation and ex vivo preculture would prove ineffective. To answer these questions, 
the biomaterials used in this work could be applied; the enzyme-degradable hydrogel 
allows for complete degradation of gels and recovery of encapsulated cells. Different 
periods of tensile culture, followed by subsequent endpoint differentiation assays, then, 
would provide useful information regarding the permanence of markers indicative of the 
tendon/ligament fibroblast phenotype. For example, MSCs could prove to be functionally 
equivalent in tissue engineering applications when compared to fibroblasts harvested 
from native tendon/ligament tissues. Alternatively, tendon/ligament fibroblasts could lose 
upregulated levels of gene expression and ECM deposition following extended culture 
periods without tensile strain.  
The results in this work also pave the way for exploring new paradigms in tendon 
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tissue engineering. Traditionally, biomaterials are used as carriers for cells and are 
implanted in vivo to replace damaged tissues. However, the use of an enzyme-sensitive 
polymer in this study enabled complete degradation of hydrogels. Cells could be 
retrieved following two weeks of culture in a biomaterial environment where multiple 
inputs were applied to induce desired differentiation. Thus, cells could be "primed" to 
express certain desired genes and deposit desired matrix ex vivo, and could be applied to 
an injury site in vivo to deposit matrix with higher efficiency compared to unprimed cells. 
If cells were observed to retain gene upregulation and ECM deposition following tensile 
culture, biomaterials could be viewed as a method for preparing cells for therapeutic 
injection into desired locations.  
Together, the information gleaned from the studies in this dissertation provide 
important information for future directions in interface tissue engineering. Techniques 
developed for determining cell position on a large scale can be expanded in future tissue 
engineering models to monitor cell migration through complex model structures. 
Additionally, the characterization of the effect of macroscopic strain on local strain 
distributions in heterogeneous hydrogels provides insight into future interface designs 
employing strain. For example, materials could be designed to localize the effects of 
macroscopic strain to particular areas of a material, using mechanical properties to 
increase tendon/ligament fibroblast gene expression and matrix deposition in spatially 
targeted areas. In combination, migration and strain-linked differentiation can be 
employed in studying the development of interfaces using cocultures and other 
heterogeneities in construct formation. 
The use of synthetic biomaterials enables the precise presentation of adhesive and 
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degradable ligands to encapsulated cells. By recapitulating native ECM properties in a 
3D material, cell behaviors can be precisely studied in a system that mimics a cell's 
natural microenvironment. Adjusting biomechanical and biomaterial parameters enables 
the study of cell spreading, migration, gene expression and ECM deposition in response 
to system perturbation, and provides insight into the design of strategies for regenerating 
tissues. The model systems developed in this dissertation illustrate the complexity of 
materials with designed heterogeneity and the need for careful investigation of individual 
material or mechanical parameters in these systems, but provide useful tools for the study 
of complex, multi-layer structures in which heterogeneities are explicitly designed. These 
systems can be used in future experiments to study the contributions of individual cell 
behaviors, such as cell migration and strain-linked differentiation, on the overall 
remodeling and development of complex tissue structures. Model systems built from the 
experiments presented in this work also have applications in other tissues, where similar 
concepts of cell invasion, differentiation in response to mechanical forces, and response 
to soluble factors, to name a few, may be individually and collectively evaluated for 






CHARACTERIZATION OF INCLUSION OF ENZYME-SENSITIVE PEPTIDES 
IN PEG-BASED HYDROGELS 
A.1 Introduction 
 Poly(ethylene glycol) (PEG)-based synthetic hydrogels have been employed for 
tissue engineering applications due to their cytocompatibility, intrinsic ability to resist 
protein adhesion, and relative ease of customizing gels with specific bioactive 
functionality (10). One such functionality is the sensitivity of the gel to enzymatic 
degradation, a capability that natural polymer-based hydrogels inherently retain. To 
engineer enzymatic degradation in these synthetic scaffolds, a variety of matrix 
metalloproteinase (MMP)-sensitive sequences have been integrated into these hydrogels 
– that is, LGPA (133), GPQGIWGQ (166), and more recently, VPMSMRGG (140). 
Although the LGPA sequence has never been compared to the other two peptides, the 
latter two sequences have been directly compared, with VPMSMRGG demonstrating 
highly increased sensitivity to MMP-1 and MMP-2 compared to GPQGIWGQ (140). 
Gels formed from LGPA and VPMSMRGG have been shown to degrade upon 
administration of protease (133, 140). However, the effects on fold swelling and the 
ability to degrade due to different concentrations of enzymatically-degradable PEG in a 
previously non-degradable polymer formulation (OPF 10K:PEG-DA 50:50 wt%) were 
unknown. Furthermore, the ability of homogeneously distributed, encapsulated cells to 
spread in these gels was also untested. This work 1) details the characterization of gel 
properties and degradation in response to varying concentrations of enzymatically-
degradable PEG, 2) describes changes in cell morphology over 7 days when encapsulated 
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in enzymatically-degradable gels, and 3) provides a brief comparison of the differences in 
degradation between the LGPA and VPMSMRGG sequences. In these studies, PEG-
based gels formed with the LGPA peptide were found to be relatively slow-cleaving, 




A.2.1 Polymer synthesis 
To characterize hydrogel degradation, a mixture of various ratios of OPF 10K, 
PEG-DA, and enzymatically-degradable PEG were studied. OPF 10K and PEG-DA were 
synthesized and characterized as described (Section 5.2.1). Enzymatically-degradable 
PEG, both slow-cleaving (Acrl-PEG-GGGLGPAGGK-PEG-Acrl) and fast-cleaving 
(Acrl-PEG-GGVPMSMRGGGK-PEG-Acrl), were synthesized as previously described 
(Section 5.2.1). In cell studies, the peptide GRGDS was added to enable cell adhesion to 
the hydrogel via a monoacrylated PEG tether; Acrl-PEG-GRGDS (RGD) was also 
synthesized as previously described (Section 5.2.1). 
 
A.2.2 Fold swelling and degradation of OPF/PEG-DA gels with slow-cleaving PEG 
Total polymer was 10% of initial total gel weight. Polymer formulations consisted 
of two components: first, slow-degrading PEG; second, a mixture of 50% OPF 10K and 
50% PEG-DA by weight. Thus, a 50% slow-degrading PEG hydrogel would consist of 
50% slow-degrading PEG, 25% OPF 10K, and 25% PEG-DA by weight; a 0% slow-
degrading PEG gel would contain only OPF 10K and PEG-DA. After dissolving the 
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polymer formulation in phosphate buffered saline (PBS; Invitrogen, Carlsbad, CA) and 
sterile filtering, 18 mM ammonium persulfate (APS; Sigma-Aldrich) and 18 mM 
tetramethylenediamine (TEMED; Sigma-Aldrich) were used to thermally crosslink each 
gel for 10 min. 0%, 10%, 25%, 50%, 75%, 90%, and 100% slow-degrading PEG gels 
were polymerized in Teflon molds to create cylindrical gels 6 mm diameter and 1 mm 
thick. Gels were then swollen in PBS for 24h. One group of hydrogels remained in PBS 
over the time course of the experiment as a control. Another group of gels was instead 
immersed in PBS with 1 mg/mL collagenase type II (210 units/mg), 3 mM CaCl2, and 10 
µL/mL antibiotic/antimycotic solution (A/A; Mediatech, Manassas, VA), sterile filtered 
and refreshed daily. Gels (n=4) were weighed and lyophilized at 12h, 1d, 3d and 7d after 
initial swelling. Fold swelling was calculated as wet weight/dry weight. 
 
A.2.3 Cell source 
Bovine marrow stromal cells (MSCs) were harvested via a previously described 
protocol (118). The femur and tibia of an immature calf were isolated (Research 87, 
Boylston, MA), and marrow was placed into low glucose DMEM containing 10% FBS, 
10 mL/L A/A, and 0.01% basic fibroblast growth factor (bFGF; PeproTech, Rocky Hill, 
NJ). The resulting tissue was then physically disrupted by repeatedly pipetting using 50 
and 10 mL pipettes, followed by 16, 18 and 20 gauge needles. After centrifugation, the 
fatty layer was removed and the mixture was plated for 30 min to allow rapidly adhering 
cells to adhere to tissue culture plastic. The remaining cells in solution were then 
expanded in T-150 tissue culture flasks until confluency, then placed in Dulbecco’s 
Modified Eagle Medium (DMEM; Mediatech) with 20% fetal bovine serum (FBS; 
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Hyclone, Thermo Fisher, Waltham, MA) and 10% DMSO and stored in liquid nitrogen 
until further use.  
 
A.2.4 Cell spreading study 
Hydrogels containing 0%, 25%, 75% and 100% slow-degrading PEG were 
studied. After sterile filtration, bovine MSCs were homogenously seeded at 20x106 
cells/mL hydrogel and the resulting polymer/cell solution was polymerized in 6 x 1 mm 
Teflon molds. Following gelation, constructs were placed in media and incubated at 37ºC 
and 5% CO2. Media was changed 1h and 1d after gelation. At 3d, gels (n=4) were stained 
with LIVE/DEAD dye (Invitrogen) and imaged using an LSM 510 confocal microscope 
(Zeiss, Thornwood, NY). For each gel, five images were taken ~200 µm under the 
construct surface. MSC circularity was determined in an automated fashion using custom 
software macros written for ImageJ (NIH). Circularity is defined as 4πA/P2, where A and 
P are the cell area and perimeter, respectively; 1.0 is a perfect circle. The green channel 
of each image was thresholded (80 out of 255; number chosen arbitrarily) and particle 
analysis was performed for each image, providing the circularity of each particle (cell or 
aggregate) in each image. Circularities were accumulated across the images taken for 
each gel. 
 
A.2.5 Comparison of MMP-sensitive peptides 
Hydrogels formed with different enzymatically-degradable peptide sequences 
were fabricated and degraded as follows. Three polymers were tested: Fast-degrading 
MMP-sensitive PEG, slow-degrading MMP-sensitive PEG, and a 50:50 wt% mixture of 
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OPF 10K and PEG-DA (non-degradable). Each polymer was dissolved in phosphate 
buffered saline (PBS) to create a 90 wt% water solution, then sterile filtered using a 0.2 
µm glass prefilter (Nalgene). 0.07 wt% Irgacure 2959 (D2959; Ciba) in PBS/dimethyl 
sulfoxide was added to enable photopolymerization using UV light. Liquid prepolymer 
was deposited in autoclaved Teflon molds and exposed to UV light (10.5 mW/cm2; 365 
nm; UVP) for 10 min to fabricate 6 mm diameter x 1 mm thick gels. Gels were swollen 
in PBS overnight and then deposited in sterile-filtered PBS with 4 mg/mL collagenase 
type II (Invitrogen). Plates were then placed on a shaker plate shaking at ~1 Hz. This 
solution was refreshed every 2 days. To characterize gels (n=4), fold swelling was 
calculated by Ww/Wd, where Ww is the wet weight of the hydrogel, and Wd is the weight 
of the hydrogel after drying. 
 
A.2.6. Statistical analysis 
 Results are reported as mean ± standard deviation. For statistical analysis, all data 
were transformed using a Box-Cox transformation (243). One-factor and two-factor 
ANOVA with Tukey’s post hoc multiple comparison test were performed accordingly on 
the transformed data, with statistical significance with p ≤ 0.05 to indicate significance 
between individual samples. For fold swelling/degradation data, the factors were day and 





A.3.1 Gel degradation 
 
 
Figure A.1. Changes in fold swelling in hydrogels containing various amounts of 
slow-degrading PEG (by weight) in PBS over 7 days (n=4). * indicates significantly 
different than 0% slow-degrading PEG at each time point. Only comparisons to 0% 
slow-degrading PEG are shown for clarity. 
 
Hydrogels with varying composition of slow-degrading PEG also showed 
variability in their fold swelling after fabrication (Figure A.1). Of note, at days 1, 3, and 7, 
gels composed of 10%, 25%, and 50% slow-degrading PEG were significantly higher 
than 0% slow-degrading (100% OPF/PEG-DA) hydrogels. Further addition of slow-
degrading PEG to the hydrogel formulation appeared to decrease the resulting fold 
swelling of the crosslinked polymer to be statistically comparable to 0% slow-degrading 
PEG gels. Finally, gels that were completely fabricated from slow-degrading PEG 





Figure A.2. Changes in fold swelling in hydrogels containing various amounts of 
slow-degrading PEG (by weight) in collagenase solution over 7 days. All gels ≥ 50% 
slow-degrading PEG degraded within 0.5d (12h; not shown). § indicates 
significantly different from all other time points. * indicates significance compared 
to 0% slow-degrading PEG only; ¶ indicates significantly different from both 0% 
and 10% slow-degrading PEG. 
 
When gels containing varying concentrations of slow-degrading PEG were 
immersed in collagenase solution, gels containing ≥ 50% slow-degrading PEG degraded 
within 12 h (not shown). 25% slow-degrading PEG gels had a significantly higher fold 
swelling than the other two formulations, but all gels remained whole over 7 days. 
Following immersion in collagenase, the fold swelling of all gels was significantly higher 
than their respective gels in PBS. 10% gels were only higher than 0% gels at 0.5d and 1d 
after addition of collagenase. 25% slow-degrading gels remained significantly higher 
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than their 10% and 0% counterparts at all time points. 
 
A.3.2 Confocal Imaging and Circularity Analysis 
 
 
Figure A.3. LIVE/DEAD stained confocal images of bovine MSCs encapsulated 
within 0% and 100% slow-degrading PEG gels at 3 days. Pictures indicate 
spreading within all hydrogels containing RGD at 3 days, regardless of the 
formulation used. Scale bar and inset dimensions are 100 µm. 
 
 
 Confocal imaging revealed that bovine MSCs were viable following 
encapsulation in 0% and 100% slow-degrading PEG gels (Figure A.3). Upon visual 
inspection of microscopy images, there were no apparent differences in cell morphology 
between cells in 0% and 100% gels without RGD. In gels with RGD, there were 
noticeable changes in morphology indicative of cell spreading, but these changes 
occurred in both 0% vs 100% gels with RGD. This visual observation was confirmed in 
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circularity analysis of the confocal images (Figure A.4). The addition of RGD shifted the 
distribution of particle circularities towards lower values, and significantly increased the 
fraction of cells below a circularity of 0.7 in all gel types. However, there was little 
difference between gels with varying concentrations of slow-degrading PEG; the only 
difference noted was a significant decrease in the fraction of “spread” cells in 100% gels 
relative to 75% gels. 
 
 
Figure A.4. Particle analysis of LIVE/DEAD images (green channel only) of bovine 
MSCs encapsulated within 0%, 25%, 75%, and 100% slow-degrading PEG gels 
with and without RGD (n=4) at 3 days. a) Percentage of cells with less than 0.7 
circularity. a) Distributions of particle circularities were combined for 100% slow-
degrading gels with and without RGD (n=4). * indicates different from other RGD 
condition; # indicates significantly different from 75% slow-cleaving PEG with 
RGD. 
 
All three types of hydrogels – non-degradable, slow-degrading, and fast-
degrading - swelled in PBS overnight, with no differences between gel types after initial 
swelling (Figure A.5). Only one difference in fold swelling between non-degradable and 
fast-degrading gels in cell culture media was detected at 1 day. No changes in fold 
swelling were noted at 7 days. Upon gel exposure to collagenase, MMP-sensitive gels 
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degraded rapidly as expected; slow-degrading gels degraded in 1 hour, while fast-
degrading gels degraded in under 10 minutes (data not shown). In contrast, non-
degradable gels remained unchanged in collagenase solution over 7 days. 
 
Figure A.5. Fold swelling of hydrogels in culture media and in PBS with collagenase 
solution at 0 days, 1 day and 7 days. § relative to non-degrading gel (n=4; p ≤ 0.05). 
 
 
A.4 Discussion and Conclusions 
The incorporation of varying concentrations of slow-degrading PEG into the 
hydrogel formulation modified the resulting fold swelling ratio of the hydrogels (Figure 
A.1). Upon addition of a low concentration of slow-degrading PEG, OPF:PEG-DA gels 
abruptly increased in fold swelling; however, 100% slow-degrading PEG gels swelled 
less than 0% slow-degrading PEG gels at all time points. Enzymatically-degradable PEG 
was calculated to have an expected molecular weight of 7600 Da, well below the Mn of 
OPF 10K (19,800 Da) but higher than PEG-DA (3800 Da). Number average molecular 
weight and polydispersity index were not calculated for slow-degrading PEG following 
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fabrication, so the exact purity was unknown. However, fold swelling is linked to mesh 
size (104, 167, 274), and 100% slow-degrading gels polymerized and swelled less than 
non-degradable gels. As a hydrogel cannot be formed with poorly unconjugated products 
(275), this data provides confidence that a significant majority of the peptide conjugation 
product is presumed to be correctly conjugated. The increased fold swelling upon 
addition of a small amount of slow-degrading PEG is attributed to the modified nature of 
the crosslinked network due to different reactivities of the fumarate and acrylate groups 
(104, 109). 
Upon immersion of hydrogels formed from different ratios of slow-cleaving PEG 
and non-degradable OPF:PEG-DA in collagenase solution, hydrogels degraded 
commensurate to the amount of slow-degrading PEG (Figure A.2). While gels with more 
than 50% slow-cleaving PEG degraded by 12 hours, gels with less slow-cleaving PEG 
changed fold swelling and remained mostly unchanged over 7 days. The immediate 
change in fold swelling in 10% and 25% gels, demonstrates the high activity of the 
collagenase for degrading protease-sensitive peptides in the hydrogel backbone. Thus, 
cells could release enzymes to degrade the hydrogel locally surrounding the cell. 
Interestingly, 0% slow-degrading gels slightly increased in fold swelling over 7 days. 
This is attributed to ester hydrolysis-mediated degradation in OPF (102). 
Confocal images demonstrated that bovine MSCs were viable when encapsulated 
in PEG gels with various concentrations of slow-degrading PEG gels (Figure A.3). 
Spread cells were observed in all gels with RGD, regardless of the concentration of slow-
cleaving PEG. MSCs in gels without RGD displayed a mostly rounded morphology, in 
agreement with other work in PEG gels (169). Moreover, non-degradable gels were not 
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susceptible to enzymatic degradation (Figure A.5). This data would seem to imply that, in 
these gels, inclusion of adhesive sites was the main influence on changes in cell 
morphology, rather than proteolytic degradation.  
In these experiments, hydrogels were fabricated using two established MMP-
cleavable peptides with different MMP sensitivities (133, 140). Fabricated gels showed 
no statistical differences in fold swelling (Figure A.5), indicating that no differences exist 
in initial mesh size between the two hydrogel types (104). Bovine MSCs did not appear 
to spread in response to enhanced sensitivity to degradation; however, the data suggests 
that degradation was not sufficiently enhanced to enable increased cell spreading over 7 
days. Following exposure to collagenase, both slow-cleaving and fast-cleaving gels 
degraded in less than one hour. Although exact degradation kinetics of the LGPA peptide 
used in slow-degrading PEG are not known, the empirical study in this work identified a 
substantial difference in degradation time between slow- and fast-degrading hydrogels. 
The difference in time of degradation represents an effective difference in sensitivity to 
enzymatic degradation, and this is eventually reflected in comparisons in spreading 
between slow-cleaving and fast-cleaving gels in tensile culture (Figure 5.2). Importantly, 
enzyme-sensitive gels remained unchanged in culture medium over one week, 
demonstrating that active collagenase enzyme, and not other factors in medium, was the 
main effector of changes in hydrogel integrity. 
The work here allows for several important conclusions. First, local and bulk 
degradation of the gel can occur at a rate related to the enzymatic susceptibility of the 
particular peptide. Secondly, enzyme-sensitive gels can be completely degraded, possibly 
enabling retrieval of encapsulated cells. Finally, the disparity in degradation time 
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between different peptides, linked by the identical capability to degrade both gels 
completely, laid the foundation for studies in Chapter 5, where enhanced proteolytic 








B.1 F-actin in hMSCs in Slow- and Fast-Degrading PEG Hydrogels 
 
 
Figure B.1. AF546-phalloidin-stained hMSCs in fast-cleaving and slow-cleaving gels 
at 14 days (n=1). Each image was taken from a different region in the gel. Scale bar: 
100 µm. 
 128 
Tensile constructs were fabricated using slow-degrading or fast-degrading MMP-
cleavable PEG, seeded with MSCs, and statically cultured as specified in Section 5.2.4. 
At 14 days, gels (n=1) were removed from the bioreactor and incubated in PBS for 30 
min. Gels were then immersed in 10% formalin for 30 minutes at 4ºC, rinsed for 30 min 
in PBS, and stored in PBS at 4ºC. Gels were permeabilized with PBS containing 1% 
Triton X-100 for 30 min. Following permeabilization, gels were stained for 90 min, with 
gentle shaking, in PBS containing 1:50 Alexa Fluor 546-phalloidin (Invitrogen) and 5% 
FBS. After staining, gels were rinsed three times on a shaker plate in PBS for 15 min 
each, and then imaged on a confocal microscope (Zeiss LSM 510). Three stacks 100-200 
µm thick (5 µm interval) were taken from each gel. In ImageJ, each stack was flattened 












Figure B.2. DNA content in fast-cleaving static gels at day 1. * indicates significance 
relative to crushed samples (n ≥ 5; p < 0.05). 
 
 
Tensile constructs were fabricated using fast-degrading MMP-cleavable PEG, 
seeded with MSCs, and statically cultured as specified in Section 5.2.3. At 1 day, 
hydrogels (n=7) were split in half with a scalpel and the wet weight of each half was 
measured. One half of each hydrogel was crushed with a pellet grinder and processed for 
DNA content according to the protocol provided in Section 5.2.5. The other half of each 
hydrogel was placed in sterile-filtered (0.2 µm, Nalgene) culture medium with 4 mg/mL 
collagenase type II (Invitrogen), then shaken gently on a shaker plate for 30 min in a cell 
culture incubator at 37ºC. Gels degraded completely within that time. Each sample was 
centrifuged and supernatant was removed. After rinsing in PBS, samples were processed 
for DNA content as previously specified. Data analyzed using Student’s two-tailed t-test. 
Gel sections that were degraded resulted in significantly more DNA, approximately 8 

























C.1 OPF Synthesis 
Fumaryl Chloride (FuCl) Distillation (if necessary) 
Warning: Fumaryl chloride has a very pungent odor.  Work only in the fume hood with 
the sash down as far as possible.  Double glove, and leave jars, glassware, used gloves in 
the hood overnight to air out.   
1. Wash and dry:  
2 x 500 ml round-bottom flasks, 1 x joint for thermometer, 1 x thermometer to fit 
joint (~160°C), 1 x large condenser, 1 x glass elbow, 1 x joint for desiccators,  
1 x glass stopper, 1 x glass funnel, 1 x egg-shaped FuCl stir bar.   
2. Set up the distillation apparatus as shown, without the FuCl flask and collection 
flask: 
 
3. Replace the 500 ml collection flask with a 100 ml round bottom flask to collect 
the first 30 ml of distillate.   
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4. Clamp the apparatus to the scaffolding in the back of the fume hood.  
5. Vacuum grease and clamp all connections.   
6. Run cold, ice water UP the condenser tube using the circulation pump. This 
allows any bubbles to flow up and out of the condenser.  Make sure that the 
circulation pump is not actively heating the water by turning the temperature 
control all the way down to -20°C. 
7. Tie a KimWipe around the bottom of the condenser to catch external 
condensation.  
8. Use the funnel to pour 150 ml (100 g) of FuCl into a 500 ml round-bottom flask.   
9. Add the FuCl stir bar into the FuCl flask.   
10. Vacuum grease the FuCl flask, and connect the flask to apparatus.   
11. Place the flask in heating mantle with magnetic stirring at ~3.   
12. Insulate the flask and neck with glass wool all the way up to the condensing tube 
to promote boiling and prevent condensation.   
13. Start the transformer at 40 units.   
14. Increase the transformer by 10 units, every 5 minutes.   
15. Increase the transformer until the vapor temperature is 160°C (~80 units on 
transformer).   
16. Dispose of the first ~30 ml of distillate by turning the neck up, removing the 1st 
100 ml collection flask, and quickly replacing it with a clean 500 ml round-
bottom flask.  
17. FuCl distillate should be a light amber color.   
18. The solution in the heated FuCl flask will become darker and more viscous.   
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19. When ~50-75 ml remains the heated FuCl flask and the solution is dark brown, 
turn off the transformer, remove the glass wool, turn the condenser off, and 
replace the heating mantle with a cork ring.  
20. Stopper the FuCl distillate, parafilm the stopper, cover the flask with aluminum 
foil, and label it.   
21. Store the distillate in the 4°C explosion-proof refrigerator.   
22. Dilute the FuCl waste with tap water, and leave it in the hood overnight.  Be 
careful of HCl production in the reaction with water, and pour the water in 
SLOWLY.   
23. On the next day, use a spatula to break up the FuCl waste, retrieve the stir bar, and 
disposed of the waste in the aqueous waste container.   
24. Glassware can be cleaned with acetone and the base bath.  
Methylene Chloride (MeCl) Distillation 
Warning: Use nitrile or silver-shield gloves when handling MeCl. 
1. Wash and dry:  
1 x 1000 ml round-bottom flask, 1 x joint for thermometer, 1 x thermometer to fit 
joint (~40°C), 1 x large condenser, 1 x glass elbow, 1 x joint for desiccators,  
1 x glass stopper, 1 x glass funnel.   




3. Replace the 500 ml collection flask with a 100 ml round bottom flask to collect 
the first 30 ml of distillate. Clamp the apparatus to the scaffolding in the back of 
the fume hood.  
4. Vacuum grease and clamp all connections.   
5. Run cold, ice water UP the condenser tube using the circulation pump. This 
allows any bubbles to flow up and out of the condenser.  Make sure that the 
circulation pump is not actively heating the water by turning the temperature 
control all the way down to -20°C. 
6. Tie a KimWipe around the bottom of the condenser to catch external 
condensation.  
7. Use funnel to add 750 ml of MeCl and calcium hydride (CaH2, if needed) into the 
existing MeCl + CaH2 flask.   
8. Vacuum grease the MeCl flask, and connect the flask to apparatus.   
9. The MeCl + CaH2 flask already contains a stir bar.  Place the flask in heating 
mantle with magnetic stirring at ~4.   
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10. Insulate the flask and neck with glass wool all the way up to the condensing tube 
to promote boiling and prevent condensation.   
11. Set the transformer to 35 units.   
12. Vapor temperature should increase to ~40°C.   
13. Dispose of the first ~30 ml of distillate by turning the neck up, removing the 1st 
collection flask, and quickly replacing it with a clean 1000 ml round-bottom flask.  
14. When ~150-200 ml remains in the heated MeCl flask, turn off the transformer, 
remove the glass wool, turn the condenser off, and replace the heating mantle 
with a cork ring.  You should have ~500 ml MeCl distillate in your collection 
flask (need 340-380 ml for remaining steps).  
15. Vacuum grease the glass stopper, and stopper the MeCl distillate, and label it.   
16. Store the anhydrous MeCl distillate in the hood overnight.  Do not parafilm the 
stopper.   
17. Vacuum grease the original MeCl + CaH2 stopper, stopper the undistilled MeCl + 
CaH2, and store it in the back of the hood.   
18. Dispose of the MeCl waste in the chlorinated organic solvents waste container.   
19. Glassware can be dried in the hood, and then cleaned normally.  
Azeotropic Distillation of PEG 
Warning: Use nitrile or silver-shield gloves when handling toluene.  
1. Wash and dry:  
1 x 500 ml or 1000 ml round-bottom flask, 1 x Dean stalk, 1 x condenser,  
1 x glass stopper, 1 x Kontes #2  glass valve with LARGE hole,  
1 x egg-shaped stir bar, 1 x glass funnel, 1 x 250 ml glass graduated cylinder.   
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2. Set up the distillation apparatus as shown, without the PEG/toluene flask: 
 
3. Clamp the apparatus to the scaffolding in the back of the fume hood.  
4. Vacuum grease and clamp all connections.   
5. Run cold, ice water UP the condenser tube using the circulation pump. This 
allows any bubbles to flow up and out of the condenser.  Make sure that the 
circulation pump is not actively heating the water by turning the temperature 
control all the way down to -20°C. 
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6. Tie a KimWipe around the bottom of the condenser to catch external 
condensation.  
7. Weigh 50 g PEG 3.4K or 10K in the 500 ml round-bottom flask.  
8. Use the graduated cylinder and funnel to add 200 ml of toluene to the PEG in the 
500 ml flask.   
9. Add the stir bar to the flask, vacuum grease the flask, and connect the flask to 
apparatus.   
10. Place the flask in heating mantle with magnetic stirring at ~5.  The PEG will 
dissolve with stirring and heating.  
11. Insulate the flask and neck with glass wool all the way up to the condensing tube 
to promote boiling and prevent condensation.   
12. Set the transformer to 65 units.   
13. When the Dean stalk fills to 20 ml, dispose of the toluene by draining the solution 
from the Dean stalk into a 250 ml waste beaker. The first few batches of waste 
may be partially cloudy, while others should be clear.   
14. Repeat step 13 seven more times, removing 20 ml toluene at a time until ~160-
180 ml toluene has been removed.  
15. Turn off the transformer, remove the glass wool, turn the condenser off, and 
replace the heating mantle with a cork ring.  2-5 ml extra toluene waste may 
condense as you do this.   
16. Allow the distilled PEG and toluene to cool, and then vacuum grease the glass 
stopper and stopper the distilled PEG.  Parafilm the stopper, and label the flask.   
17. Store the distilled PEG in the hood overnight.  The PEG will solidify as it cools.   
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18. Dispose of the toluene waste in the nonchlorinated organic solvent waste 
container.   
19. Glassware can be dried in the hood, and cleaned normally.  
OPF Reaction 




PEG MW = 3,400 Da 
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50 g PEG = 0.01471 mol PEG 
1 PEG : 0.9 FuCl  10% molar excess for PEG addition to ends of FuCl 
(0.9 mol FuCl / mol PEG) * (0.01471 mol PEG) = 0.01324 mol FuCl 
FuCl MW = 153 g/mol 
(0.01324 mol) * (153 g/mol) = 2.025 g FuCl 
FuCl density = 1.415 g/ml 
(2.0235 g) / (1.415 g/ml) = 1.431 ml FuCl 
 
1 FuCl : 2 TEA  TEA removes Cl from ends of FuCl, 2 Cl per FuCl  Twice as much 
TEA as FuCl 
(2 mol TEA / mol FuCl) * (0.01324 mol FuCl) = 0.02648 mol TEA 
TEA MW = 101.2 g/mol 
(0.02648 mol) * (101.2 g/mol) = 2.6798 g TEA 
TEA density = 0.726 g/ml 
(2.6798 g) / ( 0.726 g/ml) = 3.6912 ml TEA 
 
10K Calculations: 
PEG MW = 10,000 Da 
50 g PEG = 0.005 mol PEG 
1 PEG : 0.9 FuCl  10% molar excess for PEG addition to ends of FuCl 
(0.9 mol FuCl / mol PEG) * (0.005 mol PEG) = 0.0045 mol FuCl 
FuCl MW = 153 g/mol 
(0.01324 mol) * (153 g/mol) = 0.6885 g FuCl 
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Density FuCl = 1.415 g/ml 
(0.6885 g) / (1.415 g/ml) = 0.4866 ml FuCl 
1 FuCl : 2 TEA  TEA removes Cl from ends of FuCl, 2 Cl per FuCl  Twice as much 
TEA as FuCl 
(2 mol TEA / mol FuCl) * (0.0045 mol FuCl) = 0.009 mol TEA 
TEA MW = 101.2 g/mol 
(0.009 mol) * (101.2 g/mol) = 0.9108 g TEA 
TEA density = 0.726 g/ml 
(0.9108 g) / ( 0.726 g/ml) = 1.2545 ml TEA 
 
1. Wash and dry:  
1 x 1000 ml 3-arm round-bottom flask, 2 x 60 ml dropping funnels,  
1 x joint for the N2 balloon, 1 x PTFE valve for the N2 balloon,  
2 x Kontes #2 glass valves with LARGE holes, 2 x glass stoppers, 
1 x 250 ml or 1000 ml glass graduated cylinder. 
2. Use the funnel and graduated cylinder to add 320 ml MeCl to the distilled 
PEG/toluene.  Dissolve PEG with stirring.   
3. Use the funnel to pour the PEG/MeCl into the 3-arm flask.  The PEG distillation 
stir bar can be reused in this step.   




5. Clamp the apparatus to the scaffolding in the back of the fume hood.  
6. Vacuum grease and clamp all connections.  Be careful not to vacuum grease over 
the holes in the valves, or else the FuCl and TEA will not flow through.  Also the 
PTFE valve for the N2 balloon does not require vacuum grease.   
7. Place the 3-arm flask in a small autoclave bin, filled with ice on a large stir plate.  
Optional: Add salt to the ice to keep the ice from melting.   
8. For PEG 3.4K, use glass pipettes to add 30 ml MeCl to volumes of FuCl and TEA 
calculated above (3.4K: 1.431 ml FuCl and 3.6912 ml TEA). Add MeCl to 
dropping funnels first, then FuCl and TEA.  MeCl removes the markings from 
glass pipettes, so exercise care when transferring MeCl.  
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9. For PEG 10K, use glass pipettes to add 10 ml MeCl to volumes of FuCl and TEA 
calculated above (10K: 0.4866 ml FuCl and 1.2545 ml TEA).  Add MeCl to 
dropping funnels first, then FuCl and TEA.  MeCl removes the markings from 
glass pipettes, so exercise care when transferring MeCl. 
10. Flush system with N2 gas, using the N2 tank and hose and the N2 filled balloon.  
Lift the glass stoppers from the dropping funnels slightly to purge excess air.  
Make sure the N2 valve remains open.   
11. Stir PEG solution on the stir plate at ~5.   
12. Start reaction by dropping the FuCl and TEA at the same rate of 1 drop per ~3-4 
seconds.  A slower drop rate will result in a more efficient reaction.   
13. Reaction will turn dark brown.   
14. When necessary, siphon melted water from the ice bin, and replace the ice.   
15. When dropping is complete, allow the reaction to continue on ice for the rest of 
the day.   
16. When necessary, siphon melted water from the ice bin, and replace the ice.   
17. At the end of the day, remove the ice bin, remove the dropping funnels, and 
replace the funnels with glass stoppers.   
18. Allow the reaction to continue at room temperature with stirring on a cork ring for 
at least 2 days.   
19. Check the N2 balloon over the next 2 days, and refill the balloon if necessary 
(close valve when refilling the balloon).   
20. Glassware can be dried in the hood, and cleaned with acetone and the base bath.  
Rotovaporing of MeCl 
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Warning: Use nitrile or silver-shield gloves when handling MeCl. 
1. Wash and dry:  
1 x 1000 ml round-bottom flask,  
1 x glass funnel.  
2. Turn on Rotovapor by switching Vacuum Controller V-800, Rotovapor R-200, 
and Vacuum V-500 on.   
3. Fill the water bath with distilled H2O, and heat to 40°C.   
4. Use the circulating pump to flow cold, ice water through the condensing tube.   
5. Use the funnel to pour the OPF solution into a 1000 ml round-bottom flask.   
6. Clamp and vacuum grease the flask to the Rotovapor.   
7. Lower the flask into the water bath, so the OPF solution and water levels are the 
same.   
8. Slowly rotate the flask in the water bath.   
9. Turn on the vacuum on at 850 mbar (“Set”  Up or down  “Run”).  
10. Gradually decrease the vacuum as necessary to maintain a steady drip of 
condensation into the collecting flask.  Vacuum can be decreased as low as 700 
mbar.   
11. When OPF/MeCl solution is thick and “stew-like” consistency, remove OPF from 
Rotovapor.   
12. Dispose of the MeCl waste in the chlorinated organic solvents waste container.   
13. Glassware can be dried in the hood, and cleaned normally.  
Wash in Ethyl Acetate 
Warning: Use nitrile or silver-shield gloves when handling ethyl acetate. 
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1. Wash and dry: 
2 x 2 L aspiration flasks, 1-2 x 2 L Erlenmeyer flasks, 1-2 x 2 L beakers,  
2 x Buchner funnels, 1-2 x glass funnels, 1 x stir bar, 2 x spatulas.  
2. Add ethyl acetate (EA) to the OPF solution until the flask is ~2/3 full.   
3. Stir the solution while heating with the heatgun (low speed, med heat) for 15-20 
min, rotating every 5 minutes.   
4. Solution will become less viscous and salts become visible at the surface.  Ethyl 
acetate is a solvent for the OPF, but not for the salts produced in the TEA 
reaction.   
5. Connect the vacuum and filter the solution through a Buchner funnel with #1 
Whatman filter paper (11 µm pores) into a 2 L aspiration flask.   
6. The salts will be filtered out of the solution by the filter paper.  Discard these 
salts.  
7. Add EA to the OPF to a total volume of 1500-1700 ml.   
8. Stopper the flask with a #9 rubber stopper and parafilm the stopper and aspiration 
neck, and place the flask into the -20°C explosion-proof freezer for at least 2 
hours or overnight if necessary.   
9. If necessary, clean glassware for the next step.  
10. After cooling, remove the OPF/EA from the freezer.  The decreased temperature 
alters the solubility of the OPF, causing the OPF to precipitate out.   
11. Connect the vacuum and filter the solution through a Buchner funnel with #1 
Whatman filter paper, capturing the OPF in the filter paper and pulling the EA 
into an aspiration flask.   
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12. While filtering, stir the solution, allowing the EA to be pulled through the filter 
paper.  Discard the EA.   
13. When nearly dry, transfer the OPF from the filter paper to a beaker.   
14. Add 1 L ethyl acetate to the solution.   
15. Stir the solution while heating with the heat gun to redissolve the OPF in the EA.  
Solution goes from light brown to dark brown and becomes less viscous.  
16. Use a clean glass funnel to transfer the OPF and EA to a 2 L Erlenmeyer flask and 
add EA to a total volume of 1500-1700 ml.   
17. Stopper the flask with a #10 rubber stopper, and recrystallize the OPF/EA 
solution in a 2 L aspiration flask at -20°C for 1.5 hours or overnight.   
18. Dispose of the EA waste in the nonchlorinated organic solvent waste container.   
19. After cooling, filter the solution through a clean Buchner funnel with #4 
Whatman filter paper (20-25 µm pores), capturing the OPF in the filter paper and 
pulling the EA into an aspiration flask.   
20. The second filtering step may proceed much more slowly than the first.  If 
EA/OPF is solid after removing from the freezer, add more EA to the solution.  
Tape 2 spatulas together to scoop product from the bottom of the flask.   
21. Dispose of the EA waste in the nonchlorinated organic solvent waste container.   
22. Optional: Repeat steps 13-19 for a third filtering step.  This may be necessary if 
OPF appears too dark.  
23. Dispose of the EA waste in the nonchlorinated organic solvent waste container.   
24. Glassware can be dried in the hood, and cleaned normally.  
Wash in Ethyl Ether 
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Warning: Use nitrile or silver-shield gloves when handling ethyl acetate and/or ethyl 
ether. 
1. Wash and dry: 
1 x 2 L beaker, 1 x stir bar, 1 x Buchner funnel, 2 x PTFE coated jars. 
2. When OPF is nearly dry and EA is mostly gone, add 1 L ethyl ether (EE) directly 
to the funnel to remove the EA. 
3. Once mostly dry, transfer the OPF from the funnel and filter paper to a 2 L 
beaker.   
4. Add 1 L ethyl ether (EE) to the OPF for a second wash with stirring.   
5. Filter the solution through a Buchner funnel with #4 Whatman filter paper (20-25 
µm pores), capturing the OPF in the filter paper and pulling the EE into an 
aspiration flask.   
6. Optional: Add EE to the OPF for a third wash.   
7. As the EE filters through and the OPF dries, use a spatula to break up any clumps 
of OPF.   
8. By the end, you should have a fine powder that is mostly dry.   
9. Scoop the OPF powder evenly into 2 Teflon-coated jars with the spatula.   
10. Leave the OPF in the hood overnight with the lid on loosely.   
11. Dispose of the EE waste in the nonchlorinated organic solvent waste container.   
12. Glassware can be dried in the hood, and cleaned normally.  
Vacuum Dry OPF 
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2. Tape aluminum foil to the top of the OPF jars and poke holes in the foil with a 
small gauge needle.   
3. Add liquid nitrogen to the solvent trap.   
4. Connect the vacuum to the solvent trap.  
5. Close the valves to the samples (3rd and 4th from the top).  Open the valve to the 
manometer (bottom).  
6. The top 2 valves are open to the atmosphere and should remain closed.   
7. Turn on manometer, and then the vacuum pump.   
8. Once a vacuum is established, gradually open the valves to the samples. Open the 
valve to the first sample until a vacuum is established, then close that valve.  Then 
open the valve to the second sample until a vacuum is established.  Now you can 
reopen the first sample.   
9. Pressure should be less than 10 mbar (preferably 1-2 mbar).  
10. Check the pressure and the liquid nitrogen level every 30-45 minutes.   
11. Refill the liquid nitrogen if necessary.   
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12. When OPF is dry and you cannot smell any EE in the powder, open the valve to 
break the vacuum and turn off the pump.   
13. Dispose of solvent from the solvent trap.   
14. Parafilm OPF and store it at -20°C.  
Verify Product 
1. A lighter brown color is preferred.   
2. Polymerize a 100% OPF hydrogel with thermal and photo-initiation to test 
crosslinking.  
3. Run GPC on the OPF in chloroform to verify molecular weight.   
 
C.2. PEG-DA Synthesis 
Reaction Calculations 
1) Begin with 24 g PEG, MW 3400. 
2) React with 100% excess acryloyl chloride (AcCl; 2 AcCl:1 PEG). 
24 g PEG / (3400 g/mol PEG) = 7.06 mmol PEG 
7.06 mmol PEG * 2 end groups * 2 (100% excess) = 28.24 mmol AcCl 
0.02824 mol AcCl * 90.51 g/mol / (1.114 g/mL) = 2.294 mL AcCl 
3) React with 1:1 AcCl:triethylamine (TEA) 
0.00706 mmol PEG * 2 end groups = 0.0141 mol TEA 
0.0141 mol TEA * 101.9 g/mol / (.726 g/mL) = 1.982 mL TEA 
4) Workup with anhydrous potassium carbonate (K2CO3) 
0.02824 mol AcCl * 2 mol K2CO3/mol AcCl / 2 M K2CO3 = 28.2 mL 2M K2CO3 (aq) 
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138.205 g/mol = 276.41 g in 1L = 27.641 g in 100 mL = 8.2923 g K2CO3 in 30 mL 
ddH2O 
Day 1 – Methylene Chloride Distillation 
Distill MeCl following the instructions in the OPF synthesis protocol. Keep in mind that 
you only need approximately 100 mL. Distillation is necessary to remove aqueous 
contamination (make MeCl anhydrous) that might generate unwanted side reactions in 
Day 2.  
 
Day 2 – Reaction 
What’s going on? PEG is being acrylated. TEA acts as a catalyst by sequestering HCl to 
allow the reaction to proceed to completion. MeCl is the solvent used for this reaction. 
 
Caution: AcCl doesn’t smell as bad as FuCl, but it is worse for you (eye, throat irritant)! 
 
1. Set up 3-arm round bottom flask in 
the fume hood on a stir plate. Weigh 
and add PEG to the flask. Add 
stirbar. 
2. Attach one dropping funnel, with a 
glass stopper, and a PTFE valve for 
N2 gas flow. Vacuum grease glass-
glass connections for the dropping funnel (excluding glass stopper) and the PTFE 
valve. Do not grease the PTFE valve itself. 
1
Equipment: 
1x 500 mL 3-arm round 
bottom flask 
1x dropping funnel 
1x PTFE gas valve 
3x glass stoppers 
1x glass stopcock 
1x PTFE stopcock 
 
1x stirbar 
1x glass funnel 




1x stir plate 
1x clamp 










3. Hook up N2 tubing to the valve. Continually purge the whole system as you add 40 
mL MeCl to the round bottom flask through the ungreased arm using a glass funnel. 
Stir. Gently float a glass stopper in the arm on the air being pushed out. 
4. When dissolved, use a glass pipette to add TEA. Vacuum grease a glass stopper and 
gently float the dropping funnel’s glass stopper as before. Let stir for 5 min. 
5. Use a glass pipette to add 20 mL MeCl and the appropriate amount of AcCl to the 
dropping funnel. Be aware that MeCl (and its fumes) will remove markings from 
glass pipettes. Vacuum grease and stopper the funnel while you are adding and turn 
off N2 flow. 
6. Remove the N2 hose and attach an N2 balloon. 
7. Drip the AcCl/MeCl mixture into the round bottom flask (about 1 drop every 3-4 
seconds). Drip AcCl in MeCl very slowly (about 1 drop every 4 seconds). 
8. After dripping is complete, you can replace the funnels with stopcocks. 
9. Let stir overnight. 
 
Day 3 – Workup 
What’s going on? To remove TEA-HCl, we first react the 
mixture with potassium carbonate to produce KCl, which 
will transfer to the aqueous phase. Some TEA will remain 
in the organic phase for Day 3 filtration. 
 
10. Use a glass funnel to transfer the mixture from the 
Equipment: 
1x 250 mL separatory 
funnel 
1x glass stopper 
1x glass funnel 
1x glass stopcock 






round bottom flask to a separatory funnel with a greased stopcock. (Don’t forget to 
close the stopcock prior to transfer. Also, remember to wipe vacuum grease from 
connections before pouring.) 
11. Add appropriate amount of 2M K2CO3 to the separatory funnel. 
12. Stopper funnel, hold vertically, and give it a quick shake or two. Immediately open 
the stopper to release CO2. Repeat a few times. 
13. Hold the separatory funnel horizontally, but with the tip tilted higher. One hand 
should hold the glass stopper, the other holding the stopcock knob up. Rotate 
vigorously, and open the stopcock periodically to release CO2. Repeat until all gas is 
released. Solution should have the consistency of a milky-white emulsion. 
14. Leave overnight. Place a beaker underneath to capture any leaked product. 
 
Day 4 – Filtration and Drying 
What’s going on? We isolate the mixture from KCl in the 
aqueous phase, add MgSO4 to remove any additional 
aqueous solution, and precipitate PEG-DA in ethyl ether. 
TEA should remain in solution. 
 
15. Drain the two organic phases into a 250 mL beaker on a 
stir plate with stir bar. 
16. While stirring, add MgSO4 until the mixture goes from a lumpy consistency to a well 
dispersed mixture of powder and organic solvent. It should appear as opaque milk – if 
it doesn’t look like milk, add more MgSO4. Add ~20-40 mL MeCl to keep the PEG-
DA in solution (may help to have a smaller bottle or beaker with MeCl). The goal 
Equipment: 
2x 250 mL beakers 
1x 1L aspiration beaker 
1x 2-3L beaker 
2x stir bars 
2x Buchner funnels 








here is to add as little MeCl as possible to keep the solution saturated with PEG-DA. 
But, if you add too much, no sweat. 
17. Prepare a Buchner funnel with aspiration flask and filter paper and pre-wet the filter 
paper with MeCl. 
18. Pour the mixture into the filter and a clear liquid should be collected (containing 
PEG-DA). If the liquid is cloudy, filtration should be performed again. The vacuum 
will also begin to evaporate MeCl. Thus, you can elect to evaporate MeCl if 
necessary. 
19. Prepare a 2L beaker with 1.7L ethyl ether and a stir bar. Pour in the PEG-DA solution 
and wait 10 min to precipitate PEG-DA. 
20. Prepare another Buchner funnel with two filter paper sheets, and pre-wet with ethyl 
ether. 
21. Filter to separate PEG-DA. If the filtrate is not clear, re-filter. Pound into bits. See an 
older grad student to measure your performance. 
22. Dry under vacuum until no ether can be smelled (at least 5 hours). At least some of 
this vacuum drying must be performed immediately after filtration. 
23. Store at -20ºC. Expected recovery is approximately 75%. 
 
Note: If necessary, you may need to dialyze the resulting product to remove impurities. 




C.3. Gel Permeation Chromatography 
Safety Precautions: 
You must be trained to use the GPC. See Peter for details. 
You must wear, at the very least, nitrile gloves. Double glove. Change whenever you 
get chloroform on your gloves. You can also wear silver shield gloves. 
 
Materials Needed 
Chloroform – Chloroform for HPLC; > 99.8%, ethanol as stabilizer Fisher/C606-4 
Main glass syringe – BD Multifit glass syringe, Luer-Lok; 2cc 
Needles – 18 gauge 
Filters – BD Puradisc 25mm PTFE 0.45µm filters  Fisher/14-823-10A 
Vials – 1.5 mL vials with septa    Fisher/03-391-9 (vials) 
        Fisher/03-391-32 (septa) 
Clean rinse/waste beakers 
 
Overview of GPC Setup 
• When not being used, pump is always set at 0.1 mL/min. 
• Samples are 5 mg/mL; injection volume 50 µL; run time 15 minutes; refractive index 
detector. 
• Flow rate during use is 1 mL/min. Maximum pressure is 500 psi, set to 450 psi via 
software. 




• Use 5 standards with molecular weights around your estimated range. 
• Sample concentration should be around 5 mg/mL. Final sample volume should be 1-2 
mL (5-10 mg). 300 µL is the absolute minimum. 
• Make sure you have enough chloroform in the supply bottle. 
• Record all requested information in the log book. 
 




1. If instruments are turned off, turn them on with the CBM module last. 
2. Purge the autosampler. If you just turned it on, get the large glass syringe and hook it 
up to the small loose tube at the bottom of the autosampler. Use the controls to turn 
the manual purge on and let the autosampler pump 5-10 mL into your syringe (you 
don’t need to pull). Dispose of the chloroform in a waste container in the hood. 
3. Create a folder on the Desktop to store your data. Each run must have its own folder. 
4. Click EZStart 7.4 on the Desktop. You should hear a machine beep indicating a 
successful CBM connection. If not, turn off all instruments and reboot the computer. 
5. Ramp up the flow rate to 1 mL/min over 10 minutes. 
a. Select File > Method > Ramp Up Revised.met 
b. Select Control > Single Run 
i. Sample ID: Blank 
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ii. Data file: Ramp Up 
iii. Data folder: Your data folder 
iv. Vial number: -1 (will not inject a vial) 
v. Injection volume: [not important; either 0 µL or 50 µL] 
c. Select Start. 
d. Pressure should gradually increase (~270 psi). Record the maximum pressure in 
the log book.  
e. At the end of the run, the flow rate should stay at 1 mL/min. 
f. If the oven is not on, turn it on (green light under “Oven” on CTO-20A) by 
pressing Oven. 
g. If the system beeps, and the UV detector screen complains of “Low Set Temp,” 
this is normal. Using the software, choose Control > Instrument Status, and 
click Clear Error. 
6. Load the standard method and save. 
a. Select File > Method > Open Standard Waters Method.met 
b. Select File > Method > Save As. Save the method in your own data folder with a 
unique name. 
c. Select Method > Instrument Setup… > Download Method. 
7. Balance the RID. 
a. Click Flow (Det. B) on the EZStart toolbar (second row). The image looks like a 
spigot, and the “R flow” light will appear on the RID. 
b. Wait 5 min and click Flow (Det. B) again to turn it off. 
c. Repeat a-b 5 times (~25 mins total). 
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d. Flow should be off before you continue. 
e. Click Balance (Det. B) and watch the RID-10A detector readout. The detector 
readout will go positive, negative and then suddenly zero. Repeat until Balance 
values are near zero. If you have to balance more than 3 times, see Peter. 
8. Click Zero (Det. A) and Zero (Det. B) to zero both detectors. 
9. It is suggested at this time that you start repeating blanks until the baseline stabilizes. 
Repeat step 4 with your method, monitoring the baseline drift until it stabilizes. You 
may need to balance or zero the detectors before you actually run your samples. 
a. Data file: Blank 1, Blank 2, etc. 
b. Vial number: 1 




1. Weigh out all your samples (5-10 mg). 
2. Fill your rinse beaker with around 100-200 mL chloroform. 
3. Rinse the 2 mL syringe 3x with chloroform, dumping used chloroform into the waste 
beaker. 
4. Add the appropriate amount of chloroform to all your samples. 
For each sample 
5. Pull up approx 1.5-2 mL of the dissolved solution. Deliberately withdraw air to 
prevent squirting. 
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6. Invert the syringe, remove the needle, attach a PTFE filter and push the filtered 
solution into an unused, labeled 1.5 mL vial. 
7. Remove filter, attach another needle, and rinse the syringe 3x with chloroform. 
8. Make a blank vial with filtered chloroform as the first vial in your sequence. 
9. After your last sample has been filtered, separate the two parts of the syringe for 
storage. Let syringe evaporate in the hood before storing. 
10. Load the autosampler tray with your samples. Make careful note of your loading 
sequence. 
Setting up samples 
1. Select File > Sequence > Sequence Wizard... 
a. Method: The one you just created (should be selected) 
b. Sample ID: Leave blank 
c. Data Path: Select your data folder 
d. Data File: Leave blank  
e. Number of unknown runs: Number of vials in the autosampler 
f. Check the “Create a line for each repetition” checkbox. 
2. Click Next. 
a. Unknown vials of sequence – Start: 1. Increment: 1. 
b. Autosampler injection volume: 50 µL 
3. Click Next twice to bypass the calibration and summary windows. 
4. Click Finish. 
5. A new “Sequence” window should be visible. For each vial, edit both the Sample ID 
and the File Name fields for each sample, labeling what is what. Tip: Name standards 
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like so: S009601 where 00960 is the molecular weight (Mp), and 1 is the repetition 
(see next step). Copy your sample ID over to the File Name field. 
6. For long runs, run the standards again at the end to look for drifting. You can do this 
by adding additional entries in the sequence. 
7. Add a few blank samples to the beginning. You can make the system repeatedly 
sample the first vial. 
8. Add a Ramp Down run: 
a. Method: C:\EZStart\Projects\Default\Method\Ramp Down.met 
b. Data file: Ramp Down.dat 
c. Vial: -1 
9. Similarly, add a Shutdown run: 
a. Method: C:\EZStart\Projects\Default\Method\Shutdown.met 
b. Data file: Shutdown.dat 
c. Vial: -1 
d. Run Type: Shutdown 
10. Save your sequence in your data folder by selecting File > Sequence > Save. 
11. Choose Control > Sequence Run. The sequence and method files should be already 
loaded. 
12. Click Start. 
13. While the sequence is running, you can change the viewing axes. Right click the 
window and choose Axis Setup. You can also drag and select a section of the 
chromatogram to look at. To zoom back to your original axes, just double click the 
window. 
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14. You can also simultaneously view previous data. To do so, right click the window 
and choose Add Multiple Traces. Select your files and click Add, then change each 
entry from SPD-20A to RID-10A. 
15. To stop the run suddenly, click the Stop button on the toolbar. 
16. If you need to run additional samples, you can create a new sequence file using the 
EZStart Offline program, add additional vials to the autosampler tray, and use Control 
> Sequence Run… to load your sequence. Clicking “Submit Priority” will implement 
your new sequence in the middle of the original sequence – after the currently 
running one, your new sequence will go, and then it’ll finish the first sequence 
afterwards. Pretty neato… 
Shutting down 
1. If you have data that you didn’t put in your own data folder, it will be in 
C:\EZStart\Projects\Default\Data. Move any relevant data inside there to your own 
folder. 
2. Make sure the oven is not active (press the Oven button if light is on). 




• You can only analyze one data file at a time.  
• Make sure to select RID-10A at the top of the screen or else you will be analyzing 
irrelevant data.  
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• Sometimes the software will look like it’s set to RID-10A when it’s not. Periodically 
flip between an SPD channel and the RID-10A channel if your clicking doesn’t look 
like it’s doing anything. 
1. Open EZStart Offline on the desktop. 
2. Open your method. 
3. Select the RID-10A channel (toolbar). 
4. Select Method > SEC Setup. Check the box to enable GPC/SEC Analysis. 
a. Make sure it is Narrow calibration, Linear curve fit, Time slice 1 sec. 
5. Load the standard curve. 
a. For each standard, open its data file. 
b. At the bottom of the screen, there are a number of buttons. Choose SEC Peaks. 
Select the beginning and end of the peak with the mouse, and click OK to enter 
that peak into the SEC Setup window. 
c. Repeat for each data file. 
d. Enter the molecular weights (Mp) into the SEC Setup window for each time point. 
e. Save the method. 
6. Process your standards. 
a. Open your sequence file. Save as a different sequence name e.g. “Sequence 2.” 
b. Delete all entries except for your standards. Save your sequence. 
c. Select Sequence Menu > Process. 
i. Make sure Print Method Reports is checked. 
ii. Click Start. 
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iii. Make sure your filenames are correct as they save (remove Z:\My 
Documents\ from the first file name). 
iv. Repeatedly click Save each time the dialog box comes up. 
7. Load the baseline and result range and analyze your data. 
a. Open each data file. 
b. Select the result range. 
i. Select SEC Result Range (from bottom toolbar) and click tightly around the 
entire peak.  
ii. Choose a baseline that is ± ~30 sec around your result range (your choice). 
iii. Click OK to enter the result range into the SEC window. You might want to 
check the RID-10A channel is properly selected. 
c. Select Analyze on the toolbar (blue button in the middle). 
d. Select the Print button > Reports > Method Custom Report. Give a 
meaningful file name. 
e. Repeat for each data file. Reuse/remove baselines/result ranges as necessary. 
8. Combine all the PDFs into one using your tool of choice. Mn and PI are what you are 
looking for, by the way. In Adobe Acrobat Professional: 
a. Select File > Create PDF > From Multiple Files 
b. Choose your files. 
c. Drag the files in order of the run. 




C.4: Acrl-PEG-NHS/MMP Peptide Conjugation 
Purpose: To attach PEG-acrylate to each end of an MMP-cleavable peptide. 
Materials: 
Plastic conical vial, 200-250 mL beaker, 2-3L beaker, stir plate 
Acrl-PEG-NHS (SVA) [MW: 3400 Da]; MMP cleavable peptide [MW: 769.86 Da 
GGGLGPAGGK] 
Dialysis tubing (3500-5000 Da MWCO; Spectrapor 131201/131204) and clips 
Preparation: 
1) Wash glassware and dialysis clips (Alconox, water, dH2O) 
2) Make a 50mM sodium bicarbonate buffer solution and pH to 8.5. For reacting 100 
mg peptide, this means 420 mg sodium bicarbonate in 100 mL ddH2O in the 200-
250 mL beaker. Shield your beaker from light. 
3) Calculate amounts of Acrl-PEG-NHS (2.2:1 moles of NHS to peptide) needed for 
cleavable peptide. For 100 mg peptide, you need 971.6 mg Acrl-PEG-SVA. 
Reaction: 
4) Dissolve the peptide in 20% of your buffer in a 15 or 50 mL conical (100 mg in 
20 mL). 
5) Dissolve the Acrl-PEG-NHS in the buffer that’s left in your beaker (971.6 mg in 
80 mL). The beaker should be shielded from light. 
6) Immediately add peptide solution to your beaker, stir (~6) and cover with 
parafilm. 
7) Allow to stir for 3-4 hours at room temperature. 
8) Prepare tubing for dialysis. Each (super-wide, 131204) strip should hold as much 
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solution as possible. 100 mg peptide = 100 mL buffer = 3-4 tubes usually. 
9) Rinse dialysis tubing 4x in a 2L beaker, 15 min between each rinse, to remove 
sodium azide. 
10) Close one end of each dialysis strip with a weighted closure. Due to potential 
leakage, fold over the tubing before sealing with the closure.  
11) Use a transfer pipette to add the solution to each tube. Close the open end of the 
tubing with a non-weighted closure and fold over the tubing before sealing, 
similar to step 10. 
12) Dialyze to remove byproducts for 2 overnights. If starting on the morning of the 
first day change the water the morning and night of the second day. Keep from 
light. 
Lyophilization: 
13) Transfer solution from tubes to vials, with approximately 12-13 mL per 
scintillation vial. 
14) Remove the caps from the scintillation vials and place aluminum foil over the 
tops and tape this foil down. Poke holes in the top of the foil with a needle to let 
air escape. 
15) Freeze vials in liquid nitrogen and lyophilize the product for 2 overnights. 
16) Combine all powder into one scintillation vial, preweighing the vial so that the 
mass of the product inside the vial can be determined. 




C.5: Cell Encapsulation 
Purpose:  Gels will be created with cells incorporated in them. 
Materials: 
Media (prepared day before) 
Sterile PBS 
15 and 50 mL conicals as needed 
3 and 10 mL syringes, with one 18G needle for each. 
1 mL syringe 
Sterile filters 
12-well plates 
Sterile containers for your gels (Teflon molds, or other molds) 
Spatulas, sterilized 
The day before your encapsulation 
1. Combine the polymers desired in a scintillation vial. You can freeze this vial 
down until the day of encapsulation.  Note: You will lose about 200-300 µL due 
to sterile filtration, so adjust accordingly by making a gel that requires 300 µL 
more than the PBS you would have added to your polymers. 
2. Sterilize Teflon molds and spatulas as required. Always a good idea to have extra. 
3. Make sure you have enough sterile filters and other items for your encapsulation. 
 
Day of encapsulation 
Polymer side 
4. Warm up your polymer powders, trypsin, and your media. 
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5. If doing a thermal encapsulation, create 0.3 M stock solutions of APS and 
TEMED in scintillation vials as you would normally. 
a. APS: 684.6 mg in 10 mL PBS 
b. TEMED: 0.348 g (~350 µL) in 10 mL PBS 
6. Add sterile PBS to each vial according to your calculations and vortex. 
7. Let the solutions sit at 37 °C for at least 30 min in order to remove bubbles. 
8. Filter sterilize APS and TEMED solutions (if you’re using them) into 15 mL 
tubes.  Make sure to cover the tubes with aluminum foil to prevent photoinitiation. 
a. Open the packaging of a syringe filter, but leave the filter in its container. 
b. Attach a needle to a 10 mL syringe, and draw up the contents of a 
scintillation vial. 
c. Invert the syringe and remove the needle. 
d. Grip the sides of the filter container, and screw the syringe onto the filter. 
e. Filter into an open 15 mL tube. 
9. Prepare the UV lamp and warm it up if you’re doing a photo encapsulation. 
10. Place sterile, autoclaved molds into petri dishes (one mold per dish). 
11. Filter sterilize your prepolymer mixtures. Tip: For a gel less than 1 mL, use a 3 
mL syringe, then after pulling up the gel, pull up additional air. The air helps with 
sterile filtering. 
12. Transfer the correct amount of gel to a separate 15 mL tube. 
13. Place your sterile spatulas. 
14. Prepare and label your 12-well plates. 
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Important note: At minimum, steps 4-11 must be completed before the actual 
encapsulation itself. 
Cell side 
15. Rinse your flasks twice with PBS, and trypsinize your flasks as normal. 
16. While you count your cells, spin down the cells in the centrifuge. Caution: 
Before you spin down the cells in this step, make sure steps 4-11 are done. 
17. Aspirate the media off the cells, then resuspend the pellet in sterile media, 
typically at a concentration of 50x106 cells/mL. 
• Amount of media to resuspend in µL = # of cells/desired concentration x 1000 
• e.g., with 10,000,000 cells total, then 10e6 / 50e6 x 1000 = resuspend my cell 
pellet in 200 µL of media. 
Crosslinking/encapsulation 
18. Add cell solution according to your calculations and quickly mix with the pipette 
(do not vortex). If the cell solution has a concentration of 50x106 cells/mL and 
you used the standard gel calculator, this will give a final solution of 10x106 
cells/mL. 
19. If doing a thermal encapsulation, add APS according to your calculations and mix 
with pipette. Then, add TEMED according to your calculations and mix with 
pipette. 
20. If doing a photo encapsulation, add sterile D2959 to your solution and mix with 
pipette. 
21. Deposit the appropriate amount of the resulting solution in your molds. The 
standard is 30 µL of gel in a 1.0-mm Teflon mold well. 
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22. Cover petri dish and place it in the incubator for 10 min for thermal 
polymerization; leave under lamp for photo polymerization. 
23. Aliquot 2 mL media into each well of a 12-well plate, depending on how many 
gels you have. 
24. Remove from the heat and carefully move the gels into the 12-well plate using a 
sterile spatula. Put the 12-well plate into the incubator. 
25. Repeat steps 17-26 as necessary with other polymer solutions. 
26. Recommended: Change media one hour after encapsulation. 
 
C.6. Tensile Culture System 
Introduction 
The tensile culture system allows you to culture 24 hydrogel constructs at a time. 
Separate platforms exist for purely static culture and dynamic tensile culture. Each 
construct is connected to two porous polyethylene “endblocks,” which are then pulled on 
by metal rakes connected to a linear actuator. A dedicated computer system, with a large 
control box and laptop with a serial port, is used to control the actuator movement and 
must be placed by the incubators for constant control. 
Components 
 Static strain and dynamic strain platforms 
 Static strain – adjust the distance of the rake by rotating the screw itself. 
 Dynamic strain – control via computer and STARTUP protocol sequence. 
 For cell culture, place dynamic strain platform on the bottom level of upper right 
incubator. The static system can go above it. 
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 Computer control modules 
 Laptop has a Dell power cord and a serial cable that connects to the control box. 
 Control box has a power cord and two cables that are connected to the dynamic 
strain platform. 
 Place both of these above the upper right incubator. 
 Acrylic platform covers and isolators 
 All these pieces can be sprayed with ethanol, but don’t autoclave them. 
 Static platform cover; no holes. Requires both trays to be installed to close 
properly. 
 Dynamic platform cover; one hole for the actuator and cables. 
 Dynamic platform temporary cover; two holes on both sides for the actuator as 
well as the second rake. Use when you’re done with the first rake and you’re 
working on the second one. 
 Tray isolator (2); place on trays when you want to keep them sterile. 
 Partial tray isolator; place on the portion of the tray under the rake when you want 
to work on the rake itself. 
 Construct wells or trays 
 All autoclavable, etc. 
 Static well trays (2); mostly opaque; rakes do not lock in as well as the trays are a 
little lower. 
 Dynamic well trays (2); white wells. 
 Rakes and mounts 
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 Keep at least two rakes attached to their mounts. Check holes are centered and 
aligned before you screw anything down. 
 Screws 
 Check whether the screws are stripped – both ways – before you use them in 
culture. 
 Autoclave a few at a time in a sterile package. 
 Long Allen hexagonal screws; used to screw in trays to their respective platforms, 
as well as rakes to their respective mounts. 




1. Set up the hood. 
2. Place dynamic system in the hood; the control box and computer go above the 
incubators. 
3. Hook up all cables, then turn all systems on. 
4. Make sure all indicators are indicating ready 
a. LinMot module has solid green READY light (blinks twice when system is 
not initiated) 
b. Reinshaw linear encoder is green (indicates sensor is properly obtaining a 
value) and detects reference point (turns red briefly) 
5. Make sure to lubricate all parts (rail and linear motor) before each run 
6. Open the Motion Perfect 2 software. 
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7. Open the terminal window (click terminal icon) and select terminal 0. 
Note: Do not screw rake into place before running the setup program. It involves the 
retraction of the linear motor all the way to the retract position which could break the tray, 
the rake, the motor or all three. 
Calibration 
1. Run STARTUP_1 
2. Use the following parameters: choose system 1 
Note: Offset value should be adjusted to optimize the rest position of the rake before each 
run.  
• Offset is ~4.2 for a 15.4mm gel (50:50, OPF-3k, 0.018M thermal, 75 wt%) 
Assembly 
You’ll need one or two grippy tweezers, and one of those long tweezers with a curve at 
the end. 
1. Screw each tray down, placing a tray cover on top. 
2. Remove the tray cover of the inner tensile tray (closest to the motor) and add 2 
mL media into each well. 
3. Place a hydrogel into each well. Once hydrogels have been placed in each well, 
move them onto the plastic peg of each well. Align them properly, then add ~1 
mL after they are in place. 
4. Place rake into place by carefully pressing each of the rods into the endblock 
holes. Screw down lightly to the motor actuator. 
5. If you want to check alignment and movement, run a quick INTERMITTENT 
program with 10 or 20 cycles, so you can see 
 170 
6. Cover the current setup with the temporary cover, then add media and hydrogels 
to the outer tensile tray. 
7. Cover the inner portion of the outer tensile tray with the partial tray cover.  
8. Place rake into place by carefully pressing each of the rods into the endblock 
holes. 
9. Screw rake onto the holding plate mount. (4 screws) 
10. Ensure that all trays are aligned and centered; small misalignments can translate 
into serious problems. If you need to check alignment and movement, run another 
INTERMITTENT program with 10 or 20 cycles. 
Running 
1. Run INTERMITTENT 
2. Choose system 1 
3. Choose amplitude 
a. Gels will be stretched 2x amplitude. For example, an amplitude of 3 stretches 
gels from 0 to 6 mm. 
4. Choose frequency 
5. Choose mode: intermittent, continuous, or number of cycles 
a. Intermittent 
b. Continuous 
c. Number of cycles 
When feeding, remove approximately 2 mL and replace with another 2 mL fresh media. 
Notes:  
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• Make sure to keep enough PBS or any media buffer filled in each of the wells of 
the system during each run. Failure to do so will result in drying out and 
premature breakage of the hydrogels. 
• Program always starts and ends at offset set by startup. 
a. An offset of 4.35 corresponds to 0% strain on a gel 15.61 mm long with 
9.5 mm endblocks. 
 
Important Commands: 
TO STOP IMMEDIATELY – vr(1) = 0 then ENTER. 
TO STOP SERVO only – servo1 = 0. 
TO restart servo – servo1 = 1. 
TIP: If in the case that the run command is stopped or the servo is stopped, the system 
can be reset by running a short cycle through INTERMITTENT. 
 
Some commands 
• mo(#): Relative move.  Moves rake by #.  Positive numbers indicate compression.  
Negative numbers indicate tension. 
• ma(#): Absolute move.  Moves rake to # on absolute scale.  Positive numbers 
indicate compression.  Negative numbers indicate tension. 
• Defpos(#): Define position.  Defines current position as # on absolute scale. 
 
C.7: Confocal Microscopy 
Notes 
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• You must be trained to use the confocal microscopes. Email 
steve.woodard@ibb.gatech.edu for the next training session. 
• There are three scopes that you can use: 
o LSM 510 UV, in room 1328. This is what we call “the old scope.” 
o LSM 510 NLO, in room 1326. This is what we call “the multi-photon” confocal 
microscope. 
o LSM 510 VIS, in room 1326. This is currently the preferred scope. 
• Make sure to reserve a spot on the confocal microscope up to one week in advance at 
http://www.ibb.gatech.edu. You will need to make an account there if you haven’t 
already. 
• These instructions are for the LSM 510 VIS. 
Materials Needed 
• Bring a box containing gloves and your samples. 
• When working with gels, bring additional equipment: 
o Attofluor cell chamber and round glass coverslips 
o PBS squirt bottle (“PBSi”, also known as PBS + ions) 
o Spatulas and tweezers as necessary, plus kimwipes for any spills. 
Setting Up 
1. Turn on the two switches to the left of the microscope – turn these on if needed, plus 
the computer. 
2. At the login screen, hit Enter to login (Administrator/[blank password]). 
3. Click on ZEN 2008, in the middle of the screen, and click Start System.  
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4. Adjust the workspace zoom using the slider on the upper right side of the screen. Use 
an existing preset or make your own, clicking the “open folder” or “save” icons to 
save or apply changes. 
5. Turn the first two lasers on (488 must go to “standby” first, 543 is simply on/off). No 
need for 633. 
6. Below the laser controls, open the Temenoff Lab setting. This is specially configured 
for Live/Dead imaging.  
7. At the top of the second column, note the current objective being used. 
a. On the LSM 510 VIS, there are 10x, 20x and 40x air objectives. 10x is the most 
commonly used. 20x and 40x objectives give better magnification, but have less 
light exposure (and thus produce less bright images as a result). 
b. Two objectives, 40x and 63x objectives are oil-based. 
i. Select the objective using the software and place one drop of oil on the 
objective. 
ii. Mount your sample and raise the objective until it just touches and oil spreads 
out. 
iii. When you are done, wipe off the oil with lens paper, not kimwipes. 
8. Note other settings for averaging images (usually 1, with more for 20x/40x 
objectives), the resolution of your images (preferred is 1024x1024), and make sure 
scan speed is set to “Max” (9). 
9. Note your physical controls. To the right of the microscope is an X-Y controller. 





1. Prepare a sample for viewing. 
a. If you’ve got a plate, just place the plate on top and you are all set. 
b. To prepare for viewing a gel, place a glass cover slip on the bottom piece of the 
cell chamber. Screw both pieces together and squirt some PBSi into the chamber 
to keep the gel hydrated. Then load your sample into the circular grooves on the 
microscope platform. 
2. Control your imaging using the Channels area in the 2nd column. 
a. Pinhole size refers to how much light is let through. Higher pinholes let through 
more light but will increase the amount of light captured in the Z-direction (that is, 
above and below your image). A preferred pinhole size is 1 AU (Airy unit, 
showing the lowest Z distance that will be captured). You can increase this if 
necessary. 
b. Detector Gain amplifies light received by the detector. Higher gain, brighter 
images, but also more noise. You should settle for a max of around 800 on both 
channels; sometimes you may even go below 700. 
c. Digital Offset eliminates light below a certain threshold. Use this to eliminate 
stray bright pixels. 
3. Click Fast on the upper left hand of the screen to begin continuously scanning. 
4. How to make images clear 
a. Something important is that imaging is highly subjective and depends on what 
you are looking for. Microscopy experts don’t like saturating images, but our lab 
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usually tends towards that. Use your experience and be consistent in how you 
image, and things’ll turn out fine. 
b. Set the offset and gain on each channel to near maximum. Lots of noise should fill 
the screen. 
c. To the left of the image, choose Split to separate the red and green signals. 
d. Scan to where you can find cells. This can be done by moving up and down 
(using the focus knob on the side) or by xy translation. Look at where the laser 
hits the gel to determine where you are. For Z location, check the Z Stack section 
(lower right, 2nd column) for your height. 
e. Below the image, there are colors indicating what is being shown. Click the colors 
below the “Merged” button to change the display to Range Indicator mode. Red 
mean oversaturation, blue means undersaturation, and black/gray is somewhere in 
between.  
f. For each channel, you can use the Detector Gain and Offset controls to change 
how things look. You want just a tiny amount of red, and any spots NOT of 
interest should be totally blue. Eliminate as much noise as possible without losing 
areas of interest. 
g. Exit Range Indicator mode and see how your images look. You may want to 
retweak as necessary.  
h. Your calibration should be good for the rest of your wells/gels. 
Taking Pictures 
1. Taking single pictures 
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a. Use Fast to assist as you scan for areas of interest. When you find one, click 
Single in the upper left, then save the current image. 
b. Images should be saved in D:\[your name] in .lsm format. 
2. Taking Z stacks 
a. The Z Stack section is below Channels. Check the box to the right of the title to 
activate it (without it, the Start button in the upper left will be grayed out). 
b. Use Fast to select your bottom image (if imaging whole gel, start with a 
completely black image) and click Set First. 
c. Use Fast to select your top image and click Set Last, then click Stop. 
d. Make sure Keep Interval is selected. This will keep the z slice size constant, even 
if you later decide to change the # of slices or the upper and lower limits in your 
stack. Typically the slice size in our lab is set to 10 µm. 
e. Click Start. A scan will automatically begin. To view the images as they are being 
generated, click Gallery to the left of the image. 
f. Don’t forget to save your Z stack (also in .lsm format). 
 
Saving Data 
Note: Do not expect your data to be backed up. It usually is, but there’s no guarantee. We 
make it easy for you to save your data to the Temenoff lab drive. 
1. Click Start > Run: \\zoe.bme.gatech.edu\temenoff-lab 
2. When it asks for a username and password, give it your BME credentials. 





a. Shut down the Argon laser (or put it on Standby if you know someone else will 
use it). 
b. Shut down the HeNe laser (or leave it on). 
2. If you need to shut down the system, give the lasers a few minutes to finish cooling 
(you should hear a noise stop in 2-3 minutes). Shut down the computer first, then flip 
both switches (the ones to the left of the scope) off. 
3. If working with gels, rinse out the cell chamber and throw away the glass cover slip 
in biohazard glass trash. Wash the cell chamber with soap and distilled water and 
leave the individual pieces on the rack in the cell culture room to dry. Do not use 
ethanol; it dries out the rubber O-ring. 
 
Working with Pictures 
1. The free LSM 510 Image Browser (downloadable from Zeiss) can be used to view 
images. Pretty much the only reason you’d really need to use it, other than viewing 
pictures and exporting them to various formats, is the Projection feature. 
a. Select your Z stack and open it. 
b. Select Projection. Rotate around the Y axis, and choose the most projection 
images (64/panorama) to generate to ensure a smooth 3D projection. 
c. The created projection can be slowed and manipulated, as well as stored along 
with the database. 
d. This can also be exported to a movie file. 
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2. You can also use the image browser to create your own databases with custom images. 
Use the Copy and Paste functions in the toolbar. 
3. You can also use the Zeiss ZEN LE software (essentially, ZEN without the 
microscope controls). 
4. You can also use ImageJ, especially if you’re not on Windows. 
Confocal microscope settings 
You can use the FITC/CY3 as an initial setting. 
Below the imaging buttons, check Z-Stack. 
Turn on the Argon and HeNe543 lasers. (Argon must go to standby first, and after a 
while you can set it to On. This is very important - don't forget to turn it off of Standby.) 
Imaging Setup 
Mode Switch track every 
Channel Mode Frame 
 
First channel name: Fluorescein 488-517 (FITC) 
Second channel name: Rhodamine 543-600 
Select the fluorescein channel. 
Light path: To the left of laser, select HFT 488/543. 
Above HFT 488/543, select NFT 545. 
To the right of NFT 545, select BP 505-530, and check Ch2. Select green for Ch2. 
Above NFT 545, select Plate. 
Next on the path, select LP 560. Check Ch1 and select Red. 
 




Objective Scan mode Frame size Line step Speed Averaging 
10x Frame Click X*Y 
1024 x 
1024 
1 Click Max 
9 
1 
Averaging isn’t important unless you want to fiddle around with how it averages images. 
Useful for poor visibility. 
Channels: Fluorescein 
Laser power Pinhole Gain Digital offset Digital gain 
3.0 1 AU 1100-1200 set; 
700-750 
operating 




Channels: Rhodamine  
Laser power Pinhole Gain Digital offset Digital gain 
35.0 1 AU 1100-1200 set; 
800 operating 




Z Stack: Rhodamine  
Interval Keep 
10 microns Interval 
  
Use "Set First" and "Set Last" to specify the beginning and end of a stack. 
Once all of this has been set up, click the Save icon near the Configuration name near the 
upper left corner, and save it under your own custom preferences. 
 
C.8: PicoGreen Assay 
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Pico Green Preparation v1.3 
Purpose:  The Pico Green assay quantifies the amount of DNA present which is an 
indirect measure of the number of cells. 
Materials: 




96 well plates 
For Gels 
1. Remove media. 
2. Add 2ml iPBS. 
3. Remove iPBS. 
4. Add 3-4ml iPBS 
5. Place in incubator for at least 30 min.  Leave in incubator until gels are no longer 
the color of the media and have become clear. 
6. Transfer the gels between pieces of weigh paper to remove excess water and 
weigh the gels.  Then put the gels in 1.5 ml eppendorf tubes. 
7. Homogenize the gels with a pellet grinder in the tubes.  Be careful not to loose 
any of the gel. 
8. When the gel is well ground add ddH2O to the tube depending on the size of the 
gel (750 µl for those cast in the caps).  Some of the ddH2O can be used to wash 
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the pellet grinder tip into the tube and to wash the side of the tube.  This will 
maximize the amount of gel that is available for the bioassay. 
9. Let sit at room temperature for 30 min. 
10. Store at -20 °C if needed. 
  
Lysing the cells 
11. Freeze the cells at -80 °C for a minimum of 1 hour. 
12. Thaw at room temperature for 30 minutes. 
13. Sonicate for 30 min. to lyse the cells. 
Note: The sonicator will heat up after each usage.  Ice should be added to the 
water in order to cool the sonicator down.  If this is not done the DNA in the 
sample could break down. 
Safety note: The sonicator is meant to lyse the cells.  Do not put fingers into the 
water bath while the sonicator is on or cells in your fingers will be lysed. 
 
14. Repeat steps 11-13 two additional times. 
15. If the samples are being stored before the assay is done freeze them at -80°C . 
 
For Plated Cells in a well plate 
1. Aspirate liquid from the wells of the plate 
2. Add 2 ml PBS to rinse. 
3. Repeat steps 1-2. 
4. Add 1 ml distilled, deionized water (ddH2O). 
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5. Let sit at room temperature for 30 min. 
6. Store at -20 °C if needed. 
Lysing the cells 
7. Freeze the cells at -80 °C for a minimum of 1 hour. 
8. Thaw at room temperature for 30 minutes. 
9. Sonicate for 30 min. to lyse the cells. 
Note:  The sonicator will heat up after each usage.  Ice should be added to the 
water in order to cool the sonicator down.  If this is not done the DNA in the 
sample could break down. 
Safety note: The sonicator is meant to lyse the cells.  Do not put fingers into the 
water bath while the sonicator is on or cells in your fingers will be lysed. 
 
10. Repeat steps 7-9 two additional times. 
 
Making the plates 
Standards 
11. Make sure to thaw out samples and PicoGreen reagents for about 20 minutes 
before doing the assay. 
12. Make up buffer solution and PicoGreen according to the PicoGreen calculator.  
Vortex both solutions to make sure they are mixed thoroughly. 
 Note: When creating the buffer solution make sure to take the volume in the DNA 
standards into account.  Also, cover the PicoGreen solution in aluminum foil to 
protect it from light. 
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13.   Make up DNA standards according to the table below. 




0.5 50 of 5 ug/ml 450
0.3 50 of 3 ug/ml 450
0.1 50 of 1 ug/ml 450
0.05 50 of 0.5 ug/ml 450
0.03 50 of 0.3 ug/ml 450
0.01 50 of 0.1 ug/ml 450
0 0 1000  
 
14. Add 43 µl of your sample solutions into the appropriate wells of a 96 well plate.  
Make sure to change tips between samples. 
15. Add 107 µl of the buffer solution into the wells. 
16. Add 150 of the PicoGreen Solution to the wells. 





Real-Time, Reverse Transcription Polymerase Chain Reaction (RT-PCR) Protocol 
RNA Extraction 
Extract RNA using Qiagen RNeasy Mini Kit  
(Consult the RNeasy kit manual for more specific protocols depending on your 
cell/tissue source) 
Materials 
Molecular BioProducts RNase Away Spray (VWR 17810-491; 475 ml) 
Aerosol Filter Pipette Tips for Rainin LTS, 20 µl (VWR 83009-688; pack of 960) 
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Aerosol Filter Pipette Tips for Rainin LTS, 200 µl (VWR 82003-196; pack of 960) 
Aerosol Filter Pipette Tips for Rainin LTS, 1000 µl (VWR 82003-198; pack of 576) 
QIAshredder (Qiagen 79654 or 79656; 50 or 250 runs) 
RNeasy Mini Kit (Qiagen 74104 or 74106; 50 or 250 runs) 
Optional Alternative: RNeasy Protect Mini Kit (Qiagen 74124 or 74126; 50 or 
250 runs) 
EMD 2-Mercaptoethanol (VWR EM-6010; 100 ml) 
RNAse-free DNase Set (Qiagen 79254; 50 runs) 
Protocol 
For plated cells 
I. Trypsinize cells and centrifuge (10 min, 1000 rpm). 
II. Aspirate supernatant, resuspend pellet in media, and centrifuge (10 min, 1000 
rpm). 
III. Aspirate supernatant, rinse pellet with PBS, and centrifuge again (10 min, 1000 
rpm), aspirate PBS. 
For gels 
I. Soak gels in PBS for ~ 1h to remove media. 
II. Transfer the gel to an RNase free, DNase free microcentrifuge tube. 
III. Break the gel into small pieces using a pellet grinder. 
1. Lyse cell pellet or cells in gel in 350 µl Buffer RLT with β-mercaptoethanol 
(add 10 µl BME per 1 ml Buffer RLT). 
2. Put solution in purple QIAshredder column and centrifuge (2 min, 14000 rpm). 
3. Discard filter and add 350 µl 70% ethanol to eluted substance.   
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4. Transfer suspension to pink RNeasy column and centrifuge (15 sec, 14000 rpm). 
5. Discard eluted substance and put filter back on.  (Do NOT mix Buffer RLT or 
RW1 with bleach when discarding.  Contact with acids forms highly reactive 
guanidine salts and liberates very toxic gas) 
6. Add 350 µl Buffer RW1 to column and centrifuge (15 sec, 14000 rpm).   
7. Discard eluted substance and put filter back on. 
8. Add 10 µl DNase I (lyophilized DNase I is resuspended in 550 µl RNase-free 
water) to 70 µl Buffer RDD for each sample. 
9. Add 80 µl of DNase/RDD solution directly onto RNeasy membrane and incubate 
at room temperature for 15 min. 
10. Add 350 µl Buffer RW1 to column and centrifuge (15 sec, 14000 rpm). 
11. Discard eluted substance and put filter back on. 
12. Add 500 µl Buffer RPE (add 44 ml of 96-100% ethanol to starting 11 ml of 
Buffer RPE concentrate before first time use) to column and centrifuge (15 sec, 
14000 rpm). 
13. Discard eluted substance and put filter back on. 
14. Add 500 µl Buffer RPE to column and centrifuge (2 min, 14000 rpm). 
15. Discard eluted substance and transfer column to new 2 ml collection tube. 
16. Centrifuge (1 min, 14000 rpm).   
17. Discard 2 ml collection tube, and transfer column to new 1.5 ml collection tube 
with cap. 
18. Add 30-50 µl RNase-free water and centrifuge (1 min, 14000 rpm). 
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19. The water elutes the RNA into the collection tube – cap the tube and store RNA at 
-80˚C. 
Quantify and check purity of RNA 
Materials 
MP Biomedicals RNase, DNase-free water (VWR IC821739; 500 ml) 
Corning UV Transparent 96-well plate (Fisher 07-200-623; pack of 25) 
Protocol 
1. In a UV-transparent 96-well plate, add 2 µl of extracted RNA and 98 µl RNase-
free water to 3 wells (dilution factor = 50). 
2. In 3 more wells, add 100 µl RNase-free water. 
3. Take absorbance readings at 260 nm and 280 nm light. 
4. Quantity of RNA can be calculated using the following equations: 
• Corrected A260 = average sample A260 – average blank A260 
• Concentation in µg/ml = (corrected A260) * (44 µg/ml) * (dilution factor) 
(using above protocol, dilution factor = 50) 
• Total mass in µg = (µg/ml concentration value) * (µl volume) / 1000 
(volume of RNA extraction sample; using above extraction protocol, volume 
= 30-50 µl) 
• Volume in µl needed for 1 µg RNA = (1 µg RNA) * 1000 / (µg/ml 
concentration value) 
(1 ng to 5 µg RNA can be used for Reverse Transcription) 
• Volume of water in µl needed  = 10 µl total volume – RNA volume 
determined above 
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5. Purity of RNA can be calculated using the following equation: 
• Purity = A260 / A280 
• This value should be between 1.5 and 1.9. 
Reverse Transcription 
Reverse Transcription with SuperScript III Reverse Transcriptase 
Materials 
Oligo(dT)15 Primer (Promega C1101; 20 µg) 
PCR Nucleotide Mix, 10 mM (Promega C1141; 200 µl) 
SuperScript III Reverse Transcriptase (Invitrogen 18080-093 or 18080-044; 2000 or 
10000 units) 
Invitrogen RNaseOUT RNase Inhibitor, 40 units/ml (Invitrogen 10777-019; 5000 
units) 
Protocol 
1. Add the following components to a nuclease-free PCR tube: 
• 1 ng to 5 µg total RNA: 10 µl 
• Oligo(dT)15 (500 µg/ml): 1 µl 
• dNTP Mix (10 mM each): 1 µl 
• RNase, DNase-free water: to 12 µl final volume 
2. Heat mixture to 65˚C for 5 min and chill on ice for at least 1 min. Collect the 
contents of the tube by brief centrifugation and add: 
• 5X First-Strand Buffer (250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl2): 
4 µl 
• 0.1 M DTT: 1 µl 
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• RNaseOUT (40 units/µl): 1 µl 
3. Mix contents of the tube gently.  Incubate at 42˚C for 2 min.  
4. Add 1 µl (200 units) of SuperScript III RT and mix by pipetting gently up and 
down.  
5. Incubate at 50˚C for 30-60 min. 
6. Inactivate the reaction by heating at 70˚C for 15 min. 
7. Store cDNA at -20˚C. 
8. Amplification of PCR targets (>1 kb) may require the removal of RNA 
complementary to the cDNA. To remove RNA complementary to the cDNA, add 
1 µl (2 units) of E. coli RNase H and incubate at 37˚C for 20 min. 
Primer Preparation 
Reconstitute primers (100 µM) 
Materials 
Custom Primers/Oligonucleotides, desalted (Invitrogen; 25 nmol) 
Protocol 
1. Find the total nmoles from the information sheet that came with the primer. 
2. The volume of DNase-free water needed to create a 100 µM stock can be 
calculated using the following equation:  
• Volume of DNase-free water in µl = (nmoles of primer) *1000 / (100 µM) 
Make 10 µM aliquots 
Protocol 
1. Briefly spin the primers and add the needed amount of water for a 10-fold dilution. 
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2. Make a 10-fold dilution (1 part primer: 9 parts DNase-free water) to obtain a 10 
µM aliquot. 
Polymerase Chain Reaction 
Run PCR 
Materials 
SYBR Green Master Mix (Applied Biosystems 4309155; 5 ml) 
Applied Biosystems StepOnePlus Real-Time PCR System and Materials 
• MicroAmp Fast 96-Well Reaction Plates, 0.1 ml (Applied Biosystems 
4346906; 20 plates) 
• MicroAmp Optical Adhesive Films (Applied Biosystems 4360954; 25 films) 
OR  
• MicroAmp Fast 8-Tube Strips, 0.1 ml (Applied Biosystems 4358293; 125 
strips) 
• MicroAmp Optical 8-Cap Strips (Applied Biosystems 4323032; 300 strips) 
• MicroAmp 96-Well Trays for Veriflex Blocks (Applied Biosystems 4379983; 
10 trays) 
Protocol 
1. Thaw the following components on ice: 
• SYBR Green mix 
• 10 µM forward primer of interest 
• 10 µM reverse primer of interest 
• Sample cDNA 
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2. To make Master Mix, count the number of wells needed for each primer, add 2, 
and multiply this number by the following to obtain enough Master Mix for all 
wells of the primer: 
• 12.5 µl SYBR Green mix 
• 10.5 µl DNase-free water 
• 0.5 µl 10 µM forward primer 
• 0.5 µl 10 µM reverse primer 
3. Load PCR wells: 
• Load 24 µl of Master Mix into each well for that primer (target sequence of 
interest). 
• Add 1 µl of sample cDNA into the well with Master Mix and mix by 
pipetting up and down.  
(change pipette tips between each well) 
4. After all wells are loaded, cover with optical tape or caps, and put entire plate on 
ice until ready to run PCR.  
5. Load plate into StepOnePlus system: 
• Load plate into machine (A1 in upper-left, H12 in lower-right). 
• Open “StepOne Software v2.0” program.  
• Click “Advanced Setup” button.  
• Under “Experiment Properties,” enter an Experiment Name, select 
“StepOnePlus Instrument (96 Wells)” for the instrument, select “Quantitation 
– Comparative CT (ΔΔCT)” for the experiment, select “SYBR Green Reagents” 
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for the reagent (melt curve is optional), and select “Standard” for the ramp 
speed.   
• Under “Plate Setup,” add your targets and samples under “Define Targets and 
Samples,” changing the Reporter to “SYBR” and the Quencher to “None.”  
Under “Assign Targets and Samples,” assign the appropriate targets and 
samples to each well, selecting your control sample as the reference sample, 
GAPDH as the endogenous control, and “ROX” as the “dye to use as a 
passive reference.”   
• Under “Run Method,” change the reaction volume to 25 µl and set the method 
to the following: 
- Hold at 95˚C for 10 min (100% ramp). 
- Cycle 40 times at 95˚C for 15 sec and 60˚C for 1 min, collecting data 
at 60˚C.  
- Optional melt curve: 95˚C for 15 sec, 60˚C for 1 min, and +0.3˚C 
ramp, ending at 95˚C for 15 sec and collecting data during the +0.3˚C 
ramp.   
• Save the file.   
(Templates can be saved to reduce setup time.) 
• Select “Start Run.”   
• After the run, click “Analyze” (settings can be modified under “Analysis 
Settings”) and resave the file.   
• Export results to Excel by clicking “Export…” and export “Results” as “One 
File” with “.xls” file type.   
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C.10: PCR Analysis 
 
Most of this tutorial is taken shamefully from: 
Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, and 
Moorman AFM. Amplification efficiency: linking baseline and bias in the analysis of 
quantitative PCR data. Nucleic Acids Res. 2009 Apr;37(6):e45. 
 
Introduction 
Let’s review the basics of PCR amplification and detection. We start with a few basic 
equations: 
!! = !!!!   ! = !!!!!!    !! =
!!
!!! 
where N = concentration of amplicon, E is the efficiency of the PCR reaction (where 1 
means no amplification, and 2 is 100% amplification), and C is a cycle threshold of 














assuming the concentrations of the two genes are the same (given, say, a fluorescence 
threshold). If you then make the next assumption that the efficiencies are the same (say, 
100%), then 
!common
!!,GAPDH!!!,collagen I = !common
! !!,collagen I!!!,GAPDH ≈ 2!∆!! 
To compare to day 1, we write 
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!!,collagen I, day 7
!!,collagen I, day 1
= !common
! !!,collagen I, day 7!!!,GAPDH, day 7
!common
! !!,collagen I, day 1!!!,GAPDH, day 1
≈ 2
!∆!!,day 7
2!∆!!,day 1 = 2
! ∆!!,day 7!∆!!,day 1
= 2!∆∆!! 
 
These calculations are contingent on a few assumptions: 
• Baseline fluorescence is something that can be eliminated. 
• Efficiency is common (and perhaps, also, that it’s 100%) among different genes, 
primer sets, etc. 
• Cycle to cycle efficiency does not vary throughout amplification. 
 
Typical PCR analysis errors 
If there is baseline fluorescence in your sample, you will introduce error into your 
estimation of efficiency: 
!!∗ = baseline+ !!!!   !∗ = baseline!!!!!baseline!!!  


















which for even a 5% difference in efficiency can be 1.05!"!!" = 1.05!" = 7.03 times 
different. 
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What LinRegPCR does 
 Estimates individual well baseline by reconstructing the log-linear portion of the 
amplification curve: 
 Discards any samples where low amplification is detected. 
 Calculates the second derivative maximum (SDM) to find the plateau. 
 Subtracts baseline, then fits both the upper and bottom portions of log-linear 
region. 
 When the lower and upper sections’ slopes match, the baseline has been found. 
 Calculates individual PCR efficiencies for every well 
 Calculates mean efficiency and starting amount (N0) for a given amplicon. 
 Mean efficiencies are adequate for calculating fold regulation values 
 Differences are more a result of statistical error than true differences in 
efficiency. 
 What about running multiple plates for the same gene? 
 Individual efficiencies can vary significantly 
 
How to use LinRegPCR 
1) Process your data in StepOne first. 
a) Do a quick quality control check on your samples and remove samples that didn’t 
amplify well, that have a high standard deviation, etc. 
b) Disable the auto baseline feature in StepOne for each target. 
c) Export the data to Excel – check Sample Setup and Amplification Data. 
2) Open the spreadsheet and then open LinRegPCR. 
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Note: LinRegPCR will not work correctly unless Excel is opened beforehand. 
3) In LinRegPCR: 
a) Read in your data. 
i) Check the drop-down boxes to make sure Amplification Data is selected. 
ii) Select Step-One Plus (ABI) and DNA binding dye (SYBR Green). 
iii) Select columns A through D, rows 8 through 3848 (that is, a 40-cycle run. A 
50-cycle run would go to row 4808.) 
iv) Make sure ss cDNA is checked, and select No for “Data are baseline-
corrected.” 
b) Click the red button labeled determine baselines. 
c) Check each sample to examine efficiencies and tweak if necessary. 
d) If necessary, use the Amplicon Groups tab to set amplicon groups. The boxes 
there can help you auto-select amplicon groups quickly for each gene. 
e) Set the log(fluorescence) value on the left. 
i) Note: Make sure to keep this consistent between all plates with the same gene. 
ii) Note: In StepOne, the threshold fluorescence is usually less than 1, which is 
why the log(fluorescence) value in LinRegPCR is negative. 
f) Save this data to Excel. 
4) Back in Excel: 
a) Use the sample setup tab to help re-label your samples and rearrange your data to 
your liking. You may want to pick up some Excel-fu to summarize and put all of 
your wells together, do any extra quality control, etc. 
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i) Note: Remember to use geometric means when averaging data. (Taking the 
geometric mean is the same as taking the arithmetic mean of the cycle 
thresholds.) 
b) To calculate fold regulation, use the starting concentration of your gene, or N0. 
The value of N0 has already been calculated by LinRegPCR using the mean 
efficiency for the amplicon group. 
i) If many of your wells did not use the mean efficiency to be calculated, it may 
be a good idea to calculate a new N0 based on each individual well’s PCR 
efficiency. 
ii) You can do this using the equation !!∗ = fluorescence threshold valueEff!! . 
c) Calculate a manual ∆∆ method; that is, divide a sample’s gene’s N0 by the 
sample’s GAPDH N0 value, then divide by the geometric mean of your day 1 
sample. 
d) Perform statistical analysis on the divided-by-GAPDH values. 
 
C.11: Immunohistochemistry 
Rules to remember: 
• Do not let your sample dry out. This will encourage non-specific binding (and 
staining) from anything floating around in the air, etc. If you need to stop, make 
sure samples are wet or otherwise sitting in PBS. 
• Store samples at -80°C prior to staining to maintain maximum antigenicity. 
• Rinsing with PBS can be done using a slide rack. Place slides into the stain rack, 
then gently lower into the stain holder with PBS. After two minutes, raise and 
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lower the rack gently, then remove the rack completely. Do this twice, discarding 
PBS between washes. You’ll need ~1000-1200 mL PBS for 12 slides if you use 




a) Warm up slides at room temperature for 30-60 minutes. 
b) Lightly fix in ice cold acetone for 10 minutes. Place a stain holder containing 
acetone into an ice bucket, then lower the slide rack inside. 
c) Let slides air dry for 30 minutes, then do a PBS wash. Change acetone between 
slide racks if you’re doing more than 12 slides at a time. 
2) Preparation (while slides dry) 
a) 1% BSA solution (Get BSA frozen from histology room; make 1 g BSA / 100 mL 
PBS; store at 4°C) 
b) Serum from species of secondary Ab (goat, horse, or rabbit; get from histology 
room) 
c) Make a humidified chamber using a 150 mm petri dish with a wet paper towel in 
the bottom, plus 4-5 small petri dishes with water inside. Each chamber can hold 
4 or 5 slides. 
3) Peroxidase Blocking 
a) Use a slide rack/stain holder to immerse slides in 0.3% peroxide/methanol 
solution (1 mL 30% H2O2 in 100 mL methanol; store in foil < 1 week at 4°C) for 
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10 minutes at room temperature. You can reuse the peroxide/methanol solution 
between racks. 
b) At this point, samples should be completely free of OCT and other trash. Circle 
each sample with a PAP pen to isolate future liquids to the sample, then PBS 
wash. 
4) Serum Blocking 
a) Normal Serum Block Solution (60 µL/sample, mix in 10 mL and store at 4°C):  
i) 1% BSA solution in PBS (stabilizer) – 9.7 mL 
ii) 2% serum (blocking) – 200 µL 
iii) 0.1% Triton X-100 (penetration enhancer) – 100 µL 
b) Incubate sections for 20 min in blocking solution – serum should be same species 
as secondary antibody. Tap the slide on a kimwipe to remove the solution. Don’t 
do a PBS wash afterwards. 
5) Primary Antibody 
a) Prepare the working dilution of the primary antibody in 1% BSA. If using an 
antibody for the first time, you’ll need to run a series of dilutions to determine the 
optimal working concentration).  With our antibodies, 1:10, 1:100, 1:500, 1:1000 
is a good start. 
b) Use a 10 µL pipette to carefully apply 8 µL primary antibody to each sample. 





6) Secondary Antibody 
a) Remove slides from the humidified chamber and PBS wash. 
b) Incubate sections in 1:20 goat biotin conjugated secondary antibody in PBS for 30 
minutes at room temperature, then PBS wash. 
7) Signal Amplification 
a) Solution: Vectastain ABC Elite Standard kit 
i) 5 mL PBS + 2 drops of solution A + 2 drops of solution B, added into the 
provided bottle.  
ii) Allow solution to sit for 30 min before use. 
b) Drop solution onto slides. Incubate for 30 min, then PBS wash. 
8) Chromagen/Substrate Stain 
a) Immediately after rinsing, make the peroxidase substrate solution using 1 mL 
substrate buffer and 20 µL chromogen. There should be no delay between making 
the solution and adding it to your slides. 
b) Allow color to develop for 5-10 minutes (you will need to experiment with this 
time).  
c) Immediately rinse with PBS twice. All DAB waste should be added into a 
separate waste container and brought to the histology room for disposal. 
9) Cover slip 
a) The slide should be wet from the PBS wash you just did. Place a drop of 
FluoroGel with Tris buffer on each of your samples within a PAP pen circle. 
FluoroGel should mix with the water already on the slide. 
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b) Place additional FluoroGel (can use two drops; may use more if desired) outside 
of the PAP pen circles. 
c) Tilt the bottom edge of the cover slip against the bottom edge of the slide. Tilt the 
slide as necessary so the cover slip catches a consistent edge of liquid along the 
bottom, then gently lower the top edge so the liquid rides over the PAP pen circles 
and catches the entire surface of the slide. 
d) Allow slides to dry overnight. You can view them on a microscope sooner than 
that (a few hours after coverslipping), but sometimes liquid will leak from a slide 
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